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Development of Novel Phenanthroline and Thiazole Orange Derived G-quadruplex
Ligands and Telomerase Inhibitors.

Abstract

by Siwen Wang
University of the Pacific
2018

The end of the human chromosome is protected by telomeres which contain a
special tandem guanine-rich DNA sequence, 5’-TTAGGG. The length of telomeres is
shortened during cell replications, and its length limits the replication capacity of cells.
Telomerase is over-expressed in 85–90% of cancer cells, responsible for extending the
telomere length in cancer cells. Guanine-rich DNA sequence can self-assemble into
unique G-quadruplex structures that interfere with the extension of telomeres by
telomerase. Therefore, DNA G-quadruplex has recently received much attention because
of its important regulatory functions in telomerase-mediated cancerization. The formation
of G-quadruplex requires monovalent cations (Na+ and K+) or small molecules known as
G-quadruplex ligands. In the present work, we developed a serial of G-quadruplex
ligands by tethering side-chains to two core structures: 1,10-phenanthroline (Phen) and
thiazole orange (TO). Biophysical studies including DNA thermal denaturation monitored
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by fluorescence orcircular dichroism, fluorometric titration, and ESI-MS spectrometry
reveal that the binding of the synthesized ligands to G-quadruplex is side-chain
dependent. The arylsulfanyl side chains significantly improve the binding affinity and
selectivity of 1,10-phenanthroline towards G-quadruplex over duplex DNA. The
polyamine side chains are a suitable structural motif for remarkable G-quadruplex
binding affinity based on the results from both Phen and TO derivatives. These ligands
greatly inhibit the telomerase activity in vitro, determined by a modified telomeric repeat
amplification protocol (TRAP) assay. Amongst these promising telomerase inhibitors, a
thiazole orange derivative containing a side chain of spermine shows an outstanding
telomerase inhibition effect at nanomolar concentrations, which is comparable to the
most effective synthetic telomerase inhibitors, BRACO-19.
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Chapter 1. Introduction to DNA

1.1. DNA Basics
1.1.1. Central dogma. DNA occupies an essential position in the biological
system, which is described by Francis Crick using the central dogma of molecular
biology (Figure 1-1. solid and dotted arrows).1 This scheme implies the general flows of
genetic information, which is transcribed from DNA into RNA and ultimately translated
into protein.

Figure 1-1. The Central dogma of molecular biology.2
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Genetic characteristics are stored in DNA as linear codes composed of nucleotide
monomers in the chromosome. During self-replication process, DNA polymerase is
employed to synthesize daughter sequences by adding nucleotides that are
complementary to the DNA template. This process yields identical copies of the DNA
which are passed down into descendent cells after cell division. High fidelity of DNA
self-replication is the basis of biological inheritance. Transcription and translation are
spatially and temporally separated in eukaryotic cells. Transcription occurs in the
nucleus, and one of the DNA strands (non-coding strand with anticodon) is used as a
template to produce mRNA by RNA polymerase. The pre-mRNA is processed to produce
the mature mRNA, which is transported into the cytoplasm. Because of the absence of the
nucleus, prokaryotic cells immediately translate their transcripts while the mRNA is still
being synthesized. In the translation process, mRNA is decoded in ribosome by inducing
the binding of complementary tRNA anticodon sequences to mRNA codons. The tRNA
carries specific amino acids that are coupled together into a polypeptide. The polypeptide
later folds into an active protein and performs its functions.
Other than above general genetic information flows (solid arrows in Figure 1-1),
Crick also included several special routes (dotted arrows in Figure 1-1) in the original
central dogma. The discovery of reverse transcriptase in some retroviruses proved that
RNA could make modifications to DNA.3 Telomerase is another case that RNA is used as
a template to synthesize DNA which plays an important role in cell aging and cancer
development.4 Most viruses have RNA genomes that are replicated and transcribed by
RNA polymerases which provides another special case in which RNA could be
synthesized from an RNA template.5 The direct synthesis of protein from DNA templates
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has not been discovered so far in vivo, but has been observed under certain suitable
conditions in vitro.6
After decades of studies, an additional genetic flow is characterized which was
unknown when the original central dogma was conjured. The recent studies of the
behaviors of prions illustrated an information feedback flow from protein to the genome
(dashed arrow in Figure 1-1). As a part of the epigenetic process, environmental stress
resistant phenotype was coded into DNA to become genotype through protein
conformational changes. This observation has been found to be intrinsically stochastic,
nevertheless, important in evolution because of the look-ahead effect.7-8
Above all, the seven general and specific genetic information flows constitute the
comprehensive central dogma which captures the upstream role of DNA in molecular
biology.
1.1.2. The history of DNA discovery. DNA was first discovered by Friedrich
Miescher in 1868, who was dedicated to identifying the fundamental components of cells.
In his experiments, Miescher isolated an unknown substance from leukocytes and sperm
which was distinct from protein and lipid: It was resistant to protease, containing
phosphorous but not sulphur, and it could be stained by alkali dyes. This molecule was
named as nuclein because of its abundance in nuclei. It was also presumed by Miescher
that nuclein might have a role in the passing of hereditary traits because it was rich in
sperm cells. However, what could not be rationalized, at that time, is that how the same
substance could result in the diversity of different animal species.9
In the 1880s, Albrecht Kossel (awarded the Nobel Prize in 1910) and Richard
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Altmann developed new protocols that permitted them to isolate pure nucleic acids and
enabled them to analyze its detailed chemical compositions. Kossel identified the
fundamental building blocks of nuclein—the purine and pyrimidine bases, sugar, and
phosphoric acid in 1901 and altered the designation "nuclein" to "nucleic acid".10 DNA
and RNA were named as "thymus nucleic acid" and "yeast nucleic acid" after their
isolation sources.
Protein but not nucleic acid was considered as the chemical basis for heritable
transformations until 1943 proved by Oswald T. Avery. In his exquisite experiments, it
was found that inert Streptococcus pneumoniae can only be transformed into lethal
strains in the presence of DNA but not protein or carbohydrate. Avery stated that
“Deoxyribonucleic acid plays a central role in determining specific characteristics in the
course of reproduction".11 This discovery excited further research into the nature of DNA,
including X-ray diffraction studies of its structure.
Almost a decade passed before, in 1952, Rosalind Franklin photographed
crystallized DNA fibers. She calculated the dimensions of the strands and also deduced
that the phosphates were on the outside of what was probably a seemly helical structure.12
In 1953, using the available X-ray data and model building, Francis Crick and James
Watson (awarded the Nobel Prize in 1962) deciphered the double helical structure of
DNA. They illustrated that DNA was comprised of paired sequences of complementary
bases and, by the order of its bases, encodes the genes.13
In the following years, the machinery of DNA self-replication, tRNA and mRNA
were discovered.14-15 In 1964, Marshall Nirenberg (awarded the Nobel Prize in 1968) first
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deciphered the bases in each codon which are used in protein synthesis.16 In 1977,
Frederick Sanger (awarded the Nobel Prize in 1958 and 1980) developed rapid DNA
sequencing techniques which dramatically advanced the gene mapping.17 In the next
decades, gene started to be isolated and specific genes were found to be associated with
diseases including Huntington's disease, breast and ovarian cancer.18-19
In 1988, the National Research Council announced a program to map the human
genome. The Human Genome Project was officially started in 1990 and completed in
2003.20-21 Availability of genetic information in an enlarged scale makes understanding of
genetic basis of complex human traits become practical.
Throughout today, the understanding of DNA has been continuously developed.
There have also been breakthroughs in the molecular biology and medical fields in which
not only DNA, but also DNA-associated processes have become the targets for
therapeutic applications.
1.2. DNA Structures and Functions
1.2.1. DNA structure basics. The functions of a molecule in the biological
process are driven by its structures including covalent bonding and three-dimensional
conformations. DNA is a polymer composed of four types of nucleotides linked by
phosphodiester bonds in a specific order. DNA primary structure commonly refers to the
linear nucleotides sequence, which is the most basic covalent construction of the
molecule.
The monomer of a nucleic acid sequence, which is a nucleotide, consists of three
components: nucleobase, sugar, and phosphate. Based on their chemical structures,
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nucleobases are classified into purines (Adenine and Guanine) and pyrimidines
(Cytosine, Thymine, and Uracil). A, G, C, and T are the four nucleobases that form a
conventional DNA sequence and U is only present in RNA (Figure 1-2). It is logically
hypothesized that DNA is originated from RNA in the course of evolution, in which, U is
methylated to T. One of the main reasons for this modification is to identify and repair the
deamination of cytosine into uracil in DNA, which is a common spontaneous reaction.
By utilizing T instead of U, in DNA, these deaminated C (U) can be differentiated from
native T and repaired by corresponding enzymes to avoid any further lethal mutations.22
In addition to these conventional nucleobases, there are some minor modified
nucleobases, such as 7-methylguanine, Inosine, and 5-methylcytosine playing important
roles in epigenetic genomes (Figure 1-2).

Figure 1-2. The structures of nucleobases present in human genome.

The nucleobase is connected to a pentose sugar which brings another significantly
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different feature between DNA and RNA: β-D-ribofuranose for RNA and β-D-2'deoxyribofuranose for DNA. The 2'-OH in an RNA ribose can readily attack the
phosphodiester bond and lead to strand breaks. Hence, ribose is replaced by deoxyribose
in the process of evolution, which makes DNA more stable than RNA. The nucleobase is
anchored to the C1' position of the sugar by a β-N-glycosidic bond at the N9 of purine
and N1 of pyrimidine. The torsional angle of the C'1-N-glycosidic bond can adopt two
possible orientations (anti or syn), which are shown in Figure 1-3.

Figure 1-3. The two conformations of N-glycosidic bonds.

The sugar ring is not planar, and the sugar pucker is described as the relative
positions of C2' and C3' atoms with respect to the C1'-O4'-C4' plane. The sugar can adopt
either C2'-endo or C'3-endo conformation (Figure 1-4). The conformational features of
base torsional angle and sugar pucker significantly contribute to the stability of different
DNA secondary and tertiary structures.
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Figure 1-4. Conformations of deoxyribose sugar pucker.

A phosphate group forms two ester bonds to connect the 5'-OH and 3'-OH of the
adjacent sugars. The DNA backbone is constituted by these repetitive linking units of
sugar-phosphate-sugar (Figure 1-5). The terminals of 5'-OH and 3'-OH endow a
polynucleotide directionality.

Figure 1-5. An example of the primary structure of DNA.
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The linear sequence of DNA is the foundation of genetic information coding. This
unique design of DNA primary structure makes compact information storage practical in
the biological system. In order to carry out its other functions, including reading and
replicating genetic information, DNA employs base pairings to form a duplex.
1.2.2. DNA duplex. DNA adopts double strands (duplex) under most
circumstances in living cells, with two strands progressing in opposite directions. When
replication or transcription occurs, two strands are separated in certain regions, and the
resulted single strands have to be stabilized by particular proteins.
In 1953, James D. Watson and Francis H.C. Crick proposed a three-dimensional,
right-handed double helical B-DNA model based on their analysis of a DNA fiber
diffraction data. In this famous model, the bases from two single strands form specific
base pairs through hydrogen bonds and form rungs of a DNA ladder.13 With this basepairing rule, one DNA strand is able to define the complementary one which enables it to
replicate and transcribe. Figure 1-6 shows a detailed view of the Watson-Crick base pair.
Hydrogen bonds form between the aligned donors (oxygen or nitrogen bonded to
hydrogen) and the acceptors (oxygen or nitrogen). The G-C and A-T base paring system
is used because it maximizes the number of hydrogen bonds and minimizes the torsional
strains in the backbone.23
Since the phosphate groups are densely negatively-charged, the DNA backbone is
very polar. To stabilize the structure, DNA adopts a conformation in which the polar
phosphate backbones helically coil and shield the hydrophobic nucleobases inside. Thus,
the charge distribution can be optimized to reduce the repulsion. Meanwhile, the bases
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can be well stacked on each other, so the aromatic stacking force will greatly contribute
to the double helix stabilization. The negative charges on the phosphate backbones are
very important for DNA stabilities, protecting the ester linkage from being attacked by
exogenous and endogenous nucleophiles.

Figure 1-6. Watson-Crick base pairing.

When the two strands are coiled into a double helix, the phosphates form two
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ridges, and the two edges of the base pairs form two grooves back to back (Figure 1-7).
The edge composed of the C1' from two sugars, the N3 of purine, and the C2 of
pyrimidine is located in the minor groove, while the other edge is located in the major
groove (Figure 1-6). The features of the grooves vary in depth and width depending on
the types of the helix.

Figure 1-7 DNA double helix and two grooves.

More than one type of helix can be formed by DNA double strands (Figure 1-8),
and their features are summarized in Table 1-1. B-form DNA helix is the predominant
conformation under physiological conditions and was firstly characterized by Watson and
Crick. B-form DNA adopts a right-handed (twisting direction follows the right-hand rule)
helix with the C'2-endo sugar pucker and anti-N-glycosidic bonds. The minor groove is
narrow in B-form DNA while the major groove wide, with nearly the same depth (Figure
1-8).24 These two grooves create distinguishable microenvironments for protein and small
molecule recognition.
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Under different environmental conditions, such as ionic strength, temperature,
humidity, and nucleotide composition, DNA can adopt several distinct helical
conformations.25 Two of the most well studied: A- and Z-form DNA helix, will be
discussed here.
With relatively low hydration and low ionic strength, B-form DNA will transform
into A-form. RNA-DNA hybrid and RNA double strands can also adopt A-form helical
conformation.26-27 A-form DNA has the C3'-endo sugar pucker and tilted base-pairing
which make it distinct from B-form. From the top view of an A-form helix, a large cavity
can be observed located at the center because the coils are displaced away from the
axis.28 As a result of the above features, the major groove in A-form DNA is narrow, and
the minor groove is shallow and wide (Figure 1-8).

Figure 1-8. Three DNA helices.
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Z-form DNA is usually observed in continuous pyrimidine-purine sequences in
highly concentrated NaCl solutions in vitro ((CG)n in 3-4 M NaCl). It is utilized as a
rotor in DNA origami because it adopts a left-handed helix.29 Z-form DNA has more base
pairs in every helical turn and is longer than the other conformations. The major groove
in Z-form DNA is wide and shallow, and the minor groove is deep. Because of the
torsional conformation, the sugar pucker and N-glycosidic bond conformation in a Zform DNA keep changing alternatively along the sequence.
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Table 1-1. Summary and comparison of double-helical DNA structure parameters.
Properties

A-DNA

B-DNA

Z-DNA

Helix sense

Right-handed

Right-handed

Left-handed

Helix diameter

26Å

20Å

18 Å

Repeating unit

1bp

1bp

2bp

Base pair/turn

10.7

10

12

Degrees of
inclination of base
pair from normal
to the helical axis

19

-1

-9

Rise per base pair

2.3 Å

3.3-3.4 Å

3.8 Å

Pitch per helical
turn

24.6

33.2

Glycosyl ring
conformation

C3'-endo

O1'-endo to C2'endo

45.6
C: C2'-endo
G: C2'-exo C1'exo C3'-endo

Glycosyl angle
conformation

Anti

Anti

Anti at cytosine,
Syn at guanine

Major groove

Narrow and deep

Minor groove

Wide and shallow

Wide and deep
Narrow and
deep

Flattened
Narrow and deep

1.2.3. DNA triplex. The conventional DNA helix is based upon Watson-Crick
base pairs (G-C and A-T), which are the most thermodynamically stable base-pairing.30
However, several alternative base pairs have been discovered with important roles in
DNA higher order structures and functions. One of them was Hoogsteen base-pairing,
named after the scientist who first characterized it.31 In Hoogsteen base pairs, the N7 of
purines can accept hydrogens and form additional hydrogen bonds. The N3 of cytosine
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can also be protonated under acidic conditions to become a hydrogen bond donor (Figure
1-9). The formation of Hoogsteen base pairs constructs several alternative DNA
structures including triplexes and G-quadruplexes.

Figure 1-9. Hoogsteen base pairs in DNA triplexes.

The three-stranded polynucleotide was first observed by using X-ray diffraction in
1957 by Felsenfeld, in which, a synthetic third strand poly(U) binds into the major groove
of a poly(U)/poly(A) duplex.32 Two common triplets are A-T(U)-T(U) or G-C-C+ and C
needs to be protonated in the latter under acidic conditions. In general, a triplex is formed

41
when a pyrimidine base binds onto the Hoogsteen position of an existing Watson-Crick
base pair (Figure 1-10).

Figure 1-10. DNA triplex.

The Triplex Forming Oligonucleotide (TFO) sequence specifically occupies the
major groove of a DNA duplex, which is also the binding site of most proteins and small
molecules; therefore, the binding event could significantly affect the DNA replication and
transcription process. Because of this, the formation of DNA triple has attracted many
interests for potential applications in site-specific gene therapy. Since the formation of a
triplet G-C-C+ requires an unusual acidic condition, the A-T(U)-T(U) motif becomes the
more suitable choice for genome therapy applications.
TFOs have been successfully used for site-directed mutagenesis.33-34 However,
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there are many difficulties in the triplex-forming strategy in clinical applications. For
instance, sufficiently long polypurine sequences, which are critical for the binding of
TFO, is rarely present in human genome. In addition, delivery of exogenous
polynucleotides into cells is always problematic because of the cellular uptake and
biological stability.35
1.2.4. DNA G-quadruplex. The basics of G-quadruplex structures. In addition
to triplex DNA, DNA G-quadruplex (G4) is another alternative structure that can be
formed through Hoogsteen hydrogen bonds. The self-assembly of guanines was first
proposed by Gellert et al. in 1962 using X-ray diffraction from a concentrated GMP
(guanosine monophosphate) solution, and guanine-rich sequences later was found in
telomeric DNA and many gene promotor regions.36 Figure 1-11 shows the top view of a
G-quartet, in which, four guanines self-assemble via Hoogsteen hydrogen bonds (N1-O6
and N2-N7). The planar G-quartets stack on top of each other with a torsional angle,
forming a four-stranded helical structure. Naturally, G-quadruplex was proved to be
stabilized by monovalent cations such as K+ and Na+ sitting at the center of the Gquartets. The important factors that contribute to the G-quadruplex formation are
discussed here.
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Figure 1-11. The top view of a DNA G-quartet (left) and a sketch of a G-quadruplex
(right).

Hydrogen bonding of G-quadruplex. There are six electronegative atoms present
in a guanine, and four of them are open to hydrogen bond formation except for the N9
(used in the N-glycosidic bond) and N3 (too close to the backbone). In canonical WatsonCrick base pairs, the O6 (carbonyl oxygen) accepts hydrogen from the N4 of cytosine,
while the N1 and N2 donate hydrogens to the N3 and O6 of cytosine. Noticeably, guanine
is also able to accept hydrogen bonding with its N7 on the other side. When the
hydrogens from the N1 and N2 (Watson-Crick side) are accepted by the O6 and N7
(Hoogsteen side) of an adjacent guanine, Hoogsteen hydrogen bonds can form.37 The two
sides of a guanine are shown in Figure 1-12. With four guanines, a cyclic planar structure
can be constructed (Figure 1-11). It should be emphasized that the hydrogen bonds
between guanines are not the most crucial factors in G-quadruplex stability, because the
strand distortion greatly reduces the hydrogen bonding strength.38 G-quadruplex can be
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formed even with less hydrogen bonds when guanine is substituted by other derivatives,
while cation residing in the center channel is inevitable.39

Figure 1-12. Hoogsteen side and Watson-Crick side for guanine hydrogen bonding.

Metal cation and guanine charge-charge interactions. In the absence of cations,
G-quadruplex does not form unless specific stabilizing ligands are present. The central
cavity of the G-quartet produces a space that a cation with a suitable size can fit in. The
lone pair electrons of four O6 are coordinated by the cation to reduce the charge
repulsion. Na+ with an ionic radius of 0.95 Å is reported as the maximum size of a cation
that can fit into the G-quartets. Larger cation such as K+, with a radius 1.33 Å, therefore,
is observed sitting between the two quartets and coordinated by eight oxygens (Figure
1-13).38 Other cations such as NH4+, Rb+, Ti+ and even some divalent cations such as
Sr2+, Ba2+, and Pb2+ were also reported stabilizing G-quadruplex to some extent.40-44
Cations also affect the G-quadruplex polymorphism. It was reported that G-rich
sequences adopted different conformations in the presence of Na+, K+ and other cations.
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For instance, a telomeric repeat sequence (GGGTTA)3GGG forms a parallel Gquadruplex in K+ solution and mixed parallel-antiparallel conformation in the presence of
Na+.45-47 Because of this feature, G-quadruplex is also developed as a highly sensitive
tool to detect alkali metal ions.30, 48

Figure 1-13. G-quadruplexes with coordinated cations. (A) A parallel G-quadruplex with
Na+ ions, (B) A parallel G-quadruplex with K+ ions.38

Base stacking force of G-quadruplex. Like other canonical nucleic acid
structures, the nucleobase π– π stacking is crucial to the formation of G-quadruplex.
Individual G-quadruplex can stack on the others even without covalent bond linkage.36, 4950

Three common stacking geometries found in the G-quadruplex unit are shown in

Figure 1-14.51 The orientation of G-quadruplex forming strands, and the glycosidic bond
angle are the major factors affecting the stacking mode.
Besides the above factors, G-quadruplex is also stabilized by super helical stress,
molecular crowding, as well as particular G-quadruplex binding proteins and small
molecules,52 which will be discussed in Chapter 2.
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Figure 1-14. Illustrative examples of base stacking mode in G-quadruplexes.51

Topology of G-quadruplex. G-quadruplex can be formed through one, two or four
G-rich strands. Each G-rich strand has specific direction defined by sugar-phosphate
backbone from 5'-3'. The segment between G-tracts will form loops hanging outside the
unit. Therefore, G-quadruplex can adopt various topologies, as the consequence of a wide
variety of possible combinations of strand directions and loop sequences. The general
structure can be described as a central unit of at least two stacked G-quartets, in which
the G-rich sections are connected by loops of intervening nucleotides that are not
involved in the quartets.
According to their strand directions, the polymorphic G-quadruplexes are
classified into parallel and antiparallel structures.53 When four G-rich strands are all in
the same direction in a G-quadruplex unit, it is termed as a parallel G-quadruplex (Figure
1-15A). Obviously, there is no need for a loop if it is formed by four disconnected
sequences. If at least two of these adjacent G-strands are from the same sequence in
parallel G-quadruplex, there will be loops left outside the unit connecting the top and
bottom quartets. This type of connecting sequence (Figure 1-15B) is referred as a
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propeller loop which is found in both telomeric and non-telomeric G-quadruplex.50, 54
Guanine glycosidic bonds in parallel quadruplexes all adopt the anti-conformation
(Figure 1-16A).

Figure 1-15. Various topologies for G-quadruplexes.

When at least one of the four strands adopt the different direction from the others,
an antiparallel or mix-antiparallel G-quadruplex is formed (Figure 1-15C). Two distinct
types of loops, in addition to the propeller loop, are discovered in antiparallel Gquadruplexes. When two antiparallel strands from the same sequence are adjacent to each
other, a lateral loop connects them (Figure 1-15D). When the antiparallel sequences are
located in diagonally, a diagonal loop connects them crossing of the G-tetrads (Figure
1-15E).50, 55-56 Antiparallel G-quadruplexes were found in both telomeric and non-
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telomeric G-quadruplexes.57-59 Antiparallel G-quadruplexes require both anti- and synguanine glycosidic bonds to maintain the particular conformation (Figure 1-16B).

Figure 1-16. Glycosidic bonds conformations in various G-quadruplex topologies. Synguanines are shown in yellow and anti-guanines are in grey.

Four grooves are formed in a G-quadruplex structure defined by the
phosphodiester backbones and the features are depending on the particular topology. A Gquadruplex with only lateral and diagonal loops has relatively simple groove features,
while propeller loops in a parallel G-quadruplex may insert into the groove generating
more complex features.
As mentioned in the previous section, alkali cations stabilize G-quadruplex in the
center channel of the G-quartets and consequently neutralize the negative charges from
the O6 of guanine. K+ and Na+ induce different topologies in some of G-quadruplexes,
but not necessary for all of them.47, 60
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Biological relevance of G-quadruplex. By using sequencing methods, Gquadruplex was found extensively present in the genome frequently coupled with
important regulating functions such as telomere length maintenance and oncogene
expression.
More than 300,000 potential G-quadruplex forming sequences were discovered
across the genome, by searching using a universal G-quadruplex forming motif
represented by d(G3+N1–7G3+N1–7G3+N1–7G3+).61 Many of them are highly conserved in
both prokaryotic and eukaryotic organisms. These conserved regions are mostly present
in mammalian species, followed by non-mammalian, and lower organisms. This
observation indicates that the natural selection pressure tends to maintain G-quadruplex
functions in the evolution process.62
Most of the potential G-quadruplex formation sequences were found in telomeric
regions where up to 15,000 bps of repeated TTAGGG units were discovered.63 The Gquadruplex formation and stabilization in telomeric regions are crucial in regulation of
telomere length maintenance and chromosome end protection.
G-quadruplexes are also located in many oncogene promoter regions, such as
MYC, JUNB, FGF4, and TERT, and regulate their transcriptions. Figure 1-17 shows a
scheme of this regulation process. In a normal transcription process, an RNA polymerase
binds onto the non-coding strand (with anticodons) of the DNA, and the generated RNA
will have the same sequence as the coding strand (with codons). When G-quadruplex is
present in the non-coding strand (S region), polymerase binding and the downstream
RNA transcription are stopped at this position. Meanwhile, an unusual G-loop will be
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induced on the complementary coding strand. RNA can be generated from this loop and
form a stable co-transcription RNA/DNA hybrid. Consequentially, a strand exchange
(recombination) can be introduced, which significantly changes the genetic
information.63-65
Because of its crucial functions in the biological process, a range of G4-targeting
ligands have been synthesized in order to regulate the telomere stability and oncogene
expression. It was reported that the expression of c-MYC in cancer cell lines was downregulated to 20% with a 48h G4 ligand TMPyP4 treatment in vivo.66 (Design of G4
ligands will be extensively discussed in Chapter 2.)

Figure 1-17. Structures formed upon replication and transcription of regions containing
G-quadruplex motifs.

It has been noticed that G-quadruplex can be both stabilized and destabilized in
order to regulate the related biological process. During the replication and transcription,
DNA single strands are exposed and may spontaneously form unnecessary G-
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quadruplexes. In most cases, G-quadruplex helicases (including BLM, WRN, FANCJ,
and others) are employed to recognize and unwind these structures to maintain genetic
stability.67-69 Deficiency of these enzymes leads to certain genetic diseases.70
Telomere and the DNA end replication problem. Telomeres have the highest Gquadruplex formation sequence abundance not only in the human genome but also other
organisms.63 They are located at the end of chromosomes and protect them against
genome instability.71 The functions and features of telomeres will be discussed in the
following topics:
Structure of telomeres. Human telomeres are composed of 9-15 kb doublestranded TTAGGG repeats (different from TTGGGG in lower organisms) ending in a 50300 nt long 3' single-stranded repeats, termed as G-overhang, whose complementary Crich sequence is digested by a 5'-3' exonuclease.72 By folding back to the double strand
region, the G-overhang at the end of a telomere can form a "T-loop" (Figure 1-18).
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Figure 1-18. The structures of telomeres and telomeric sheltering complexes.

Functions of telomeres maintaining chromosome stability. Exposed DNA strand
ends (both blunt and sticky ends) are very lethal to cells and are considered as damaged
sites because they tend to fuse randomly. Therefore, a range of enzymes that detect,
remove and repair the damage sites are utilized to protect the DNA. The ends of
chromosomes, which are natural strand terminals, have to be protected from both the end
fusion and being recognized by damage seeking enzymes. Therefore, telomeres are
employed to form stable higher order structures and cap the end of chromosomes.
As discussed before, the repetitive G-rich sequence in telomeres can form Gquadruplex which will bring challenges for DNA recognition by enzymes and selfreplication. To stabilize these higher order structures, protect the telomeres from enzyme
attacks, and also enable its replications, a complex containing six individual proteins is
evolved (Figure 1-18). In this telomeric sheltering complex, TRF 1 and 2 are bound to
double strands and POT 1 to G-overhangs which are bridged by TPP1 and TIN2. These
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binding motifs play important roles in the telomere replication regulation, chromosome
end protection, and telomere length maintaining.73-75
Telomeres are crucial to the chromosome protection; however, they are truncated
after each single replication because of the end replication problem:
End replication problem. In 1960s, Leonard Hayflick discovered that normal
human cells have limited capacity of cell division which is termed as 'Hayflick limit'. A
decade later, Alexey M. Olovnikov firstly proposed the DNA end replication problem and
gave the hypothesis of the resolutions which was later confirmed by the discoveries of
telomeres and telomerase.76-77
End replication problem comes from the natural features of DNA self-replication
machinery. With a template, DNA polymerase replicates DNA only in 5' to 3' direction,
starting from a free 3'-OH of existing DNA or RNA fragments (Figure 1-19). As
discussed earlier, a DNA double helix has two single strands that proceed in two
directions. DNA replication is semi-conservative in which the two strands have to be
separated and replicated as the templates, respectively (in a zipper-like replication fork).
DNA polymerase can only synthesize daughter DNA in 5' to 3' starting from a small piece
of RNA primer that attached to the parent DNA. This process starts in 3'-5' parent strand
(leading strand) and can proceed smoothly. However, on the other strand (lagging strand),
which is in 5'-3', replication has to be performed by small discontinuous pieces starting
from RNA primers. All the RNA primers will be removed after synthesis and the gaps
will be filled by a DNA ligase. The leading strand can be replicated to the extreme end,
but not the lagging strand. The RNA primer removed from the 5' end of the lagging
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strand will leave a gap without available 3'-OH group. In consequence, there is always an
un-replicated piece left on the 5' end of the daughter sequence and the DNA gets shorter
and shorter during replications.
Telomeres protect chromosomes by being buffer regions at the end. G-overhangs
of telomeres are shortened during the replications, and the length is considered as a mark
of DNA age. In somatic cells that without any telomere length maintenance pathway, a
loss of 100-200 bp happens in one cell division. Therefore, these cells can only undergo
certain times of telomere replications before they start to lose the protection functions.

Figure 1-19. An illustration of DNA end replication problem.
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In yeast, short telomeres, derived from the end replication problem, directly lead
to cell senescence.78 Mice with short telomeres were found with shorter life-span and
fertility defections.79 In human, Dyskeratosis Congenita (DC) and Idiopathic Pulmonary
Fibrosis (IPF) have been proved related to irregularly short telomeres.80-81 Even though
short telomeres can lead to critical cell damages, human aging is still a complicated
process that cannot be simply explained by telomere shortening as a single factor. Age
limitation is a consequence of accumulated effects from many contributors including
telomere length, oxidative stress, and DNA mutation damages.
Telomerase. Since telomeres are progressively truncated and losing the protection
functions during cell replications, certain strategies have to be utilized to maintain the
telomere length by those 'immortal' cells, such as stem cells, germline cells, and cancer
cells. Telomerase, a reverse transcriptase, is found overexpressed in these cells. It
maintains telomere length by adding TTAGGG repeats onto the telomeric G-overhangs
using its RNA element as the template.82 Telomerase was first isolated in 1984 by
Elizabeth Blackburn from Tetrahymena pyriformis and later was reported to be found in
most human cancer cell lines and nearly absent in normal somatic cells.77
Telomerase structures and functions. Telomerase is a complex with RNAdependent DNA polymerase activities (reverse transcriptase). The minimal requirement
for telomerase activity in vitro is having two subunits: the RNA template (hTERC) and
the catalytic enzyme (hTERT) (Figure 1-20).83-84
TERC, the RNA component of a telomerase, is used as the template for telomere
extension. Human TERC (hTERC) is produced by RNA polymerase II and consists of
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451 nucleotides, in which, nucleotides 46-53 are used as the true template of DNA
synthesis. The minimum segment of an RNA template for telomerase activity contains
nucleotides 10-159. The other domains form higher order structures to bind onto TERT
but have no contribution to DNA synthesis.85 A particular secondary structure of TERC is
highly conserved across a variety of mammalians (Figure 1-20).4, 82
TERT, the catalytic component of the telomerase, contains a reverse transcriptase
motif located at the C-terminus that is highly conserved across species including human,
mice, yeast, worm and even plant. A telomerase-specific T motif is located next to the
reverse transcript region and a large N-terminal region containing other functional
domains is present at the other end.86-89
The detailed step by step process of telomerase activity is still unclear so far.
Generally, telomerase functions in a complex process including binding, synthesizing and
relocating. Many telomerase-associated proteins such as Hsp90, p23, and TEP1 are
involved in to regulate the activity.90

57

Figure 1-20. Telomerase components.91

Telomerase functions and cancer. The activity of telomerase is strictly regulated
in normal somatic cells and appears at an extremely low level during most of the time and
only kept active in some particular tissues including germline cells, stem cells, and some
lymphocytes.92-93 The presence of high-level telomerase activity is consistent with the
requirement of high proliferation capacities of the listed cells. Dysfunctions of telomerase
or its related proteins in these cells lead to certain human genome diseases.
Studies showed that introduction of active hTERT into normal somatic cells can
help them bypass telomere shortening problem. These cells are enabled to unlimited
capacity of replications to some extent, but cannot differentiate and functionalize in
tissues, which is a remarkable feature of cancer cells.94-96 It is proposed that, when
telomeres become too short, very rare telomerase-positive cells (1 in 10,000,000) can
help themselves overcome the apoptosis machinery and become immortalized. This
provides a possible explanation of cell cancerization, which is supported by the
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observations that tumor cells have short telomere length compared to normal cells and
show no net loss of telomere in cell divisions.97
Today, nearly 90% of different types of tumors have been proved to have irregular
telomerase activity compared to normal tissues. J.W. Shay and S. Bacchetti did a
comprehensive survey on nearly all major types of cancer cells (Table 1-2).93 The striking
connection between cancer and telomerase makes anti-telomerase a promising clinical
therapeutic strategy.
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Table 1-2. Telomerase activity detected in different type of cancer
Type of cancer
Head and neck squamous cell carcinoma
Non-small cell lung cancer
Small cell lung carcinoma
Gastric carcinoma
Colorectal carcinoma
Pancreatic carcinoma
Hepatocellular carcinoma
Breast carcinoma
Ovary (fetal)
Leiomyosarcoma
Endometrial adenocarcinoma
Cervical carcinoma
Vaginal
Testic
Prostate carcinoma
Bladder carcinoma
Renal carcinoma
Wilms'tumor
Oligodendroglioma
Meningioma

Telomerase positive tested
86%
78%
100%
85%
89%
95%
86%
88%
100%
100%
100%
100%
100%
100%
90%
92%
83%
100%
100%
100%
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Neuroblastoma
Squamous cell carcinoma
Basal cell carcinoma
Melanoma
Myeloma

94%
83%
95%
86%
100%

Immune Response Vaccines. One of the telomerase-related strategies is using
telomerase derived peptides or oligonucleotides as vaccines that will stimulate the
patients’ immune response to telomerase-positive cancer cells. Many approaches and
clinical trials have been performed and showed positive anticancer responses. There is no
toxic effect has been reported against non-cancer cells so far, but it was observed that
some cancer cells can bypass telomerase signaling and build up resistance. Further
modifications on the telomerase-based vaccine and more clinical trials are being
conducted.98
Direct telomerase inhibitors. To today, millions of molecules have been designed
and screened for directly telomerase targeting. However, there is no any sufficiently
effective inhibitor getting into clinical trials. The most advanced inhibitor, BIBR 1532,
only showed activity in certain model studies.
Nucleotides based telomerase inhibitors. The other strategy is DNA-telomerase
interactions based, in which, oligonucleotide-based analogs are designed to block the
access of telomerase to telomeres. One of the most advanced binders is Imetelstat which
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is a lapidated N3'-P5' thio-phosphoramidate oligonucleotide that binds in complementary
fashion to template RNA. The phase II research of Imetelstat showed very positive results
on myeloproliferative disorder, and it is under phase III safety evaluations so far.99
However, Imetelstat only exhibits inhibition effects on limited types of cancer, which
may be the consequence of known off-target effects of the lipid moiety.100
G-quadruplex telomere ligands. As discussed before, telomeres tend to form Gquadruplexes under physical conditions and these higher order structures prevent the
access of telomerase. Thus, a number of G-quadruplex ligands (G4 ligands) have been
designed and synthesized. The most effective G4 ligand is the natural product
telomestatin, which was proved to inhibit leukemia cells proliferation in vitro. The main
challenge in this strategy is to improve the selectivity of the ligands against G-quadruplex
over duplex DNA, which will be extensively discussed in chapter 2.
Lastly, it is noteworthy that some cancer cell lines (~ 10%) utilize alternative
lengthening telomere mechanism (ALT) in the absence of telomerase.101 ALT happens
when a DNA template is annealed onto the telomere and new telomeric sequences can be
simply primed and replicated from this point. This template DNA can be another
telomere region sequence or some linear fragments from the outside of the
chromosomes.102 Even though the natural coexistence of telomerase and ALT in human
cancer cells has not been found yet, it is possible in genome engineered cells in vitro.
Therefore, ALT has to be taken into considerations for telomerase-based therapies
because of the potential resistance.103
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Chapter 2. Small Molecule-DNA Non-covalent Interactions

The structural diversity of DNA provides numerous distinguished environments
for protein and small molecule recognition. A wide variety of proteins are employed to
regulate DNA related cellular processes including DNA packaging, replication and
transcription through protein-DNA interactions. Histone, for instance, is an alkaline
protein that forms complexes with duplex DNA so that DNA can be packaged into
chromatins (Figure 2-1).

Figure 2-1. The interaction of histone and DNA.
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In another case, telomere sheltering complexes bind onto DNA telomeric regions
and regulates their extensions and replications (Figure 1-18). Other than proteins, small
molecules exist naturally in cells interacting with DNA. Spermine, a polyamine
compound, binds and stabilizes DNA by neutralizing the negatively charged phosphate
backbones. All these discoveries enlightened an active research area of DNA related
therapeutics, in which, molecules are designed to bind with certain DNA structures and
consequently regulate some major disease progressions like cancer.
DNA ligands interact with DNA through both covalent and non-covalent bonds.
The first chemotherapy drug nitrogen mustard is a DNA covalent ligand that alkylates to
the N-7 of guanine. The resulting interstrand cross-links inhibit DNA replications and
transcriptions (Figure 2-2a). Cisplatin also uses the same mechanism of action by
forming interstrand links between two guanines and thus inducing apoptosis (Figure
2-2b). These alkylating agents have been widely used against cancer till today and
significantly increase the survival time of many patients with malignant tumors.

Figure 2-2. Mechanisms of nitrogen mustard (top) and cisplatin (bottom) DNA covalent
interactions.
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However, because of their non-selective binding, DNA alkylating ligands have
severe side-effects including anemia, nausea, ear damage, hair loss and dysgenesis.104-106
Furthermore, more and more cancer patients have developed drug resistance after
repeated treatments of these drugs.107 Therefore, the need for novel chemotherapeutic
drugs with less side-effects never ends. In the recent years, small molecules that interact
with DNA via non-covalent binding have attracted much attention. The characteristics of
these molecules will be explicitly discussed in the following sections based on their
binding target including duplex and G-quadruplex DNA. 1,10-phenanthroline, thiazole
orange and their analogous as DNA ligands will also be discussed in the last two sections.
2.1. Duplex Binding
Duplex is the most prevalent DNA structure in living cells and is the presumed
target of many small molecules in DNA recognition. Generally, small molecules bind to
DNA via three interaction modes: Non-specific binding, base interaction, and groove
binding. The binding mode is determined by many factors including the structures of
small molecules, DNA sequences and the experimental conditions. The same ligand may
have different binding modes in different DNA local environments, and sometimes
multiple binding modes can co-exist.
Apparently, small molecules that bind to duplex DNA sequence specifically can
effectively regulate the desired replication and transcription processes. Meanwhile, it is
always very important to study the binding selectively between duplex DNA and higher
order DNA structures such as G-quadruplex when designing DNA ligands. Improving the
selectivity is always the biggest challenge in this field.
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2.1.1. Outside edge binding (nonspecific binding). The edges of a DNA duplex
are composed of phosphate diester groups. Under physiological conditions, one negative
charge is retained on each phosphate group and two are retained on the terminals.
Through electrostatic interactions, monovalent and divalent cations including K+, Na+, or
Mg2+, are condensed in both major and minor grooves under physical conditions. These
ionic interactions were proved to be nonspecific and the cations are free to move along
the sequences. Since these cations partially neutralize the negative charges of the
phosphate groups and relieve the repulsion of the two sequences in a duplex, the melting
temperature (Tm, the temperature at which 50% duplex DNA dissociates into random
coils) increases with the increasing cation concentrations. Cation binding competes with
DNA ligand binding; therefore, a condition with a high salt concentration inhibits the
ligand binding because of the electrostatic repulsion.108 Meanwhile, in the development
of DNA groove binders, the expelled cations from the minor grooves are often observed
when ligands bind to duplex DNA, which is considered as an important contribution of
the DNA ligand stabilization because of favorable entropic effects.109
Other than cations, water molecules also condense on duplex DNA and form a
spine of hydration in the minor groove.110 The extent of hydration plays a crucial role in
different DNA conformations (discussed in chapter 1).
Some ubiquitous positively charged small molecules in eukaryotic cells also nonspecifically bind onto duplex DNA. Spermine and spermidine were originally isolated
from sperm cells and were found to be abundant in ribosomes (Figure 2-3). They have
various important functions and one of them is binding on duplex DNA through
electrostatic interactions to reduce the charge repulsion when DNA is packaged into
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chromatin.111 In biological studies, high concentration of spermine is often used to
precipitate DNA in vitro.112

Figure 2-3. Structures of spermine and spermidine.

2.1.2. DNA intercalation. Many DNA ligands with fused planar aromatic
structures intercalate into duplex DNA by aligning themselves between base pairs. The
intercalation of ligands is predominately driven by the π-π stacking force between the
ligands and nucleobases. By adding various substituents into the ligand structures,
hydrophobic interactions, hydrogen bonds, and electrostatic forces can be introduced to
enhance the binding affinity and specify the binding orientation. Most of these duplex
DNA intercalations are located on G-C base pairs because of the bigger stacking surface
of purines.113 X-ray crystallography studies revealed that in the presence of a DNA
intercalator, the base pair step is separated by several Å to accommodate the insertion.
Meanwhile, the local DNA sequence is unwound and lengthened to release the steric
hindrance.114 Duplex DNA intercalation follows the neighbor exclusion principle in
which each ligand inserts into duplex DNA with 2 or 3 base pairs at a saturation level.
This exclusion takes place due to the DNA local conformation changes after the first
ligand binding and a decreased linear charge density.115-116
Several DNA intercalators have been used as DNA dyes because the stacking of
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their cyclic electron deficient surfaces on the base pairs emits fluorescence. Ethidium and
thiazole orange are two of the most well studied and commonly used DNA dyes. An
ethidium molecule preferably inserts into G-C base pairs, and the positively charged
nitrogen interacts with the phosphate backbone.117 Thiazole orange shares a similar
binding mechanism as ethidium with much less mutagenic effect and hence is a safer
reagent in DNA research.118 Thiazole orange, as the archetypal structure of our novel G4
ligands in chapter 4, will be extensively discussed in section 2.5.
Many duplex DNA intercalators have been developed into anticancer drugs and
their binding inhibit the DNA replication and interfere the biological functions of many
DNA enzymes in cancer cells. Anthracycline antibiotics are an important class of DNA
intercalators, which are used for the chemotherapies of leukemias, lymphomas, breast,
stomach, uterine, ovarian, bladder cancers, and lung cancers. Daunorubicin is the first
anthracycline antibiotic that was isolated from Streptomyces peucetius in 1963 (Figure
2-4).119 Daunorubicin has been used for chemotherapy of acute myeloid leukemia, acute
lymphocytic leukemia, chronic myelogenous leukemia, and Kaposi's sarcoma for more
than 40 years.120 Daunorubicin has an anthracene moiety which perpendicularly inserts
into successive G-C base pairs. The methoxy group of the anthracene ring is located in
the major groove and coordinates with sodium ions there. The amino sugar group lies in
the minor groove which will expel metal cations from the DNA. The hydroxy group of
the sugar forms hydrogen bond with the proximate nucleobases.121 The mechanisms of
action of anthracycline antibiotics are multifactorial, one of which is inhibition of
topoisomerase activity by stabilizing duplex DNA. Topoisomerases are essential enzymes
that release duplex DNA supercoils in replication. Cell’s cycle was found arrested in

68
G1/G2 when they were treated by Daunorubicin.122 In addition, anthracycline antibiotics
function to elevate ROS level in cells by participating some enzymatic pathways and
induce DNA damages.123 Although being prominent anti-cancer drugs, acute and longterm cardiotoxicity has been discovered with anthracycline antibiotics in the 1970s. This
side effect significantly depends on the dose, patient age, and physical conditions.124-126
The exact mechanism of the cardiotoxicity is remains unclear so far.
Transition metals including Ru2+, Rh2+, Fe2+, Zn2+, Cu2+, and Co2+ can coordinate
with ligands such as 1,10-phenanthroline and form a rigid complex that can partially
insert into DNA base pairs. The antiviral and antibacterial activities of these complexes
were firstly discovered in 1952.127 Later, high-resolution NMR and X-ray crystallography
studies showed that they bind to duplex DNA with both intercalation and groove binding
modes. There are several advantages of metallo-intercalators: 1) By simply switching the
coordinating ligands, a library of transition metal complexes with various structures as
DNA ligands can be conveniently prepared. 2) Because of the chirality of their structures,
many complexes have exhibited prominent stereoselectivities against different DNA
conformations. The enantiomers of tris(4,7-diphenyl-1,10-phenanthroline) ruthenium(II),
[Ru(DIP)3]2+, preferentially bound to left-handed Z-form DNA and right-handed B-form
DNA, respectively. In general, the complexes with the bulkier ligands have better
stereoselectivities because of a greater steric hindrance when intercalating with DNA.128
3) Transition metal complexes have been used as DNA probes due to their unique
photophysical properties. For instance, [Ru(phen)2 (dppz)]2+ glows in organic solutions
but not in aqueous solutions because the existing hydrogen bonds deactivate the excited
state of the metal ion. When it binds to DNA, changing from hydrophilic to hydrophobic
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environment makes the metal ion luminesce.129 4) These complexes can also be used as
artificial nucleases for cleavage of DNA because of their photochemical properties. The
binding sites of the complexes can be determined based on the location of DNA strand
breaks activated by photolysis.130 To sum up, transition metal complexes can act as DNA
intercalators and have been developed into stereoselective DNA binders, cleavage agents,
and luminescent probes.

Figure 2-4. Structures of DNA intercalative ligands.

2.1.3. Duplex DNA groove binding. Phosphate diester backbones and the edges
of base pairs defined two distinguished grooves in duplex DNA. The major groove of BDNA is wide and deep and provides a suitable environment for most of the protein
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binding. By contrast, most of the small molecules fit into the minor groove because of its
deep and shallow geometry, with a few exceptions of bulky transition metal complexes.
Duplex DNA minor groove binders such as netropsin and distamycin (Figure 2-5)
share common structural features of multiple small aromatic rings (pyrrole, furan,
benzene, imidazole etc.) linked by torsional bonds. Because of the flexible linkage, these
ligands can twist and form a crescent shape that snugly fits into the minor groove. These
ligands contain positive charges at the end, which further enhance the binding through
electrostatic interactions. Different from the G-C preferred intercalation, most of the
minor groove ligands locate themselves into A-T tracts. The O2 of thymine and N3 of
adenine in A-T tracts can form H-bonding with the ligand. The G-C tracts are sterically
hindered for ligand binding. The amino group at C2 of guanine, points to the minor
groove, which causes steric hindrance for ligand interactions. Generally, groove binding
ligands have been found with a higher sequence specificity compared to the intercalators.
First DNA groove binder netropsin was isolated from Streptomyces netropsis in
1951 by Finlay and the coworkers (Figure 2-5). This pyrrole-amidine structure showed
antibacterial and antiviral activities.131 High-resolution X-ray crystallography revealed
that the pyrrole rings of netropsin are located parallelly to the walls of the minor groove
and displace several H2O molecules from the groove. The binding site of this antibiotic
was identified as AATT or ATAT.132 Another polyamide-antibiotic, distamycin, was also
harvested from Streptomyces netropsis. Interestingly, distamycin binds strongly to A-T
base pair minor groove as a dimer. DNA minor groove binders that have elevated binding
to G-C tracts have been developed. When one of the pyrrole rings of distamycin is
replaced by an imidazole ring, the resulting ligand known as lexitropsin showed similar
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affinity against G-C and A-T. In this case, the imidazole ring can form H-bonding with
the NH2 group of guanine.133

Figure 2-5. Structures of dsDNA groove binders.

Studies on netropsin and its analogues revealed the polyamide motif could be
useful for sequence-specific recognition of DNA via groove binding. In light of this
finding, Dervan and co-workers designed and synthesized an array of hairpin-like
polyamides with tandem imidazole and pyrrole rings: imidazole (Im), pyrrole (Py), and 3hydroxypyrrole (Hp). The binding of these ligands follows a base-specific recognition
rule that four ring-pairings (Im/Py, Py/Im, Hp/Py, and Py/Hp) distinguish all four
Wastson-Crick base pairs in the minor groove of DNA.134 By constructing a polyamide
with a β-Alanine linker, Dervan and co-workers were able to specifically target a 16 nt
sequence in a HIV regulatory region.135 More Recently, Sugiyama and co-workers
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reported the recognition of telomeric duplex DNA using a polyamide trimer.136
2.1.4. DNA intercalation vs. groove binding. Both DNA intercalators and groove
binders have aromatic rings in their structures that interact with nucleobases. Most of the
intercalators employ fused ring structures to form a rigid surface that stacks on
nucleobases. Groove binders tend to utilize free flexible linkers that fit the molecules into
the DNA groove. It is important to note that these two binding modes are not utterly
exclusive, and some structures can adopt both of them simultaneously or depending on
the target sequence. For instance, DAPI (4',6-diamidino-2-phenylindole) is extensively
used in fluorescence microscopy and cell flow cytometry as a DNA dye (Figure 2-6).
DAPI had been considered as a classical DNA groove binder for a long period of time
preferably binding to AT-tract minor grooves. Later, an NMR titration experiment
revealed that DAPI also intercalates to G-C base pairs, and the two binding modes coexist under the same conditions.137 Other DNA intercalators such thiazole orange that
contain non-fused aromatic rings have also been observed with two binding modes.138

Figure 2-6. Molecules with two binding modes against DNA.
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2.2. G-quadruplex Binding
DNA G-quadruplex is formed by guanine-rich DNA single strands with stacking
G-quartets. Because of the abundant presence of G-rich sequences in telomeres and
oncogene promoter regions, G4 ligands have become a fast-developing area of research.
By targeting G-quadruplexes, telomerase mediated telomeres length maintenance in most
cancer cells can be inhibited and leads to cell cycle arresting. Oncogene such as c-myc
can also be down-regulated after the treatment of G4 ligands. Therefore, many G4 ligands
have been developed so far with various core structures and side chains. For the clinical
applications of G4 ligand in vivo, precisely targeting G-quadruplex without interferences
with duplex DNA is always the major challenge. Thus, both affinity and selectivity are
critical for a successful G4 ligand. Because of their planar aromatic and negative charged
structures, most of duplex DNA intercalators can also bind to G-quadruplexes with
different affinities and selectivities. Due to the shape of the G-quartets in Gquadruplexes, ligands with larger aromatic surfaces, especially those with similar
geometry as a G-quartet, are more suitable for G-quadruplex binding. Therefore,
structures including porphyrin, acridine, quindoline, and phenanthroline become the core
archetypes of many well-developed G4 ligands. Side chains with positive charges,
flexible linkers or sugar rings that can fit into the grooves or associate with the loops are
often used to enhance both affinity and selectivity. In this section, the most potent G4
ligands are discussed according to their binding mode: end stacking, intercalating and
groove/loop binding.
2.3.1. G-quadruplex end stacking ligands. Most of the aromatic ligands adopt
an end stacking mode at the one or two terminal G-quartets through π-π stacking force.
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The most potent G4 ligand with the best selectivity so far is a natural product
telomestatin (Figure 2-7). Telomestatin was discovered when researchers were screening
for telomerase inhibitors from natural products. It is a macrocyclic compound with five
oxazole rings and isolated from Streptomyces anulatus 3533-SV4. The IC50 of telomerase
inhibition of telomestatin is as low as 5 nM which is 1000-fold lower than one of the
strongest synthetic G4 ligands TMPyP4.139 An ESI-MS study showed that telomestatin
stacks on the two terminal G-quartets of G-quadruplexes.140 A molecular simulation study
revealed that the heterocyclic structure of telomestatin provides rich positions for
hydrogen bonds with guanines of the G-quartets. The nitrogen atoms in the center of
telomestatin interact with the carbonyl channel formed by guanines through electrostatic
force.141 More importantly, telomestatin is the best selective ligand against G-quadruplex
and has almost no binding affinity to duplex DNA. The length of telomeric G-overhang
was shortened when the cells were treated by telomestatin.142 The IC50 value of
telomestatin against two telomerase positive cell lines SW39 and SW26 are 4.1 and 1.8
µM, respectively, without obvious cytotoxicity towards normal cells.143 The high binding
affinity and excellent selectivity of telomestatin is the consequence of its macrocyclic
structure that facilitates its stacking on G-quartets and prevents the intercalation with
duplex DNA. However, due to its structural complexity, the large-scale synthesis of
telomestatin is always problematic. The total synthesis of telomestatin gave a very low
yield, and isolation from Streptomyces anulatus only yielded 3.2 mg from 84 L culture
fluid.144 Several attempts have been made to develop the telomestatin derivatives by
Kazuo Nagasawa and co-workers. Two promising candidates of them, 6OTD and 7OTD,
exhibited fairly good affinity and selectivity comparable to telomestatin.145
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Figure 2-7. Structures of G4 ligands.

It is noteworthy that some experiments revealed that telomestatin exhibited cell
toxicities on ALT (Alternative Lengthening of Telomeres) cell lines, suggesting that
telomerase-positive is not the requirement for a G4 ligand to perform its anti-cancer
activities.146 In ALT cells, topoisomerase III binds onto telemetric region and regulates
the recombination and elongation of telomeres. This process can be inhibited by
stabilizing the G-quadruplexes using telomestatin.
Cationic porphyrin compound TMPyP4 was first synthesized as a photosensitizer
and later was used as an intercalator for duplex DNA via a threading mode (Figure
2-7).147 In addition, it was found to stabilize G-quadruplexes with an end stacking mode
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due to its large aromatic surface and four N-methylated side chains.148 TMPyP4 is one of
the strongest G4 ligands, but with a poor selectivity. TMPyP4 shows positive effects on
down-regulating the expression of oncogene c-myc by inducing G-quadruplexes in its
promoter region. The expression of the subunit of telomerase hTERT, which is regulated
by c-MYC was also reduced after the treatment of TMPyP4.149 The IC50 values of
TMPyP4 against tumor cell lines are in the range of 9.0-28.2 µM, and between 1.7-15.5
µM against normal cell lines, further suggesting its low selectivity.150 Although with a
poor selectivity, TMPyP4 is still commonly used as a positive control since it can be
conveniently purchased.
Many modifications have been attempted to improve the selectivity of TMPyP4.
By coordination with the metal ion Mn3+, its selectivity against G-quadruplex over
duplex DNA was improved by 10-fold. In addition, side chains containing amides were
discovered to improve the binding affinity and selectivity of TMPyP4 derivatives. Thus, a
cationic porphyrin Mn3+ complex with extended amide side chains was found with 1000fold higher selectivity compared to TMPyP4. This molecule has been used to locate Gquadruplex in living cells (Figure 2-7).151-153
BRACO-19 is one of the best synthetic G4 ligands with a remarkable selectivity,
in which an acridine core is surrounded by three protonated side chains (Figure 2-7).
Molecular modeling experiments suggested that the acridine moiety in the structure
stacks on the G-quartets and each of the side chains occupies a groove. The selectivity of
BRACO-19 is dependent on the types and positions of the side chains.154 BRACO-19 was
cytotoxic against human uterus carcinoma cell line UXF1138L with an IC50 value at 2.5
µM and significant telomere shortening was observed after a long-term treatment. The G-
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quadruplex-regulated expression of telomerase subunit hTERT was found significantly
decreased after the treatment of BRACO-19.155 In another study, BRACO-19 also
exhibited anti-HIV activity by stabilizing the viral G-quadruplexes.156 Similar to many
other DNA ligands, BRACO-19 has poor pharmacological properties mainly because of
its high polarity. Therefore, the pre-clinical studies of BRACO-19 is still being conducted
to improve its uptake efficiency.155
Similar to TMPyP4 and BRACO-19, there have been many other examples of G4
ligands equipped with positively charged side chains. PIPER, a perylene based
compound, has two piperidine moieties with positive charges on the terminals and can
efficiently stack with G-quadruplexes and inhibits telomerase (Figure 2-7).157-158 An
interesting observation for PIPER is that their binding selectivity against G-quadruplexes
over duplex DNA is correlated their aggregation states in solution. Monomeric molecules
intercalate into duplex DNA and aggregated products stack on G-quartets.159
From above well-developed G4 ligands, many lessons of designing highly
selective G-quadruplex stacking ligands can be learned: 1) A highly extended aromatic
system is the best core structure for G-quadruplex stacking and provides the best
selectivity (like telomestatin); 2) For relatively small ligands with practical synthetic
yields, the side chains are crucial. The structures and locations of the side chains do not
only improve the binding affinity but also affect the selectivity for G-quadruplexes over
duplex. 3) Potent G4 ligands are always tethered with side chains with positive charges
and optimized geometry for G-quadruplex interactions.
Metallo-aromatic structures are another group of potent G-quadruplex binders in
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which small molecular ligands coordinate with a metal ion and form an extended
aromatic surface. Other than the planar geometry of the coordinating ligands stacking on
G-quartets, the metal ions at the center also interact with the guanine channel through
electrostatic force. 1,10-Phenanthroline is an example of such aromatic ligands for Gquadruplex recognition, which will be extensively discussed in section 2.4.
2.3.2 G-quadruplex groove binders. G-quadruplex is formed by four successive
G-rich segments where adjacent sequences form loops and provide distinct recognition
environments for groove binders. Pyrrole amide antibiotics were discussed in the section
of duplex DNA groove binders and they can also bind to G-quadruplex grooves (Figure
2-8). An NMR study revealed that distamycin dimers can bind with two opposite grooves
in a G-quadruplex through hydrogen bonds and electrostatic force. Widened grooves
were observed to accommodate the distamycin molecules.160 In another study of
distamycin derivatives, the formamide group in distamycin was replaced by a charged Nformimidoil moiety and the resulting compound decreased the duplex DNA binding
(Figure 2-8).161 Alkaloids peimine and peiminine were also reported interact with Gquadruplex through groove binding (Figure 2-8). These two compounds showed clear
preference to a parallel G-quadruplex rather than duplex DNA, which may result from the
different geometry of the grooves in these structures.162
Lastly, ligands that intercalate into the G-quartets have not been discovered
experimentally to our best knowledge, and only a few computational studies were
reported.163 The G-quadruplex structure is highly compact, which makes intercalation
difficult.
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Figure 2-8. Structures of G-quadruplex groove binders.

In summary, G4 ligands have recently attracted much attention for their anticancer activities. Though natural product telomestatin exhibited excellent binding affinity
and selectivity against G-quadruplexes, its clinical applications are hindered by the
extremely complicated synthesis. Therefore, the development of small molecules that
selectively target G-quadruplexes is highly demanded. Lessons can be learned from the
above studies that both the binding affinity and selectivity are significantly affected by
side chains. The numbers, orientations and positive charge densities are the factors for
potent binding. In light of these findings, we selected two core structures, 1,1phenanthroline and thiazole orange and studied the binding affinity and selectivity toward
G-quadruplex DNA. A brief summary of the research on these two types of compounds
will be presented below.
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2.3. 1,10-Phenanthroline Analogues Metal Complexes as G-quadruplex Ligands.
1,10-Phenanthroline (1,10-Phen) is a heterocyclic organic compound that chelates
a broad-spectrum of metal ions (Figure 2-9). The structure of 1,10-Phen is similar to 2,2'bipyridine, but with a much higher coordinating efficiency. It has been used as a
photometric reagent for chelating Fe2+ ions in solution. In addition, 1,10-Phen is
commonly used as an important building block for synthesis of alkaloids and their
analogues.

Figure 2-9. Structures of 1,10-phenanthroline (left) and 2,2'-bipyridine (right).

When DNA G-quadruplex became a promising target for cancer therapy, 1,10Phen has been used as a building block for developing G4 ligands because of its extended
aromatic surface. In addition, the chelated metal ions may enhance the interactions by
substituting the cations in the G-quadruplex. It is commercially available and can be
readily synthesized. In this section, the previous development of 1,10-Phen and its
analogues as G4 ligands will be reviewed and serve as the important background of our
research in the following chapter.
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2.4.1. 1,10-phenanthroline analogues as G-quadruplex ligands. As discussed
in previous sections, the two common features of G4 ligands are extended aromatic
surfaces and suitable positively charged side chains. 1,10-Phen has a well-defined
crescent shape with fused aromatic rings, which is a suitable trait of G4 ligands. De Cian
and co-workers designed a 1,9-disubstituted-1,10-phenanthroline compound (Phen-DC3),
in which, two quinolinium groups were anchored to the 1 and 9 positions of 1,10-Phen by
amide linkers (Figure 2-10a).164 Phen-DC3 at 1 µM elevated the melting temperature of a
human telomeric G-quadruplex by 29.7 °C monitored by fluorescence. More importantly,
Phen-DC3 showed a remarkable selectivity against G-quadruplexes, which is comparable
to telomestatin and better than most of the known synthetic G4 ligands. An X-ray
crystallography revealed that Phen-DC3 has a similar surface size compared to the Gquartet providing optimized stacking force. Later, an NMR titration experiment showed
that Phen-DC3 binds to G-quadruplexes by end stacking mode with 1-1 and 1-2 ratios.
The phenanthroline core structure and two quinolinium rings overlap with the four
guanines of the terminal G-quartets.165 It is noteworthy that the two amide linkers in
Phen-DC3 help to lock the structure in a planar conformation that greatly enhances its Gquadruplex binding affinity. Removing this amide connectivity will lose its G-quadruplex
stabilization effects.166 The in vivo G-quadruplex stabilization of Phen-DC3 showed that
it can efficiently inhibit G-quadruplex unwinding by helicase without affecting other
regular dsDNA.167
Likewise, Wang et al. developed another group of 2,9 disubstituted-1,10-Phen
(Figure 2-10b). The amide linkers were preserved because of the hydrogen bond locking
effects. Cationic piperidine, pyridine, and tertiary amine groups were attached as side
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chains. Slightly better G-quadruplex stabilization was achieved for these structures,
compared to Phen-DC3. It was also proved that these ligands preferably bind to antiparallel G-quadruplexes. Cell viability experiments revealed their cytotoxicity was shown
at approximately 2 µM.168

Figure 2-10. Structures of Phen-DC3 (left) and its cationic amino side chain derivatives
(middle); 4,7-diamino-1,10-Phen derivative (right).

Other than 2,9 disubstituted-1,10-Phen, 4,7 disubstituted derivatives were also
studied. Nielsen and co-workers synthesized a range of 4,7-diamino-1,10-Phen. Many of
them stabilized G-quadruplex examined by CD (Figure 2-10c). The derivatives with
longer side chains bearing positively charged guanidine groups exhibited better
stabilization compared to shorter and neutral side chains. It was also noteworthy that
1,10-Phen itself did not stabilize G-quadruplexes in the absence of metal ions because of
its small planar structure.169
To the end, many modifications have been made at the 2,9 and 4,7 positions of
1,10-Phen. To our best knowledge, reports on modifications made at 5 and 6 positions of
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1,10-Phen for developing G4 ligands are scarce. NMR and X-ray crystallography studies
of 1,10-Phen derivatives suggested that side chains at 5 and 6 positions could effectively
interact with G-quadruplex grooves.164-165
2.4.2. 1,10-phenanthroline analogues metal complexes as G-quadruplex
ligands. Because of the two well-organized nitrogen atoms, 1,10-Phen is an outstanding
chelating agent which can form complexes with a broad range of metal ions including
nickel(II), copper(II), ruthenium(II), platium(II), manganese(II), magnesium(II), and
zinc(II) with 1-1, 1-2, or 1-3 ratios. By forming a complex, the extended aromatic surface
can significantly contribute to G-quadruplex stacking. Meanwhile, metal ions may sit at
the center of the channel of a G-quadruplex and coordinate with the carbonyl oxygens of
the guanines, further enhancing the stability. Thus, many 1,10-Phen metal complex
derivatives have been synthesized.
Nickel salphen (Figure 2-11a) is the first metal complex used as a G4 ligand and
synthesized by Reed and co-workers.170 Two piperidine structures were attached as the
side chains. Computation studies revealed that this square planar structure overlaps with
the terminal G-quartets and the Ni2+ ion lies above the center channel. Nickel salphen
exhibited an outstanding G-quadruplex stabilization and selectivity comparable to
BRACO-19.
The success of nickel salphen inspired the development of metal complexes as G4
ligands. In this scenario, the same research group designed a Pt-1,10-Phen complex with
a piperidine side chain on the carbon 9 (Figure 2-11b). This compound adopts an amide
linker that similar to Phen-DC3 and the nitrogen atoms coordinate with the Pt2+ ions. A
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computational study suggested that the conformation is fixed in a plane so that the
benzene ring stacks on the guanines, and the extended piperidine side chain interacts with
the grooves. The Pt2+ ion was chosen because it forms a stable planar 1-2 complex with
the ligand.171 The Pt2+ ion sits in the center of the G-quadruplex and may replace the
cationic ions in the G-quadruplex channel. In a FRET thermal denaturation experiment,
the complex at 1 µM increased the melting temperature of a telomeric G-quadruplex by
20 °C while showed negligible effects on duplex DNA. This stabilizing effect was highly
dependent on the presence of Pt2+ ion and only 9 °C increment of melting temperature
was observed in the absence of platinum ions.172

Figure 2-11. Structures of 1,10-phenanthroline derivatives.
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In another report, Pt-1,10-Phen complex (Figure 2-11c) exhibited stabilization
effects on an antiparallel G-quadruplex in the absence of any side chain. In the presence
of 1 µM complex, the melting temperature of the telomeric G-quadruplexes was
enhanced by 21 °C. An X-ray crystallography experiment revealed that Pt-1,10-Phen
complex has a dimension matching the G-quartets. Interestingly, this complex has a
remarkable preference to antiparallel G-quadruplexes. By replacing 1,10-Phen with
bipyridines (Figure 2-11d), the resulting complex did not stabilize the G-quadruplex
probably because of its flexibility, suggesting that the rigid extended aromatic structure of
1,10-Phen is pivotal for its G-quadruplex stabilization effect.173 Ruthenium ions (Ru2+)
are also frequently used in this type of complexes. Different from Pt2+, Ru2+ ions usually
form 1-3 complexes with ligands. Many Ru-1,10-Phen complex derivatives have been
developed as G4 ligands and exhibited various stabilization effects.174-178
Like in the nickel salphen, cheaper metal ions were often utilized in the
complexes to stabilize G-quadruplexes. Bianco and co-workers synthesized a bisphenanthroline, in which, two phenanthrolines were linked by a tertiary amine (Figure
2-11e). Mn2+, Cu2+, Ni2+, Mg2+, and Zn2+ ions were all studied with this ligand and the
formation of 1-1 (1 metal ion coordinated with two phenanthroline function groups)
complexes was observed.179 A FRET assay revealed that Ni2+ complexes had the best Gquadruplex stabilization effect amongst the above metal ions, followed by Cu2+ and Zn2+
complexes. Mn2+ and Mg2+ ions had a very low affinity with the bis-phenanthroline
ligand, so the complexes could not be formed readily in the solution. Compared to Pt2+
and Ru2+ complexes, the Ni2+ complex is more cost-friendly and, more importantly, can
be readily formed in solution without special reaction conditions. For Cu2+ complexes,
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DNA cleavage effect was frequently observed in the presence of a reducing reagent since
Cu2+ ion can undergo a reduction reaction to produce reactive species for DNA damage.
Cu2+-Bis-Phen complexes showed less cleavage of DNA because the generation of
reactive species requires a perpendicular arrangement of two aromatic functional groups
which is unlikely to happen for a bis-phenanthroline ligand.
Musetti and co-workers synthesized 2,9-disubstituted (K35, Figure 2-11f) and 7monosubstituted (K34, Figure 2-11g) 1,10-Phen.180 The Ni2+ and Cu2+ complexes were
investigated for their G-quadruplex stabilization. K34 formed a 1-2 complex with Ni2+
and K35 only formed a 1-1 complex, because the bulky groups at 2,9 positions hindered
the coordination of metal ions with the phenanthroline ligands. As a consequence, the Gquadruplex stabilization effect of K35 was not as good as K34, because K35 had a much
smaller stacking surface. K34 could only form a 1-1 complex with Cu2+, which in turn
had a lower G-quadruplex binding affinity compared to the Ni2+-K34 complex. All these
observations suggested that forming 1-2 complexes between metal ions and 1,10-Phen is
critical for the G-quadruplex stabilization effects. Modifications on 2 or 9 positions of
1,10-Phen may affect the coordination of ligands with metal ions because of the steric
hindrance of the substituent(s). This was also confirmed by another 9-substituted-1,10Phen derivative P120 (Figure 2-11h), which only formed a 1-1 Ni complex with a
moderate G-quadruplex binding affinity.181
Many 5 and 6 substituted 1,10-Phen compounds have been developed mainly for
photophysical detection of metal ions.182-183 Reports on the use of them as G4 ligands are
limited. Fang and co-workers synthesized a Ni2+ complex NPH (Figure 2-11i), by
coordinating a Ni2+ ion with two 1,10-Phen ligands and one p-idip (p-idip=2-(4-indole)-
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imidazo-[4,5-f][1,10]phenanthroline). This 1-3 complex could stack on the G-quartets
with a higher affinity than Ni2+-1,10-Phen complexes. A FRET assay showed that a DNA
G-quadruplex had a 14 °C increment of Tm in the presence of 1 µM of NPH.184
To that end, 1,10-Phen derivatives have been developed into a class of G4 ligands
and several of them exhibited very prominent binding affinity and selectivity. Side chains
have been attached onto different locations of 1,10-Phen. Several 2,9 substituted 1,10Phen derivatives are much better G4 ligands compared to 1,10-Phen. However, the
substituents at 2 and/or 9 positions could hinder the coordination with metal ions. Ni2+
was the most cost-friendly and efficient metal to form 1,10-Phen-based G4 ligands. To
improve the coordination efficiency with metal ions, side chains should be attached to the
outer edge (4, 5, 6, or 7 positions) of 1,10-Phen if we recognize it as a crescent shape.
2.4. TO Derivatives as G-quadruplex Ligands
Thiazole orange (TO) is a cyanine dye that was firstly synthesized by Linda G.
Lee for the staining of reticulocytes RNA in flow cytometry analysis.185 Most of this type
of DNA dyes contain two aromatic rings that skew from each other when they are free in
solution. They bind to DNA via intercalation by stacking between two nucleobase pairs,
and the fluorescence arises when the two aromatic rings are constrained on the same
plane.186 TO has a N-methylated benzothiazole ring linked to a quinolinium by a methine
bridge (Figure 2-12a). It intercalates with duplex DNA with a stoichiometric ratio of 1
dye per 2 base pairs. TO also binds to DNA G-quadruplexes via end-stacking. The
binding affinities of TO with G-quadruplex and duplex DNA are approximately the same.
As a DNA dye, TO has many advantages compared to its predecessors such as high
quantum yield and good cell membrane permeability. When it binds to DNA, it shows

88
more than 1000 times fluorescence increment.187 In addition, TO is permeable to cell
membrane which makes it highly useful for staining of nucleic acid in living cells.

Figure 2-12. Structures of thiazole orange and derivatives.

Utilizing TO as a DNA dye, David Monchaud et al. developed a fluorescent
intercalator displacement (FID) assay which has been extensively used in G4 ligands
research.188 The design rationale of the FID assay is as follows. Firstly, the binding of TO
to DNA is reversible; therefore, the bound TO could be displaced out of DNA by other
strong DNA ligands in solution. Because of the drastic difference in fluorescence between
free TO and bound TO, one can monitor the fluorescence change to determine the binding
affinity of the ligand of interest. The lower the concentration (DC50 value) of the ligand is
needed to displace 50% TO, the stronger the ligand binds to DNA. Secondly, because
thiazole orange binds to G-quadruplex and duplex DNA with almost the same affinities,
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the FID results can be used to evaluate the selectivity of the ligand for G-quadruplex over
duplex DNA.
Due to its distinct property of fluorescence, TO has been used as a structural motif
for developing G4 ligands. For instance, some known G-quadruplex selective moieties
were fused onto the quinolinium ring of TO such as benzofuroquinolinium (d),
isaindigotone (c), and pyridodicarboxamide bisquinolinium (b) (Figure 2-12). These
extended aromatic structures all exhibited improvements on G4 selectivity over duplex
compared to thiazole orange.189-191 These TO based derivatives could be used as good Gquadruplex probes but their binding affinities to G-quadruplex DNA are moderately
increased compared to TO. In addition, the synthetic approach is not convenient to
generate a large library of TO with various side chains.
Interestingly, a recent report suggested that TO can bind to a string of consecutive
G-quadruplexes with high selectivity over duplex DNA. In the same report, the authors
even detected the strong binding of TO to the G-quadruplex string in the absence of Na+
and K+. In addition, the binding of TO with other noncanonical DNA structures was
observed.192 Given the fact that consecutive G-quadruplexes are most likely formed in
vivo, this report have aroused more interest to use TO as a template to develop novel G4
ligands
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Chapter 3. 5-Substituted 1,10-Phenanthroline Ni(II) Complexes as G4 Ligands

G-quadruplex has received much attention because of its important regulatory
functions in telomerase-mediated cancerization and oncogene expression. Phenanthroline
is a type of G4 ligand scaffold that coordinates with metal ions, and the consequent
complex has an extended aromatic surface that can aptly stack on G-quadruplexes. In this
project, a series of 5-substituted phenanthroline-based Ni(II) complexes were investigated
for their ability to bind to telomeric G-quadruplex DNA and inhibit telomerase.
Biophysical studies including Förster Resonance Energy Transfer (FRET) G-quadruplex
thermal denaturation, Circular Dichroism (CD) titration, and Fluorescence Intercalator
Displacement (FID) indicated that complexes with either cationic side chains or aromatic
side chains bound to and stabilized telomere G-quadruplex DNA with significant
affinities. More importantly, complexes with arylsulfanyl side chains at the 5-position
exhibited improved selectivity against G-quadruplex over duplex DNA, which can be
used as a promising motif for G4 ligand development in the future. Results from a
Telomeric Repeat Amplification Protocol (TRAP) assay suggested that these complexes
can inhibit telomerase activity in vitro with micromolar concentrations. Cytotoxicity was
also observed for these complexes against telomerase positive cancer cell lines.
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3.1. Introduction
Cancer is the second leading cause of death in the United States and was
responsible for 22.5 percent of deaths over the last five years.193 More than 100 types of
cancer have been discovered so far while finding the efficient therapy with low sideeffects is still a huge challenge. The most common treatments for cancer are surgery and
chemotherapy, and obviously, surgery is only feasible for solid tumors, not metastatic
cancers. The very first chemotherapy drug nitrogen mustard was investigated in 1942,
which had been used as a chemical weapon in World War I. Since then, many other
cytotoxic compounds have been developed as anti-cancer drugs. Most of these
compounds were designated to target DNA and subsequently lead to cell cycle arrest by
forming stable adducts or cross-links in DNA. Regression of tumors was observed after
the treatment of these drugs; however, the acute and long-term toxicity becomes a huge
obstacle in their applications for cancer chemotherapy. In the 1980s, thanks to the
advanced knowledge and technologies of cell biology, a network of cell signaling
pathways was deciphered, and some biomarkers of cancer were discovered and became
the targets of receptor inhibitors. Glivec (a kinase inhibitor), Gefitinib (an EGFR
inhibitor), and Avastin (a VEGF antibody) are the benchmarks of these targeting drugs
and exhibit outstanding effects on several major types of cancer. However, the overexpression of the corresponding biological targets is patient-dependent, and hence only
individuals with a certain genotype, determined by genomic tests or proteomics, are
sensitive to specific drugs. Therefore, in spite of acute side-effects, cytotoxic drugs are
still playing pivotal roles in cancer therapy and usually are combined with the targeting
inhibitors, nowadays.194 The development of new broad-spectrum chemotherapy drugs
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with low side-effects is still a pressing task for researchers.
DNA is the target for most of the chemotherapy drugs. Some of them like
nitrogen mustard and cisplatin form stable DNA adducts or cross-links, and thus inhibit
the DNA replication. However, these drugs are non-selective and lead to acute side
effects. As mentioned in the previous chapters, G-quadruplex is a secondary DNA
structure that is formed by successive G-rich sequences through Hoogsteen hydrogen
bonds. G-quadruplex is prevalently present in oncogene promoter regions and telomeric
regions. Its formation and stability are closely correlated to cancer cell proliferation.
Oncogene such as c-myc can be down-regulated in the presence of stabilized Gquadruplexes. Meanwhile, G-quadruplexes in telomeric regions hinder telomerase
binding and inhibit the consequent telomere length maintenance, which is only present in
cancer cells. In light of these observations, many strategies have been developed to use
G-quadruplexes as a target for potential anti-cancer therapies.
Like duplex DNA ligands, some small molecules have been found interact with
G-quadruplexes, and consequently increase their stability. There are two principles of
successful G4 ligands: 1) high binding affinity with G-quadruplex DNA; 2) sufficient
selectivity against G-quadruplex over duplex DNA. Therefore, most of the outstanding
G4 ligands were designed with two types of functional motifs: 1) positively charged side
chains that interact with DNA backbones to enhance the binding affinity; 2) an extended
planar aromatic system that can stack with the G-quartets to enhance the selectivity. A
natural product, telomestatin is one of the most potent G4 ligands with remarkable
selectivity. However, its structural complexity became a huge obstacle for its efficient
synthesis and production as a drug.139 Some synthesized small molecules have been
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developed targeting G-quadruplex utilizing fused aromatic ring structures including
acridine, perylene, naphthalene, phenanthroline, etc. Many of these compounds have high
binding affinities against G-quadruplexes; however, very few of them have sufficient
selectivity. Several phenanthroline derivatives exhibited remarkable affinity and
selectivity against G-quadruplex DNA.164 In addition to having a rigid aromatic crescent
structure and various side chain attaching positions, phenanthroline can also coordinate
with metal ions and form complexes with a large stacking surface. The metal ions sit in
the center of the planar surface, which may replace the original cations of Gquadruplexes and coordinate with the guanines.
Many of these phenanthroline derivatives have been synthesized, and their Gquadruplex stabilization effects were evaluated in the presence and absence of metal ions.
A majority of developed derivatives were modified by tethering cationic moieties such as
bisquinolinium, piperidine, pyridine, and amino groups at the 2 and 9 positions of
phenanthroline and exhibited remarkable G-quadruplex binding affinities.164, 168, 172, 180-181
The modifications at the 4 and 7 positions of phenanthroline has also been reported, and
the resulting derivatives showed limited selectivity for G-quadruplex over duplex
DNA.169, 180 To the best of our knowledge, the modification at 5 or 6 positions of
phenanthroline for G-quadruplex stabilization has not been extensively studied. NMR
and X-ray crystallography studies revealed that when phenanthroline derivatives stack at
the end of G-quadruplexes, the 5 and 6 positions of the phenanthroline ring are closely
located at the G-quadruplex grooves.165, 172 Hence, the interactions between side chains at
these two positions and the G-quadruplex grooves could exist. A Ni complex of
phenanthroline derivative with 2-(4-indole)-imidazole at the 5 and 6 positions exhibited
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better G-quadruplex affinity and selectivity compared to the parent complex, suggesting
that the 5 and 6 positions are attractive modifying sites for developing novel G4
ligands.184
Many phenanthroline derivative metal complexes have been synthesized with Pt2+
or Ru2+ ions, and showed significant G-quadruplex stabilization effects.173, 177 Complexes
with similar structures were also prepared with cheaper metal ions including Cu2+, Ni2+,
Mn2+, Mg2+, and Zn2+, in which, Ni2+ and Cu2+ ions formed more stable complexes with
phenanthroline derivatives than the others.179 Other than the lower cost, Ni2+ ions have
another advantage over Pt2+ and Ru2+ ions that they can be conveniently coordinated by
mixing the metal salts and ligands in water solutions without any special treatment.195-196
A facile synthesis of 5-substituted phenanthroline derivatives was reported by
Samoshin and his co-workers. They kindly provided us nineteen 5-substituted
phenanthrolines for evaluation.197 Using their method, our group also synthesized an
additional derivative (21) with a piperidine side chain, which is a known moiety
enhancing G-quadruplex binding. In the previous work, Ni2+ complexes of these twenty
derivatives were prepared by simply mixing NiCl2 and the corresponding compounds
with 1-2 ratio in water solutions. The G-quadruplex stabilization was also evaluated by
FRET and CD thermal denaturation.
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Table 3-1. 5-Substituted 1,10-phenanthroline derivatives.
1

8

15

2

9

16

3

10

17

4

11

18

5

12

19

6

13

20

7

14

21

In the present research, the stoichiometry of the Ni2+ coordination was first
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confirmed by ESI mass spectrometry. FID was used to determine the G-quadruplex
stacking effects of the complexes and the results were compared with other biophysical
studies. In vitro telomerase inhibition and cytotoxicity were investigated using a modified
TRAP assay and MTT experiments.
3.2. Experimental
3.2.1. Materials and general methods. Unless otherwise specified, all chemicals
for synthesis were purchased from Sigma-Aldrich or Fisher Scientific and used without
further purification. Oligonucleotides were synthesized on an Applied Biosciences 392
DNA/RNA synthesizer using standard phosphoramidite protocols and purified using
polyacrylamide gel electrophoresis. All the chemicals for DNA synthesis were purchased
from Glen Research (Sterling, VA). The concentrations of oligonucleotide solutions were
determined by a Varian Cary 100 Bio UV-Vis spectrophotometer (Walnut Creek, CA),
using the molar extinction coefficients (in units of mol of nucleotide/L-1 cm-1) obtained
from Oligo Analyzer 3.1 (www.idtdna.com). T4 polynucleotide kinase was obtained from
New England Biolabs. [γ-32P]-ATP was purchased from PerkinElmer (Waltham, MA).
Quantification of 5' 32P-labeled oligonucleotides was carried out using a Storm 860
phosphorimager and ImageQuant 5.1 software (Molecular Dynamics). DNA labeling was
performed by incubating [γ-32P]-ATP (300 µCi) and T4 polynucleotide kinase (20 units)
in the presence of an oligonucleotide at 37 °C for 45 min. Unreacted [γ-32P]-ATP was
removed using a MicroSpin G-25 column (GE Healthcare). Cancer cell lines were a
generous gift from Dr. William. K. Chan. Cell culture media and supplements (fetal
bovine serum, L-glutamine, and antibiotic-antimycotic) were from Invitrogen. MTT
(Thiazolyl blue tetrazolium bromide) was purchased from Fisher Scientific, and the
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absorbance were read on a TriStar LB 941 multimode microplate reader.
3.2.2. Mass spectrometry analysis of complexes. A Varian 320L triple
quadrupole mass spectrometer coupled to an electrospray ionization (ESI) source
(Agilent Technologies, Santa Clara, CA) was used to analyze the complexes in positive
ion mode. The sample solutions were prepared by dissolving 5-substituted phenanthroline
derivatives and NiCl2 in a 2:1 ratio with 50% methanol-water (unless otherwise
specified), and the final concentration of complexes was 200 μM. An aliquot of the
sample solution (20 μL) was introduced into the ESI source via a six-port valve. The
following instrument parameters were employed: 4.5 kV for the ESI needle onset voltage,
30 V for the capillary voltage, 30 psi for the nebulizing nitrogen gas, and 10 psi and
150˚C for the drying gas. The designated ions were isolated for the collision-induced
dissociation (CID) measurements which were performed at collision energies of -40~- 50
eV.
3.2.3 Fluorescent intercalator displacement assay. A stock solution containing
100 μM human telomeric G-quadruplex sequence (PCG1) (5’-AGG GTT AGG GTT
AGG GTT AGG GT-3’) or duplex (D1) (5’-AGC GAT GAG AGG CCA CGA GGA ATC
GCT GGT ACC G-3’/ 5’-CGG TAC CAG CGA TTC CTC GTG GCC TCT CAT CGC T
-3’), 10 mM lithium cacodylate buffer (pH=7.0) and 50 mM KCl was prepared and
incubated at 90 ℃ for 5 min, and slowly cooled to room temperature. All solutions were
stored at 4 ℃ before further use.
The reaction solution containing 0.25 μM DNA, 10 mM lithium cacodylate buffer
(pH=7.0) and 50 mM KCl was prepared from the stock solution before use. This solution
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was incubated with 0.5 μM thiazole orange (TO) for 30 min in the dark. Aliquots of
ligands were added into this mixture solution and equilibrated for 5 min in the dark
before measurement. The fluorescence spectra (λ excitation: 501 nm, slit width: 5.0 nm,
scan speed 120 nm/min) were recorded from 510-650 nm after each addition. The percent
fluorescence displacement (%FI displacement) was calculated at λ max by using the formula
%FI displacement=100-[(FA/FA0)×100], where FA0 is the initial fluorescence intensity in the
absence of ligand, and FA is the fluorescence intensity upon addition of ligand.
3.2.4. Preparation of cell lysate for TRAP assay. Cell lysates containing
telomerase were extracted from cultured HeLa cells. The cells from a 90% confluent 225
cm2 culture flask were washed once with cold phosphate-buffered saline (PBS) and
scraped off from the culture flask in 1 ml cold PBS. The cells were pelleted in a 1.5 ml
centrifuge tube by spinning for 5 min at 1000 rpm and suspended in 1 ml cold
TRAPeze® 1× CHAPS Lysis Buffer (Millipore, Sigma). The suspension was incubated
on ice for 30 min and centrifuged at 12,000 X g for 10 min at 4°C. The supernatant was
extracted and stored at -80°C.
3.2.5. Real-time PCR telomeric repeat amplification protocol (TRAP) assay.
The reaction mixture (30 µl) was prepared containing 1×SYBR Green Mix (Thermo
Fisher Scientific, polymerase included), EGTA (1 mM), TS primer (2 µM, extension
substrate of telomerase, 5’-AATCCGTCGAGCAGAGTT-3’), RP (1 µM, reverse primer
for telomerase extended products, 5’-GCGCGGCTTACCCTTACCCTTACCCTAACC3’), cell lysis (2.5 µl, lysis buffer was used in control samples) and ligand (various
concentrations). Samples were incubated at 30°C for 30 min in a 96-well plate for
telomerase extension followed by 95°C for 10 min to deactivate telomerase and activate
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polymerase. A two-step PCR thermal cycle (95 °C for 15 s, 60 °C for 60 s) was
performed for 41 times using an MJ research option-2 real-time PCR machine (St. Bruno,
Canada) and fluorescence was recorded after each cycle using the SYBR Green setting
mode of the instrument. The data was plotted as the logarithm of fluorescence signal
versus the cycle number, and the threshold was set to the value of 10 times standard
deviation of the background.
3.2.6. 32P telomeric repeat amplification protocol (TRAP) assay. The 5′-[32P]
end-labeled TS primer (0.1 μg, 5’-AATCCGTCGAGCAGAGTT-3’) was incubated in a
reaction mixture (50 μL) [buffer: Tris-HCl (20 mM, pH 8.3), MgCl2 (1.5 mM), KCl (63
mM), 0.05% Tween 20, EGTA (1 mM)] with cell lysate (1 μL), RP (0.1 μg, reverse
primer for telomerase extended products, 5’GCGCGGCTTACCCTTACCCTTACCCTAACC-3’), NT (0.1 μg, primer for polymerase
as internal standard, 5’-ATCGCTTCTCGGCCTTTT-3’), TSNT (0.01 amol, template for
NT primer, 5’-AATCCGTCGAGCAGAGTTAAAAGGCCGAGAAGCGAT-3’), 2 units
of Taq polymerase, dNTP mix (50 μM), and ligand (3.125-100 μM) at 30°C for 30 min
and 94°C for 2 min to deactivate telomerase. The reaction mixture was then incubated
using a three-step PCR method (94 °C for 20 s, 59 °C for 30 s, and 72 °C for 30 s) with a
total of 25 cycles. The reaction solutions were mixed with 10 μL 10×loading dye and
resolved with 10% denaturing polyacrylamide gel [5% crosslink, 45% urea w/w].
3.2.7. MTT cell viability assay. MCF-7 cells (human breast adenocarcinoma
cells) and HeLa cells (cervical cancer cells) (a generous gift from Dr. William Chan,
UOP) were maintained in advanced DMEM medium supplemented with 5% fetal bovine
serum, L-glutamine and antimycotic (antibiotic) at 37 °C in a humid atmosphere
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containing 5% CO2. The compounds were pre-dissolved in sterilized water. The cells
(3000 cells/well) were seeded in 96-well plate. After 24h incubation, the supernatant was
removed followed by adding 200 µl FBS free media containing the compound. After 72h
incubation, 20 µl MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-di- phenyl tetrazolium
bromide) (0.5 mg/ml) was added for further another 4h incubation. Formazan product
was dissolved in 150 µl of DMSO, and the absorbance was measured at 590 nm using a
TriStar LB 941 Multimode Microplate Reader. Untreated cells and media without cells
were used as controls. To calculate the viability (%), the following equation was used:
(𝐴𝑡𝑟𝑒𝑎𝑡𝑒𝑑 )−(𝐴𝑚𝑒𝑑𝑖𝑎 )
𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 )−(𝐴𝑚𝑒𝑑𝑖𝑎 )

Viability (%)=(𝐴

× 100%

Atreated: The absorbance of the solution containing treated cells
Amedia: The absorbance of the media
Auntreated: The absorbance of the solution containing untreated cells
3.3. Results and Discussion
3.3.1. 5-substituted 1,10-phenanthroline formed 1-2 and 1-3 complexes with
Ni(II) ions. Ni2+ ions were reported forming 1-1, 1-2 and 1-3 (Ni2+/Phen) complexes with
different 1,10-Phen derivatives. In the previous work of our group, a continuous variation
analysis (Job plot) was performed and the stoichiometry of the complexes 20-Ni and 21Ni was determined.198 In these experiments, Ni2+ ions were titrated against compound 20
and 21, and the UV absorbance was measured after each addition. The molar extinction
coefficients at 315 nm were plotted against the metal ion molar fraction [metal ion molar
fraction = metal ion concentration / (metal ion concentration + compound
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concentration)]. The cross points were determined at 0.34 and 0.30 for 20-Ni and 21-Ni,
respectively (Figure 3-1). This observation revealed the dominance of forming a 1-2
complex between Ni2+ and these two compounds in solution.

Figure 3-1. Job plots obtained based on continuous variation analysis for (A) 20-Ni and
(B) 21-Ni.

To further confirm the stoichiometry, we used a triple quadrupole mass
spectrometer coupled to an electrospray ionization (ESI) source to analyze the
representative complexes that have a good solubility in methanol (1-Ni, 12-Ni, 15-Ni, 18Ni, 20-Ni and 21-Ni). All spectra (Figure A-1 to Figure A-5) are shown in relative
abundances with the most abundant ion in each spectrum corresponding to 100% ion
intensity (base peak).
To study the effect of solvent on complexation, the spectra of Ni-1,10-Phen complex (1Ni) were prepared in three different solution compositions with 0%, 50% and 90%
methanol, respectively. Both of the complex ion [1-2]2+, m/z 209.02, and complex ion [13]2+, m/z 299.12 were identified (
Figure 3-2). The [1-3]2+ ion was the more abundant ion under all three conditions.

102
The relative abundance of the 1-2 complex increased from 49.21% to 82.20% with the
increasing methanol ratio from 0 to 90%. This trend can be a result of the different
dissociation rate of water molecules from Ni(II) chloride in different solvent
compositions.199

Figure 3-2. ESI spectra of phenanthroline and Ni2+ solutions with a 2:1 molar ratio in
three different solvent compositions.

Then, five other derivative complexes (12-Ni, 15-Ni, 18-Ni, 20-Ni and 21-Ni)
were analyzed in 50% MeOH solutions, and both 1-2 and 1-3 complexes were observed
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for all of them (Figure A-1 to Figure A-5). Different from 1-Ni, all five derivative
complexes had 1-2 complexes as the more abundant ions compared to the corresponding
1-3 complexes (Table 3-2). There was no 1-1 complex present in any of the samples. It
was reported that the mechanism of the kinetics of complexation between Ni2+ and
phenanthroline derivatives are side-chain dependent. The formation of the complexes can
be significantly affected by the solvation properties of the ligand with different side
chains.199 Although the accurate explanation of the side-chain effect remains unclear, the
five derivative complexes exhibited a notable preference for 1-2 complexation when
compared to the parent compound 1-Ni. Interestingly, chloride ions were observed in the
1-2 complexes for 20-Ni and 21-Ni, but not for their 1-3 complexes. It is possible that the
chloride ions coordinated with the Ni2+ ion instead of interacting with the side chains;
otherwise, it should also be found for 1-3 complexes and has the same number as the
compound.

Table 3-2. Characteristic m/z values and the relative abundance (%) in ESI-MS spectra of
the 1,10-Phen-Ni complexes.
12-Ni
1-2 complexes m/z

367.11 a

15-Ni

18-Ni

353.22 a

305.99 a

20-Ni
340.161 a
358.11b
715.163c

Relative abundance
100
100
100
134.28d
(%)
1-3 complexes m/z
536.22
515.33
448.107
495.81
Relative abundance
47.00
71.02
65.85
100
(%)
a
: [1-2]2+; b: [1-2-ClH]2+; c: [1-2-Cl] +; d: Sum of multiple species.

21-Ni
352.20 a
739.10b
112.02d
513.8
64.34
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The collision-induced dissociation (CID) experiments were used to confirm the
structures of 20-Ni and 21-Ni. Fragmentation of 20-Ni complex [1-2-Cl]+, m/z 714.8
produced a complex ion [1-1-Cl]+, m/z 403.8 (Figure 3-3). The ion at m/z 99.9
representing a side-chain fragment ion (N,N-diethylethenamine) was observed and the
corresponding mechanisms are assigned (Scheme 3-1).

Figure 3-3. CID spectrum of 20-Ni complex ion [1-2-Cl] + at m/z 714.8.
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Scheme 3-1. Fragmentation mechanisms of Phen-Ni complexes in a CID experiment.

Fragmentation of complex ion [1-3]2+, m/z 495.4 produced a complex ion [1-1]+,
m/z 369.1 and [1-2]+, m/z 679.8 (Figure 3-4). The ion at m/z 579.7 corresponded to a
fragment ion losing a side chain. Interestingly, the 1-2 complex ion at m/z 679.8 and 1-1
complex ion at m/z 369.1 in this spectrum were present with a reduced charge state
(single charge) which was not observed for the fragment ions of 1-2 complexes. This
unexpected reduction of metal ions was also reported by another group when they
conducted electrospray mass spectrometry in positive mode, which was attributed to a
charge transfering.200 The reduction was only found in the product ions of 1-3 complexes,
indicating that the charge transferring can only take place when Ni2+ is coordinated with
three phenanthroline derivatives in the parent ions.
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Figure 3-4. CID spectrum of 20-Ni complex ion [1-3]2+ at m/z 495.4.

Similar to 20-Ni, 1-3 and 1-2 complexes of 21-Ni were also fragmented under the
same conditions. Similar fragmentation patterns were observed.
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Figure 3-5. CID spectrum of 21-Ni complex ion [1-2-Cl]+ at m/z 739.2.

A side chain fragment ion, m/z 111.9 and a complex ion [1-1-Cl]+, m/z 415.8 was
produced by the fragmentation of the complex ion [1-2-Cl]2+, m/z 739.2 (Figure 3-5).
Fragmentation of the complex ion [1-3]2+, m/z 513.8 produced a complex ion [1-1]+, m/z
380.9 and a complex ion [1-2]+, m/z 703.6 (Figure 3-6). The ions at m/z 591.6 was
corresponding to a fragment [1-1]+ complex ion losing one of the side chains. A fragment
[1-1]+ ion was also observed at m/z 269.8. Similar to 20-Ni, reduced charge state was
observed to the product 1-1 and 1-2 complex ions.
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Figure 3-6. CID spectrum of 21-Ni complex ion [1-3]2+ at m/z 513.8.

In summary, the observations from both continuous variation analysis and ESI
MS spectrometry measurements suggested that the 5-substituted phenanthroline
derivatives predominately form a 1-2 complex with Ni2+ ions, which can potentially bind
to G-quadruplexes with its enlarged aromatic surface. The 1-2 phenanthroline derived
metal complexes gave better G-quadruplex stabilization effect than the other
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complexation ratios due to their square planar geometry.180-181
3.3.2. 5-Substituted Phen-Ni complexes induced telomeric G-quadruplex
formation under Na+ and K+ deficient conditions. Circular Dichroism (CD)
spectrometry is frequently used to analyze G-quadruplex conformations and the CD
spectral features can be empirically correlated to the conformational structures of Gquadruplexes. In the present work, we used CD spectroscopy to confirm that 20-Ni and
21-Ni can induce the formation of G-quadruplexes in the absence of cations, which
indicated their strong G-quadruplex binding affinities.198 In these experiments, a CD
spectrum was first recorded for a solution containing the human telomeric DNA sequence
PCG1 (G4, 5’-AGGGTTAGGGTTAGGGTTAGG GT-3’) without Na+ or K+. It exhibited
a negative peak at 238 nm, a major positive peak at 257 nm and a minor positive peak at
295 nm, representing a typical random coil. Then, aliquots of 20-Ni and 21-Ni were
gradually added into the solution respectively, and the CD spectra were measured after
each addition. The change of the molar ellipticity revealed a transition of the
conformation from a random coil to an antiparallel G-quadruplex conformation (Figure
3-7). With the concentration of the complexes increasing from 0 to 20 µM, the peaks at
238 and 257 nm decreased, a positive peak at 295 nm and a negative peak at 260 nm
appeared. This observation is consistent with a previous report.169 In order to confirm that
the G-quadruplex was induced by the complexes but not the free 5-substituted
phenanthroline derivatives, 20 and 21 were also titrated against the human telomeric
DNA sequence under the same condition. Slightly conformational change was observed
for 20, but this change was significantly smaller compared to the one observed for 20-Ni.
Addition of 21 gave nearly no change of the molar ellipticity (Figure 3-7). These
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observations suggested that 20-Ni and 21-Ni are strong G4 ligands and promoted us to
carry out further studies to achieve a broader picture for the G-quadruplex binding
properties of the 5-substituted phenanthroline complexes.

A

B

C

D

Figure 3-7. CD spectra of PCG1 measured when titrating with A) 20-Ni; B) 20; C) 21-Ni;
D) 21. The continuous changes in the CD spectra correspond to the incremental amount
of Phen-Ni ranging from 0 -20 µM. DNA = 5 µM.

3.3.3. 5-Substituted Phen-Ni complexes with cationic and aromatic side
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chains increased the thermal stability of telomeric G-quadruplex DNA. In previous
studies, a high-throughput thermal denaturation experiment of G-quadruplex DNA
monitored by Förster Resonance Energy Transfer (FRET), was conducted to investigate
the stabilization effects of all twenty-one complexes.198 In this experiment, a fluorescence
(fluorescein) and a quencher (DABSYL) molecule were linked to the two ends of the
same human telomeric G-quadruplex sequence (5’-Fluorescence
AGGGTTAGGGTTAGGGTTAGGGT-3’-DABSYL) and form the G-quadruplex (G2).
When the G-quadruplex is folded, the fluorescence signal can be quenched by the
proximate quencher. When the G-quadruplex is dissociated at a temperature above the
melting temperature (Tm), the fluorescence signal can be restored because unfolding the
G-quadruplex into a random coil makes fluorescein and DABSYL quencher apart. The
Tm is defined as the temperature, at which 50% of the G-quadruplexes dissociate into
random coils. It can be extrapolated by the first derivatives from the plots of the
fluorescence intensities against the temperatures. The G-quadruplex melting experiments
were conducted in the presence of complexes Phen-Ni or their metal free compounds
Phen with a 4:1 (ligand: DNA) ratio on a 96 well plate using a real-time PCR machine,
and the derived ΔTm values (Tm increment compared to the compound free control 57.7
˚C) are shown in Table 3-3.
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Table 3-3. Tm values of G-quadruplex derived from fluorescent thermal denaturation in
the presence of free compound or Ni2+ complexes at a 4:1 ligand/DNA ratio.
1

Compound

2

3

4

5

6

7

R Group

No
ligand

H

Phen

57.5

57.3

58.4

58.4

57.8

58.4

56.6

57.0

Phen-Ni

57.5

62.3

64.4

60.0

67.7

65.0

66.5

58.2

Compound

8

9

10

11

12

13

14

15

Phen

57.2

57.0

57.0

57.0

57.0

57.2

56.0

56.4

Phen-Ni

58.2

58.4

68.0

60.2

57.6

63.2

60.0

56.0

Compound

16

17

18

19

20

21

Phen

58.4

56.4

56.4

57.0

59.2

57.0

Phen-Ni

59.0

64.2

62.0

60.2

69.6

68.4

R Group

R Group

Firstly, in the absence of Ni2+, compound 1 (1,10-phenanthroline) gave no Tm
increment on the G-quadruplex melting temperature (57.3 ˚C) compared to the free Gquadruplex sample (57.5 ˚C). 1-Ni increased the melting temperature to 62.3 ˚C while
free Ni2+ showed no effect. Therefore, it is safe to conclude that Phen-Ni can stabilize Gquadruplex and this effect comes from the complexation with Ni2+ ions. The
complexation provides an enlarged aromatic surface that aptly stacks on the G-quartets.
Like phenanthroline, none of the 5-substituted compounds stabilized the G-quadruplex in
the absence of Ni2+ because of their relatively small aromatic planar structures. The
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observation was consistent with previously reported studies from other groups.169, 180-181
Stabilization effects were observed for eighteen Ni-containing complexes except
12-Ni and 15-Ni. The Tm value in the presence of 15-Ni, with an octyl side chain, was
56.0 °C which was lower than the control (57.5 °C), suggesting that octyl group
significantly affected the G-tetrad stacking ability of the ligand. In principle, it is well
acknowledged that a long hydrophobic alkyl chain without positive charges cannot
efficiently interact with DNA phosphate backbones.

Figure 3-8. ΔTm (Tm increment compared to the compound free control 57.7 ˚C) values of
G-quadruplex derived from fluorescent thermal denaturation in the presence of Phen-Ni
at a 4:1 ligand/DNA ratio. π: Complexes with aromatic side chains; +: Complexes with
cationic side chains, and the pKa value of conjugate acid is between 2.0 and 7.0; ++:
Complexes with cationic side chains, and the pKa value of conjugate acid is higher than
7.0.
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Nine (20-Ni, 21-Ni, 10-Ni, 4-Ni, 6-Ni, 5-Ni, 2-Ni, 17-Ni and 13-Ni) out of
eighteen G-quadruplex stabilizing complexes have better stabilizing effects according to
the Tm values, compared to 1-Ni. In these nine compounds, five of them (20-Ni, 21-Ni,
10-Ni, 6-Ni, 5-Ni and 9-Ni) have side chains that can be positively charged (Figure 3-8).
To understand the significance of the positive charges in G4 ligands, we compared the
pKa values of the positively charged sites in these compounds (Table 3-4). Complexes 5Ni, 20-Ni, and 21-Ni all contain amines that can be readily protonated and form positive
charges under physiological conditions (pKa value of conjugate acid > 7.0). Indeed, these
three compounds were all found with stabilization effects for G-quadruplexes. Complexes
containing nitrogen atoms with lower pKa values are unlikely to be protonated under the
physical condition. Most of them were found with much less significant stabilization
effects on the G-quadruplex such as 9-Ni, 14-Ni and 17-Ni. This observation is consistent
with previously reported studies that cationic side chains can enhance G-quadruplex
binding affinity through electrostatic interactions with DNA grooves.201
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Table 3-4. Approximate pKa value of conjugate acid of the designated side chains of 5substituted phenanthroline.
#
5
6
9
10
14
17
20
21

Name of the cationic motif

Structure of the side chain

pKa*

Amine

11.0202

Pyridine

5.2202

Benzimidazole

5-6203

Triazole

NA

Benzothiazole

1.84204

Acetanilide

<2205

Tertiary amine

10.6202

Piperidine

11.1202

*: pKa values were determined experimentally in the publications for a same
functional group.

Except for positive charges, aromatic stacking is the other critical contributing
factor for G-quadruplex stabilization. Out of the nine complexes that efficiently stabilize
G-quadruplex here, four of them (10-Ni, 6-Ni, 17-Ni and 13-Ni) have aromatic side
chains. Although, overall, the aromatic side chain tethered complexes exhibited less
stabilization effect compared to those with cationic side chains in this assay, it is
important to note that aromatic motifs may provide better selectivity for the Gquadruplex over duplex DNA because the former contains a more extended aromatic
surface for stacking.
In addition to the positive charge and stacking surface, there are other factors
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enhancing the G-quadruplex binding. 2-Ni and 17-Ni have a hydroxy or carbonyl group,
which may form hydrogen bonds with nucleobases or DNA backbones as a hydrogen
donor or acceptor.162-163 Hence, due to the complexity of G-quadruplex stabilizing factors,
an accurate side-chain rule for Phen-Ni as G4 ligands cannot be successfully acquired.
However, a general trend can still be concluded. Based on the results from the FRET
assay, both cationic side chains and aromatic side chains are important factors for Gquadruplex stabilization.
In general, these observations were consistent with the previously reported G4
ligands that cationic motifs can significantly enhance the G-quadruplex binding affinity.
However, it is important to notice that, although FRET is a frequently used method for
screening G4 ligands in a high-throughput fashion, this method has its disadvantages. The
interference from the fluorophore and quencher molecules exists.206 The add-on
fluorophore and quencher molecules could affect the stability and conformation of the Gquadruplex. Meanwhile, the fluorescence signal is also temperature and pH dependent
which may introduce some bias to the data. Additionally, the interaction between the
fluorophore/quencher molecules and ligands may exist. Hence, it is necessary to crossinspect the FRET assay results using other methods as described below.
3.3.4. Aromatic side-chains enhanced the stacking affinity and selectivity of
5-substituted Phen-Ni complexes against telomeric G-quadruplex DNA. The binding
of Phen-Ni to the telomeric G-quadruplex was further investigated by the fluorescent
intercalator displacement (FID) assay. Meanwhile, we also investigated the binding of
Phen-Ni to duplex DNA using the same method. Molecules as such with a large stacking
surface, in general, could also bind to duplex DNA. Because duplex DNA is more
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abundant than G-quadruplex DNA in vivo, it is important to study the selective binding of
Phen-Ni to G-quadruplex DNA over duplex DNA, which is crucial to develop
telomerase-specific inhibitors. In our experiments, thiazole orange (TO) was first bound
to G-quadruplex DNA (G1) or duplex DNA (D1), and the pre-bound TO was
successively displaced out of DNA by the addition of a ligand. The binding of TO is
known to be end stacking and such binding is reversible. Upon binding to DNA, TO
fluorescence increases 1000-fold compared to free TO in solution that has a negligible
quantum yield. When bound TO is displaced out of DNA by a DNA ligand, a dramatic
decrease of fluorescence is detected. The amount of ligand needed to displace 50% of
pre-bound TO is defined as G4DC50 for G-quadruplex and dsDC50 for duplex DNA. Both
values can be used to compare the relative binding affinities of the ligand to Gquadruplex and duplex DNA.186
11-Ni and 7-Ni exhibited higher G4DC50 values compared to 1-Ni. 11-Ni gave the
worst G4DC50 value (46.1 μM) amongst all Phen-Ni compounds probably due to the
repulsion between the negatively charged amine oxide and DNA backbones. Glucose is
not an effective side chain for G4 ligands as the G4DC50 value for 7-Ni was also amongst
the worst, 29.9 µM. Though the sugar moiety could interact with DNA grooves via Hbonding,121 the linker of 7-Ni may not be long and flexible enough to properly position
the glucose into the DNA groove.
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Figure 3-9. The G4DC50 values of all Phen-Ni complexes from the FID assay.

The corresponding rank order of Phen-Ni with G4DC50 values less than 5
µM was 3-Ni < 10-Ni < 13-Ni < 16-Ni < 21-Ni < 17-Ni < 14-Ni < 20-Ni < 19-Ni < 8-Ni
< 12-Ni. This order did not exactly match the order of these complexes from the thermal
denaturation experiments with G2 (Table 3-3). For instance, 21-Ni and 20-Ni that
stabilized G2 the most were only ranked at the 5th and 8th. 3-Ni showed no significant
thermal stabilization of G2 (Tm = 60.0 °C); however, it exhibited the lowest G4DC50 value
(0.92 μM). Other discrepancy was also overserved. 6-Ni showed a very high G4DC50
value (30.5 μM) but with a good stabilization of G2 (Tm = 66.5 °C). Such discrepancy for
3-Ni and 6-Ni could result from the interference of fluorophore and quencher with the
complexes in solution in fluorescence melting as mentioned in the previous section.206
Another plausible explanation of the observed discrepancy, especially for complexes
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containing positively charged side chains such as 21-Ni and 20-Ni is the difference in
binding sites. In the melting experiments monitored by fluorescence, the thermal
stabilization of G-quadruplex DNA is direclty correlated to the binding affinity of the
ligand. 21-Ni and 20-Ni gave the highest Tm values of G2 probably because they both
contain a positively changed side chain that electrostatically interacted with DNA
backbones and further stabilized DNA. On the other hand, such an interaction may cause
21-Ni and 20-Ni not to bind to the exact site as TO binds. Therefore, in the FID assay, the
displacement of TO by 21-Ni and 20-Ni is not as efficient as that by other ligands,
resulting in slightly higher G4DC50 values. Further evidence of this explanation comes
from the observation that except for 20-Ni and 21-Ni, all the complexes with low G4DC50
values contain an aromatic moiety as a side chain. The proper alignment of the aromatic
side chains could enhance their end-stacking with G-quartets and more efficiently
displace TO out of G-quadruplex DNA. Without Ni2+, 5-substituted phenanthrolines 20
and 21 could not act as potent G4 ligands because their G4DC50 values were drastically
large, 83.2 μM for 20 and 72.3 μM for 21. The G4CD50 values for 20 and 21 were 28 times
and 36 times higher than those of 20-Ni and 21-Ni, respectively (Figure 3-10). The
compounds 20 and 21 also showed no stabilization of G2 in the melting experiment
monitored by FRET. These observations suggest that the end-stacking interaction is an
important factor for the binding of phenanthroline derivatives to G-quadruplex DNA.
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Figure 3-10. The G4DC50 values of free 20, 21 and 20-Ni, 21-Ni determined by FID assay.

For eleven complexes (except for 10-Ni and 16-Ni, reason explained in the next
section) with a

G4

DC50 value less than 5 µM, their corresponding dsDC50 values (Figure

3-11) were measured using a DNA duplex (D1), and their selectivity of G-quadruplex over
duplex was determined by the ratio of dsDC50/G4DC50. The rank order for such selectivity
was 3-Ni (8.2) > 14-Ni (7.2) > 13-Ni (5.5) > 17-Ni (5.1) > 19-Ni (4.1) > 8-Ni (3.9) > 12Ni (2.7) > 20-Ni (2.3) > 21-Ni (1.4). 20-Ni and 21-Ni containing cationic groups at
physiological pH gave the worst selectivity amongst these nine complexes. The

G4

DC50

value for 20-Ni was 2.99 µM, 2.3 fold lower than its dsDC50 (6.94 µM). It is clear that 20Ni more preferably binds to G-quadruplex than duplex DNA. The

G4

DC50 value of 21-Ni

was 2.01 µM, 1.5 fold lower than that of 20-Ni, suggesting that 21-Ni is a slightly stronger
G4 ligand. However, the selectivity of 21-Ni to G-quadruplex over duplex was worse than
that of 20-Ni because the

G4

DC50 value of 21-Ni was only 1.4-fold lower than its dsDC50
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(2.75 µM). Although the piperidine moiety in 21-Ni is a known effective side chain for G4
ligands, its ability to dictate binding selectivity is strongly pH-dependent. Kerwin and
coworkers reported that PIPER (with piperidine as a side chain) had diminished binding
selectivity for G-quadruplex and duplex DNA at low pH.207 The G4DC50 value was 23.4 µM
for 1-Ni, 7.7 fold and 11.6-fold higher than that of 20-Ni and 21-Ni, respectively. This
observation clearly reveals that side chains at the 5 position are important for developing
such phenanthroline-based G4 ligands.

Figure 3-11. The G4DC50 and dsDC50 values of the Phen-Ni complexes from the FID
assay.

Overall, the results obtained from the FID assay were somewhat in agreement
with the data from the thermal denaturation experiments. However, a clear discrepancy
between G4DC50 and Tm values could not be neglected. Thermal denaturation monitored
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by fluorescence is suitable to capture a coarse picture of the effect of Phen-Ni on Gquadruplex stabilization in a high-throughput manner; however, it cannot provide precise
information due to the nature of its system. Indeed, in the thermal denaturation
experiments monitored by fluorescence, we were not able to observe a saturation plateau
of the melting temperature (Tm) even when the concentration of Phen-Ni was increased to
a ligand/DNA ratio of 10. Such a saturation plateau was observed when we conducted
thermal denaturation of a native G-quadruplex DNA (same sequence as G2) monitored by
circular dichroism, suggesting the possible interference amongst fluorescein, DABSYL
and Phen-Ni. The FID assay allows us to directly compare the binding affinities of the
ligands with similar binding modes semi-quantitatively. It is particularly useful to
compare the binding selectivity of the ligands between G-quadruplex and duplex DNA.
The results presented above further validates that cross inspection of the fluorescence
melting data with other methods is important. It is necessary to point out that the
observed discrepancy between the data from fluorescence thermal denaturation and FID
could also result from the temperature dependence of affinities in Tm. Nevertheless, all
the biophysical methods mentioned above clearly indicate that side chains and Ni2+ ions
are two crucial factors to make 5-substituted phenanthrolines good G4 ligands. A
positively charged side chain tethered to the 5-position of phenanthroline is a structural
motif for enhancement of the binding affinity G-quadruplex DNA but it has little effect
on the selectivity for G-quadruplex over duplex DNA. By contrast, an arylsulfanyl group
tethered to the 5-position of phenanthroline is useful to improve both the binding affinity
and selectivity of the ligand because it expands the stacking surface of the ligand. The
surface of G-quartets is much larger than base pairs; therefore, ligands with expanded
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stacking surface bind more tightly to G-quadruplex DNA than duplex DNA.
3.3.5. 5-Substitued Phen-Ni complexes inhibited telomerase activity in vitro.
Upon confirming the binding and stabilization of telomeric G-quadruplex DNA by our
novel 5-substituted phen-Ni complexes, we investigated their inhibition of human
telomerase activity in vitro using a TRAP (Telomeric Repeat Amplification Protocol)
assay. As discussed in the previous sections, telomerase is an enzyme that can bind and
extend telomeric DNA and maintain the telomere length. Telomerase is over-expressed in
90% of tumors and helps cancer cells to compensate telomere shortening. It is well
acknowledged that stabilized G-quadruplexes formed by the telomeric DNA can
efficiently inhibit the telomerase binding and extension activity. Therefore, in the
development of G4 ligands and telomerase inhibitors, quantitative analyses of telomerase
activity are crucial, and the most frequently used method is the TRAP assay.
Before PCR became an extensively used technique, telomerase activity had been
directly studied in vitro by the following method. Radioactively labeled nucleotide 5’triphosphates were incorporated to its substrate sequence by telomerase. The resulting
radioactive products were measured using autoradiography. Due to the low abundance of
telomerase in living cells, the quantitation of telomerase activity with this assay was not
reliable, even a large amount of radioactive materials were used.208-209 To increase the
detection sensitivity, Kim and coworkers developed the first PCR-based TRAP assay. It
can also be used for the detection of telomerase activity in a high throughput fashion.92
A PCR-based TRAP assay can be divided into two main stages: elongation of
primers by telomerase and subsequent amplification of telomerase products using PCR.
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In the elongation stage, the primer oligonucleotides (TS) are extended with addition of
repeat segment (5’-TTAGGG) by telomerase. The pure form of telomerase is not
commercially available. The experiments are normally conducted by using cell lysate
extracted from telomerase-positive cells such as HeLa cells. In the following PCR
amplification stage, these extended products are used as the templates and amplified in
the presence of a reverse primer ACX. Utilization of the PCR amplification significantly
increases the detection sensitivity; therefore, the products can be detected using low-dose
radioactive materials or even conventional fluorescent DNA dyes such as SYBR Green
(Figure 3-12).

Figure 3-12. Scheme of a TRAP (Telomeric Repeat Amplification Protocol) assay for
telomerase activity detection.

In the present work, we explored the feasibility of using two different TRAP
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assays. In the first method (real-time PCR TRAP), we conducted the PCR amplification
in a real-time PCR machine and monitored the amplified products using SYBR Green.
This assay was carried out in a 96-well plate in a high throughput fashion, which in
principle can screen hundreds of compounds in a 3-4 hours period. The biggest advantage
of this method is free of radioactive materials. In the second method, we used a 5’-32P
labeled primer in the PCR amplification and the final products were measured using
autoradiography. Both methods will be explicitly discussed in the following section.
Real-time PCR TRAP. SYBR Green is a conventional DNA dye. Upon binding to
DNA, it fluoresces with an excitation wavelength 497 nm (blue light) and an emission
wavelength 520 nm (green light). The intensity of the fluorescence is positively
correlated to the amount of the DNA present in solution. During the real-time PCR
amplification, the fluorescence of the solution is recorded after each thermal cycle, and
the intensities are plotted versus the cycle number. Telomerase-positive cell lysate can
extend the primer to yield products that are used as templates in the PCR amplification.
The fluorescence intensity of such a sample increases as a function of increasing thermal
cycle numbers in PCR. No fluorescence increment can be observed if telomerasenegative cell lysate is used. A threshold of the fluorescence intensity was set as 10 times
over the deviation of the background in a DNA free sample. The thermal cycle number is
needed to reach the threshold is defined as a Ct value. In the presence of a G4 ligand,
telomerase is inhibited so it produces fewer extended products, namely fewer template
copies for PCR amplification. Hence, more thermal cycles (Ct) are needed to reach the
fluorescence threshold. The Ct value is correlated to the ability of a G4 ligand to inhibits
telomerase. The greater the Ct value is, the stronger the inhibition effect is. To determine
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this concept, we used a well-studied G4 ligand TMPyP4 as a model compound. The
results are shown in Figure 3-13. In the absence of TMPyP4, it requires 25 thermal cycles
to reach the threshold. As the concentration of TMPyP4 increases, more thermal cycles
are needed to reach the same threshold. For instance, in the presence of 6.25 µM
TMPyP4, it requires 34 cycles to reach the threshold. When the concentration of TMPyP4
are larger than 12.5 µM, the threshold cannot be reached even after 41 thermal cycles that
is pre-defined limitation number for this method.

Figure 3-13. The results of real-time PCR TRAP concentration-dependent inhibition
profile for TMPyP4.

All twenty-one Ni containing complexes and the free phenanthroline derivatives
were studied by this real-time PCR TRAP assay (Figure 3-14). In the absence of Ni2+, all
compounds except for 13 exhibited no telomerase inhibition effect. This observation is

127
highly consistent with the data from the FRET and FID assays. 5-Substituted
phenanthroline derivatives are not good G4 ligands due to the relatively small aromatic
surfaces. Interestingly, compound 13 showed a telomerase inhibition effect in this TRAP
assay, but it had no G-quadruplex binding ability based on other two assays. Hence,
compound 13 was suspected to be a telomerase inhibitor that may directly affect the
telomerase without interactions with DNA. This assumption warrants further
investigation.
Ni2+ containing complexes 3-Ni, 8-Ni, 10-Ni, 12-Ni, 13-Ni, 14-Ni, 16-Ni, 17-Ni,
19-Ni, 20-Ni, and 21-Ni had Ct values that were greater than 40 (pre-defined limitation of
the thermal cycle numbers), suggesting the inhibition of telomerase activity by these
complexes. These results were highly consistent with the previous conclusion from the
FID experiments that they are good G4 ligands. However, there are nonnegligible
discrepancies between the TRAP and the FRET assay. Complexes 19-Ni, 16-Ni, 3-Ni, 14Ni, 8-Ni and 12-Ni showed higher G-quadruplex binding affinities (determined by the
FID assay) and better telomerase inhibition effects (determined by the TRAP assay) than
1-Ni. However, none of them showed a G-quadruplex stabilization in the FRET assay,
compared to 1-Ni. This discrepancy further validates our previous discussion in section
3.3.3 that the FRET assay has certain disadvantages: The G-quadruplex conformation and
ligand binding can be affected by fluorescence and quencher molecules; the fluorescence
signals can be disturbed by ligands, temperature, and pH conditions. Interestingly, all the
complexes that were underestimated in the FRET assay only contain aromatic side
chains. Therefore, it is reasonable to conclude that the aromatic moieties at the 5-position
of phenanthroline derivatives may have a notable interference with the fluorophore in the
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FRET assay.

Figure 3-14. Ct values acquired from the real-time PCR TRAP assay for twenty-one
complexes.

Concentration-dependent studies were performed for the above effective
telomerase inhibitors using the real-time PCR TRAP assay. The TRAP reactions were
performed in the presence of ligands at various concentrations ranging from 0 to 100 µM,
and the corresponding Ct values for each experiment were plotted versus the
concentrations.
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Figure 3-15. Ct values acquired from the real-time PCR TRAP assay for the
concentration studies of effective inhibitors.

Clear concentration-dependent telomerase inhibition effects were observed for all
the inhibitors (Figure 3-15). To compare their inhibition effects, a telomerase inhibition
factor was defined as the integrals of the areas under the curves in Figure 3-15 for each
complex. Overall, the rank order of the inhibition effects obtained from the TRAP assay
(Figure 3-16) is somewhat in agreement with the data from the FID experiments (Figure
3-9). Complexes 10-Ni, 16-Ni, and 3-Ni exhibited the best inhibition effects in the TRAP
assay, and they all showed strong binding affinities in the FID assay. Compound 13, in
the absence of Ni2+ ion, was a strong telomerase inhibitor without G-quadruplex
interactions and addition of Ni2+ ion even decreased its inhibition effect. The rest of the
inhibitors were all observed with efficient G-quadruplex binding in the FID assay with a
different order.
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Figure 3-16. Telomerase inhibition factors calculated from the real-time PCR TRAP
assay for effective inhibitors.

Although the real-time PCR TRAP assay is a high-throughput protocol to study
telomerase inhibitors, it has a major disadvantage. In this assay, the telomerase products
produced by telomerase in the first step and subsequently amplified by DNA polymerase
and quantified using SYBR Green in the second step. Theoretically, the formation of the
PCR products can be inhibited in either the telomerase elongation stage or the DNA
replication stage. Ideally, when telomerase adds more than four 5’-TTAGGG-3’ repeats to
the TS primers, a G-quadruplex can be induced and stabilized by a G4 ligand in
solutions. Then, the G-quadruplexes will inhibit the binding of telomerase and stop the
further extensions. This leads to fewer telomerase products as templates in the following
PCR process, resulting in a larger number of thermal cycles to reach the threshold.
However, the ligands of interest can potentially bind to duplex DNA as well due to the
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nature of its stacking surface. Such binding could inhibit DNA polymerase activity in the
PCR step. If a ligand binds to duplex DNA not G-quadruplex DNA, it will give a false
positive result because more thermal cycles are still needed to reach the threshold. In this
scenario, a telomerase inhibitor and a duplex DNA binder will give similar results in the
real-time PCR TRAP assay. This possibility could not be neglected especially for some of
our complexes such as 20-Ni and 21-Ni that function as both telomerase inhibitors and
duplex DNA binders in real-time PCR experiments. To clarify, we further performed an
electrophoresis-based 32P TRAP assay to get a more detailed picture of the telomerase
inhibition effects of the 5-substituted phenanthroline Ni2+ complexes.
Electrophoresis-based 32P TRAP assay. In a radioactive TRAP assay, the TS
primers are labeled at the 5’-end with a 32P phosphate group. Thus, when the PCR
products are resolved in an acrylamide gel, the extended TS primers with different copies
of 5’-TTAGGG-3’ can be separated by electrophoresis and form a ladder. The gel is
visualized by autoradiography and the length of the ladders is correlated to the telomerase
activities. To determine whether the positive effects resulting from inhibition of
telomerase or inhibition of DNA polymerase, we added an internal standard
oligonucleotide TSNT and its reverse primer NT into the reactions. TSNT is a non-G-rich
oligonucleotide that cannot be extended by telomerase. It can be replicated by DNA
polymerase using TS as the forward primer and NT as the reverse primer. Using this
modified method, several scenarios could exist. If a ligand binds to G-quadruplex DNA
but does not affect DNA polymerase, we should observe the PCR products of TSNT and
no elongated products from telomerase extension. If the ligand has no effect on both
telomerase and DNA polymerase, we should observe both TSNT products from PCR and
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elongated products by telomerase. If the ligand only inhibits DNA polymerase activity,
we should observe elongated products from telomerase and no TSNT products from PCR.
Therefore, the presence of the TSNT products can report the ligands selectivity against
G-quadruplex (telomerase) over duplex DNA (polymerase).
We first analyzed all the complexes with the 32P-TRAP at a relatively high
concentration (50 µM). The internal standard TSNT is a 36 nt (nucleotide) product (IS,
Figure 3-17) that has a higher mobility than the products elongated by telomerase on the
gel. The length of telomerase products starts from 50 nt and they form a ladder with a 6 nt
gap between two adjacent bands (Figure 3-17). Regardless the hybridization position of
the primer (RP) on TS, the first three telomerase products are all 50 nt long (Figure 3-17).
Thus, the band representing the 50 nt long product has a high intensity on the gel. In the
presence of a G4 ligand, the formation of the first three telomerase products will not be
inhibited, because the products are not long enough to form a G-quadruplex. Therefore,
this band can always be observed on the gel regardless the presence of the ligands.

Figure 3-17. Illustration of the telomerase-extended products in a TRAP assay.
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We employed two well studied small molecules BIBR and TMPyP4 (50 µM and
100 µM) as the control compounds. BIBR is a noncompetitive telomerase inhibitor
without interactions with DNA.210 TMPyP4 is a well-studied DNA ligand that binds to
both G-quadruplexes and duplex DNA.211-212 In the resulted gel, a telomerase positive
control lane (lane 1in Figure 3-18) gave a clear ladder for telomerase products with
different lengths and an internal standard band (IS) located at the bottom. A telomerase
negative control lane (lane 14 and 28) only showed an internal standard band. In the
presence of BIBR, no telomerase products ladder can be found, and the intensity of the
internal standard was not affected suggesting that it only inhibits telomerase not DNA
replication (lane 2). When TMPyP4 was added, both telomerase products ladder and the
internal standard disappeared suggesting the inhibition of both telomerase and DNA
polymerase activities (lane 3). The twenty-one complexes were studied with this TRAP
assay at a concentration of 50 µM, and the results are highly consistent with the data from
previous experiments (lane 5 to 27). Complexes 3-Ni, 8-Ni, 12-Ni, 13-Ni, 14-Ni, 17-Ni,
19-Ni, 20-Ni, and 21-Ni inhibited telomerase activity with various selectivity. Complexes
3-Ni, 8-Ni, 17-Ni, 21-Ni, and 20-Ni had strong inhibition effects at this concentration
because both the telomerase elongated products and internal standards were completely
missing. For these complexes, it is necessary to perform a concentration-dependent study
because when the duplex amplification was completely inhibited, it was not clear if the
telomerase extension was inhibited or not. Complexes 13-Ni and 14-Ni gave a better
selectivity at the same concentration than the others, and the internal standards were not
affected. Meanwhile, the effect of 10-Ni and 16-Ni was not able to be analyzed using
electrophoresis. Their PCR products remained in the loading wells of the acrylamide gels
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probably due to DNA condensation by these two complexes. The reason of this
condensation remained unclear to us at this point.

Figure 3-18. 32P TRAP reactions for all Phen-Ni complexes (50 µM). Reactions in the
absence or presence of Ni2+ (50 μM), BIBR (50 μM), and TMPyP4 (100 μM) were
carried out as controls. IS: PCR product as internal standard (TSNT as template). The
reaction in the right lane has no telomerase.

The results of concentration-dependent experiments for 13 and 13-Ni are shown
in Figure 3-19. Inhibition of telomerase by 13 was observed when its concentration was
larger than 25 µM. No inhibition of DNA polymerase activity by 13 was observed even at
the concentration of 50 µM. When 13 was coordinated with Ni2+ ions, the resulting 13-Ni
showed significantly decreased telomerase inhibition effect. The inhibition of telomerase
activity was barely observed when 30 µM of 13-Ni was used. By contrast, no inhibition
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of DNA polymerase by 13-Ni was observed up to 50 µM. All these results are consistent
with the data from the real-time PCR TRAP assay. It is reasonable for us to conclude the
13 may inhibit telomerase activity via the direct interaction with the protein, not the Gquadruplex formation approach. The detailed mechanism of action is still unclear. It is
noteworthy that the complex 13-Cu (50 µM) formed by mixing 13 and Cu2+ in a 1:2 ratio
also showed the inhibition effect of telomerase activity.

Figure 3-19. 32P TRAP reactions in the presence of 13 (left) at concentrations of 50, 25,
12.5, 6.25 and 3.125 µM (from left to right). 32P TRAP reactions in the presence of 13-Ni
(right) at concentrations of 50, 40, 30, 20, 15 and 10 µM (from left to right). Reactions in
the presence of 13-Cu2+ (50 μM), Ni2+ (50 μM), BIBR (50 μM), and TMPyP4 (100 μM)
were carried out as controls. IS: PCR product as internal standard (TSNT as template).
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The complex 14-Ni also exhibited a significant telomerase inhibition effect at 25
µM (Figure 3-20). No inhibition of DNA polymerase activity was observed in the
presence of 50 µM 14-Ni, suggesting selective inhibition of telomerase over DNA
polymerase could be achieved under the concentration range used. In the presence of 50
µM 14, the inhibition of both telomerase and DNA polymerase was not observed. Unlike
13-Cu, the complex 14-Cu (50 µM) could not inhibit telomerase activity.

Figure 3-20. 32P TRAP reactions in the presence of 14-Ni at concentrations of 50, 25,
12.5, 6.25 and 3.125 µM (from left to right). Reactions in the presence of 14 (50 μM), 14Cu2+ (50 μM), Ni2+ (50 μM) and BIBR (50 μM) were carried out as controls. IS: PCR
product as internal standard (TSNT as template).
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In the presence of 50 µM 8-Ni, the inhibition of DNA polymerase and telomerase
activity was observed. Selective inhibition of telomerase over DNA polymerase was
detected in the presence of 45 µM 8-Ni. The minimal telomerase inhibitory concentration
of 8-Ni was 25 µM. As a comparison, compound 8 did not exhibit any telomerase and
DNA polymerase inhibition at 50 µM.

Figure 3-21. 32P TRAP reactions in the presence of 8-Ni at concentrations of
50,45,40,35,30,25 and 20 µM (from left to right). Reactions in the presence of 8 (50 μM),
BIBR (50 μM) and TMPyP4 (100 μM) were carried out as controls. IS: PCR product as
internal standard (TSNT as template).
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In the presence of 30 µM 17-Ni, the inhibition of both DNA polymerase and
telomerase activity was observed (Figure 3-22). Selective inhibition of telomerase over
DNA polymerase was detected in the presence of 25 µM 17-Ni. The minimal telomerase
inhibitory concentration of 17-Ni was 15 µM. As a comparison, compound 17 at 50 µM
only exhibited limited inhibition of telomerase activity with no inhibitory effect on DNA
polymerase.

Figure 3-22. 32P TRAP reactions in the presence of 17-Ni at concentrations of 30, 25, 20,
15 and 10 µM (from left to right). Reactions in the presence of 17 (50 μM), BIBR (50
μM) and TMPyP4 (100 μM) were carried out as controls. IS: PCR product as internal
standard (TSNT as template).
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The results of 3-Ni were similar to all the complexes mentioned above except that
it has worse inhibitory selectivity for telomerase over DNA polymerase (Figure 3-23). At
the concentration of 30, 40 and 50 µM 3-Ni, the inhibition of both enzymes was
observed. In the presence of 20 µM 3-Ni, the inhibition of telomerase activity was
detected while no inhibition effect on DNA polymerase was observed. 3-Ni at 10 µM
showed no inhibition effect on both enzymes, suggesting a very narrow concentration
range for selectivity inhibition of telomerase over duplex DNA polymerase.

Figure 3-23. 32P TRAP reactions in the presence of 3-Ni at concentrations of
50,40,30,20,10 and 5 µM (from left to right). Reactions in the presence of 3 (50 μM),
BIBR (50 μM) and TMPyP4 (100 μM) were carried out as controls. IS: PCR product as
internal standard (TSNT as template).
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All the Phen-Ni mentioned contain an aromatic moiety (arylsulfanyl group) at 5position of phenanthroline. In this section, we studied two complexes 20-Ni and 21-Ni
that contain a positively charged side chain. At the highest concentration (50 µM),
inhibition of both telomerase and polymerase was observed (Figure 3-24). Between 6.25
and 25 µM, the telomerase extension product bands gradually decreased as a function of
increasing ligand concentration while the intensity of the PCR product remained
unchanged, a strong evidence of selective inhibition of telomerase over polymerase by
these two complexes. No telomerase inhibition could be detected at 3.125 µM, the lowest
ligand concentration used. Interestingly, when the TRAP reactions were conducted with
either 20 or 21 with Cu2+, in a 2:1 ratio, no inhibition effect could be observed. Phen and
Cu2+ most likely form a geometry intermediate between the trigonal bipyramid and
square pyramid213 which stacks to G-quadruplex DNA less efficiently. Several complexes
formed by coordination of phenanthroline and Cu2+ ions have been used as G4 ligands.
However, they were modified by attaching side chains at the inner crescent side of
phenanthroline. These side chains are closer to the chelation sites of phenanthroline can
significantly affect the chelation mode with Cu2+ ions.180-181
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Figure 3-24. 32P TRAP reactions in the presence of 20-Ni (left) and 21-Ni (right) at
concentrations of 50, 25, 12.5, 6.25 and 3.125 µM (from left to right). Reactions in the
presence of 20 or 21 (50 μM), 20-Cu2+ or 21-Cu2+ (50 μM), Ni2+ (50 μM), BIBR (50 μM)
and TMPyP4 (100 μM) were carried out as controls. IS: PCR product as internal standard
(TSNT as template).

It is noteworthy that the concentration of Phen-Ni to inhibit the telomerase
activity reported here were comparable with other known G4 ligands such as PIPER214-215
and phenanthroline derivatives216. Our TRAP results were in close agreement with the
data from the FID assay-most of the complexes with a low G4DC50 value showed a good
telomerase inhibition effect, implying that the observed telomerase inhibition by Phen-Ni
could result from their binding to/inducing G-quadruplex structures.
3.3.6. 5-Substitued Phen-Ni complexes inhibited telomerase positive cancer
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cell growth. By inhibiting the telomerase-mediated telomere maintenance, many G4
ligands showed cytotoxicity against telomerase-positive cancer cell lines.141 In this
section, we investigated the cytotoxicity of Phen-Ni against two telomerase-positive
cancer cell lines including HeLa (cervical cancer) and MCF-7 (breast cancer) using the
MTT assay.217-218
In a typical experiment, cancer cells in a growth media were incubated with the
Phen-Ni complex at 100 µM for 72h at 37 ˚C. The reaction mixture was treated with
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) and the cell
viability was determined by measuring the absorbance at 520 nm using a microplate
reader. MTT can be reduced to the colorful formazan by a reductase in live cells. The
number of liveing cells in the media is directly correlated to the absorbance.
Four complexes (3-Ni, 4-Ni, 20-Ni, and 21-Ni) significantly inhibited the
proliferation of both HeLa and MCF-7 cells and two complexes (10-Ni and 14-Ni) only
inhibited the growth of MCF-7 cells. Except for 14-Ni, all the complexes with detectable
cytotoxicity were proved to be telomerase inhibitors in the TRAP experiments. 3-Ni, with
a benzene ring as the side chain, exhibited the greatest inhibition amongst them. Though
3-Ni was the best G4 ligand, it showed moderate inhibition effect on telomerase activity.
The direct correlation between cell viability and telomerase inhibition could not be fully
established. It is plausible that the cytotoxicity of 3-Ni makes it readily permeable
through the lipid bilayer in cell membranes.219 The accumulation of 3-Ni with relatively
high concentration in cells accounts for its cytotoxicity. By contrast, 20-Ni and 21-Ni
contain cationic side chains that should have low permeability. In our experiments,
though 20-Ni and 21-Ni have the strongest telomerase inhibition, they both exhibit
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moderate cytotoxicity toward two cancer cell lines used (Figure 3-25).

Figure 3-25. Cell proliferation of two cancer cell lines in the presence of 5-substituted
Phen-Ni complexes, determined by an MTT assay.

To test if the inhibition effect came from the G-quadruplex stabilization and
telomerase inhibition, the corresponding free compounds in the absence of Ni2+ ions were
studied on HeLa cells (Figure 3-26).
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Figure 3-26. Cell proliferation of HeLa cells in the presence of free 5-substituted
phenanthrolines determined by an MTT assay. The cell proliferation in the absent of
ligand was normalized to 100%.

Interestingly, only complex 3-Ni exhibited significantly improved cell
cytotoxicity compared to the free compound. This further supported that 3-Ni was able to
be diffused into the cells and exhibited its inhibition effects. Since 3-Ni exhibited the
inhibition of internal standards in the TRAP assay, the cytotoxicity could also be, at least
partially, attributed to replication inhibition. The further studies and development of these
complexes in vivo must be combined with drug delivery vehicles that can efficiently
transport them into cells and cell nuclei.
3.4 Conclusion
We investigated a series of 5-substituted 1,10-phenanthroline Ni2+ complexes as
telomeric G-quadruplex DNA ligands. Their binding affinity and selectivity were highly
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depending on the type of their side chains. Both cationic side chains and aromatic side
chains can enhance the G-quadruplex binding affinity of the ligands. Compared to those
cationic diethyl amines and piperidine, arylsulfanyl side chains improved the selectivity
of the ligands against G-quadruplex over dsDNA, which could be used as a better side
chain motif for selective G4 ligands.
Meanwhile, we evaluated several biophysical and biochemical methods used for
studying G4 ligands. Thermal denaturation monitored by fluorescence can be used as a
high throughput method for screening G4 ligands from a large library; however, some
deficiencies must be taken into consideration due to the interferences of fluorophores on
DNA and DNA ligands. In contrast, fluorescent intercalator displacement (FID) assay is a
useful method for semi-quantitatively determine the binding affinity of G4 ligands. This
method is especially useful if the ligand of interest binding to the same location as TO. It
also provides a meaning way to directly measure the selectivity of ligands for Gquadruplex DNA over duplex DNA. Telomeric repeat amplification protocol (TRAP) is
highly useful for telomerase inhibitor studies. Real-time PCR TRAP is a high throughput
assay that can evaluate telomerase activity. However, for G-quadruplex stabilizing
telomerase inhibitor studies, real-time PCR TRAP is not able to differentiate the signals
caused by ligand binding to duplex DNA. For this reason, 32P-TRAP is a reliable method
for G4 ligand studies, in which the duplex DNA binding can be monitored by introducing
an internal standard. For minimal usage of radioactive materials and reliability, we
consider a combination of both methods is ideal for studying G4 ligands.
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Chapter 4. Development of Thiazole Orange Derived G-quadruplex Ligands and
Telomerase Inhibitors.

Thiazole Orange (TO) is a DNA dye that is frequently used to stain DNA in living
cells. The aromatic rings of TO enable it to intercalate to nucleobase pairs and light-up
the DNA as a fluorescence probe. The TO-DNA binding is a reversible process and the
TO can be displaced off from the DNA by other strong DNA ligands. This behavior is
often utilized in a Fluorescent Intercalator Displacement (FID) assay to evaluate the
DNA-ligands binding affinity. In recent years, TO attracts more attention because of its
G-quadruplex DNA binding property. G-quadruplex is a secondary DNA structure that is
closely related to the telomeres maintenance and oncogene regulations in human genome.
TO stacks on G-quadruplexes with a binding affinity that is similar to its duplex DNA
binding. In order to develop novel G4 ligands with a good binding affinity and selectivity,
our group synthesized twelve novel TO derived compounds (CP1-12). Twelve positively
charged side chains were chosen and tethered to the quinoline ring of TO to enhance the
G-quadruplex binding affinity by electrostatic interactions with DNA backbones. In the
present work, several TO derivatives exhibited better G-quadruplex stabilization than
TO, determined by biophysical studies including Circular Dichroism (CD) thermal
denaturation, fluorometric titration, and ESI mass spectrometry. Polyamine and
piperidine/pyrrolidine side chains with suitable chain length significantly improved the
G-quadruplex binding affinity of TO. In a TRAP assay, CP6, with a triply protonated
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polyamine side chain, exhibited a significant telomerase inhibition effect (nanomolar),
with is comparable with the best reported synthetic G4 ligand BRACO-19.
4.1 Introduction
As discussed in the previous sections, G-quadruplex is a DNA secondary structure
that is extensively present in DNA telomeric regions and oncogene promotor regions.
Because of its crucial roles in telomere maintenance and oncogene expressions, many
small molecules have been designed to stabilize G-quadruplexes. All successful Gquadruple ligands share two features: aromatic surfaces that stack onto the G-quartet and
cationic sites that bind onto the phosphate backbones (DNA grooves). Thiazole Orange
(TO) is one of the molecules that meet these requirements (Figure 4-1).

Figure 4-1. The structure of Thiazole Orange.

As discussed in Chapter 2, TO is a DNA dye that binds to both G-quadruplex and
duplex DNA. TO has a similar binding affinity with single G-quadruplex structure and
duplex DNA. It has been reported that TO selectively binds to consecutive G-quadruplex
structures in long G-rich sequences with 700-2000 nucleotides over duplex DNA.192
Therefore, TO is an interesting scaffold for developing novel G4 ligands.
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Most of the well-studied G4 ligands such as PIPER or BRACO-19 have long
cationic side chains that efficiently interact with DNA backbones. In a TO molecule,
there is only one positive charge, and it is located at the aromatic surface that stacking on
the G-quartets. Thus, TO does not provide sufficient interactions with DNA backbones.
As a result, the G-quadruplex binding of TO is relatively weak. In the present research,
we investigated TO derivatives with positively charged side chains, aiming to enhance
the G-quadruplex binding affinity.
Twelve TO derivatives with a range of side chains were synthesized in the earlier
work of our group (Figure 4-2). The side chains were carefully chosen to study the effects
of the factors including side chain length, positive charge density and chain flexibility.
Accordingly, these side chains can be grouped into three categories: aliphatic amines,
polyamines, and polyethylene glycol amines. The derivatives (CP1, CP2, and CP3)
containing aliphatic amino side chains with two, three or six carbons were used to study
the G4 stabilization effects depending on the distance between the positively charged
sites and TO. The derivatives (CP4, CP5, and CP6) containing polyamine with different
number of protonated sites were used to evaluate the charge density effect on the Gquadruplex binding. The derivatives (CP7 and CP8) containing polyethylene glycol side
chains were designed to investigate the effect of side-chain flexibility on G4 binding.
Lastly, the derivatives containing piperidine/pyrrolidine side chains (CP9, CP10, CP11,
and CP12) were also studied because these side chains were used in many successful G4
ligands including PIPER and BRACO-19.
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Figure 4-2 . Structures of twelve TO derivatives and TO acid.

These side chains were tethered onto the nitrogen atom in the quinolinium ring
with an amide linkage. A molecular docking study showed that, when TO stacks on the
G-quartets, the methyl group on this location points out from the G-quartets to the
groove.220 It is reasonable to conclude that a long side chain tethered to this nitrogen can
readily interact with the DNA grooves.
In another study, a homodimeric TO molecule (TOTO) was prepared by bridging
two TO molecules with a cationic chain on the designated nitrogen atoms to increase the
duplex DNA binding affinity (Figure 4-3). Based on the data of an NMR study, TOTO
adopted a bis-intercalation mode on a 5’-CTAG-3’/3’-CTAG-5’ sequence. The
benzothiazole moiety is sandwiched between two pyrimidines (CT), and the quinolinium
between two purines (AG). The N-methyl group of the benzothiazole ring protrudes the
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major groove, and the cationic linker lies in the minor groove crossing from edge to edge
with a perfect matching size (Figure 4-3). This duplex DNA binding is greatly enhanced
by the doubled aromatic stacking size of TOTO and the Columbic attraction between the
side chain linker and the DNA phosphate backbones.221 Therefore, the nitrogen atom in
the quinolinium ring was chosen as a suitable site to install the side chains in our present
research.

Figure 4-3. The structure of TOTO and an illustration of bis-intercalation of TOTO. 221

In the present work, the G-quadruplex stabilization effects of these TO
derivatives were studied using a thermal denaturation monitored by Circular Dichroism.
CP6, with a polyamine side chain, and CP9, with a pyrrolidine side chain, exhibited the
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best G4 stabilization amongst all the compounds tested. The binding affinities of these
compounds toward a human telomeric G-quadruplex DNA were determined using
fluorometric titration experiments. Results from ESI mass spectrometry suggested that,
similar to TO, the TO derivatives produced 1-1, 1-2 and 1-3 complexes with a telomeric
G-quadruplex. In addition, we evaluated their inhibition of telomerase activity in vitro
using the telomerase repeat amplification protocol (TRAP) assay. CP6 exhibited a
remarkable telomerase inhibition effect which is comparable to the most advanced
synthetic G4 ligand BRACO-19. Thus, a polyamine side chain with a suitable length
could be a potential structural motif for developing more potent G4 ligands and
telomerase inhibitors.
4.2 Experimental
4.2.1 Materials and general methods. All chemicals for synthesis were
purchased from Sigma-Aldrich or Fisher Scientific and used without further purification.
All the enzymes were purchased from New England Biolabs. Oligonucleotides were
synthesized on an Applied Biosciences 392 DNA/RNA synthesizer using standard
phosphoramidite protocols and purified using polyacrylamide gel electrophoresis. All the
chemicals and phosphoramidites for DNA synthesis were purchased from Glen Research
(Sterling, VA). The concentrations of oligonucleotide solutions were determined by a
Varian Cary 100 Bio UV-Vis spectrophotometer (Walnut Creek, CA), using the molar
extinction coefficients (in units of mol of nucleotide/L-1 cm-1) obtained from Oligo
Analyzer 3.1 (www.idtdna.com). DNA labeling was performed by incubating [γ-32P]-ATP
(300 µCi) and T4 polynucleotide kinase (20 units) in the presence of an oligonucleotide
(1 µg) at 37 °C for 45 min. Unreacted [γ-32P]-ATP was removed using a MicroSpin G-25
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column (GE Health care). [γ-32P]-ATP was purchased from PerkinElemer (Waltham,
MA). Quantification of 5' 32P-labeled oligonucleotides was carried out using a Storm 860
phosphor imager and ImageQuant 5.1 software (Molecular Dynamics). Cell culture
media and supplements (fetal bovin serum, L-glutamine, and sntibiotic-antimycotic) were
purchased from Invitrogen.
4.2.2. Circular dichroism G-quadruplex denaturation analysis. A stock
solution containing 100 µM human telomeric oligonucleotides PCG1 (5’-AGG GTT
AGG GTT AGG GTT AGG GT-3’), 20 mM lithium cacodylate buffer (pH=7.0) and 150
mM NaCl was prepared and incubated at 95˚C for 5 min, slowly cooled to room
temperature and stored at 4 ˚C for overnight to form the corresponding G-quadruplex
structure.
CD thermal denaturation spectra of solutions containing 5 µM PCG1, 20 µM TO
derivatives, 20 mM lithium cacodylate buffer (pH=7.0) and 150 mM NaCl were collected
at 290 nm as a function of temperature (25-95 ˚C) at a heating rate of 0.5 ˚C/min with a
Jasco J-810 spectropolarimeter. The data in CD mdeg units were converted into molar
ellipticity using the Spectra Manager (Jasco). Melting profiles were smoothed and
analyzed using Originlab and the temperature with the lowest first derivative was
determined as the melting temperature (Tm).
4.2.3. Fluorometric scan of TO derivatives interacting with G-quadruplex. A
stock solution containing 100 μM human telomeric G-quadruplex sequence PCG1 (5’AGG GTT AGG GTT AGG GTT AGG GT-3’), 10 mM lithium cacodylate buffer
(pH=7.0) and 50 mM KCl was prepared and incubated at 95 ℃ for 5 min, slowly cooled

153
to room temperature and stored at 4 ℃ for overnight.
Reaction solutions containing 0.25 μM PCG1, 10 mM lithium cacodylate buffer
(pH=7.0) and 50 mM KCl were prepared from the stock solution before use. This
solution was incubated with 0.5 μM TO derivatives for 30 min in the dark. Spectra
(excitation: 501 nm, slit width: 5.0 nm, scan speed 120 nm/min) were recorded in the
range of 510-650 nm.
4.2.4. Fluorometric titration of TO derivatives interacting with G-quadruplex
and duplex DNA. Stock solutions containing 200 μM human telomeric G-quadruplex
sequence PCG1 (5’-AGG GTT AGG GTT AGG GTT AGG GT-3’) or 100 μM 17 mer
dsDNA S1 (5’-GCCAGTTCGTAGTAACC-3’/3’-GGTTACTACGAACTGGC-5’), 10
mM lithium cacodylate buffer (pH=7.0) and 100 mM NaCl were prepared and incubated
at 90 ℃ for 5 min, slowly cooled to room temperature and stored at 4 ℃ for overnight. A
solution containing 0.5 µM TO derivatives, 10 mM sodium cacodylate buffer (pH=7.0)
and 100 mM NaCl was prepared and aliquots of the stock solution of PCG-1 or 17 mer
duplex DNA were gradually added. The spectra of fluorescence (excitation: 501 nm, slit
width: 5.0 nm, scan speed 120 nm/min) were recorded from 510-650 nm after each
addition. The maximum fluorescence intensities were plotted against the equivalent
concentrations of the DNA and the binding parameters were extrapolated using a
software Prism 7.0.
4.2.5. Mass Spectrometry. A human telomeric DNA sequence PCG1 (5’-AGG
GTT AGG GTT AGG GTT AGG GT-3’) and two complementary DNA sequences S1(5’AGC GAT GAG AGG CCA CGA GGA ATC GCT GGT ACC G-3’/ 5’-CGG TAC CAG
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CGA TTC CTC GTG GCC TCT CAT CGC T -3’) were heated to 95 °C for 5 mins
followed by cooling slowly to room temperature and stored in 4°C for overnight in 150
mM NH4OAc solution. TO derivatives (250 µM) were mixed with the DNA (50 µM) and
the resulting complex solutions were injected into a Thermo Fisher Orbitrap Fusion
Tribrid Mass Spectrometer (San Jose, CA) with 50% methanol-water at a rate of 5
µl/min. The ion spray voltage was set to -2,250 V and ion transfer tube temperature to
300 °C. Nitrogen sheath and auxiliary gas flows were 45 and 0 arbitrary units,
respectively. The collision energy was adjusted to 5 or 10 arbitrary unit (au). MS spectra
were recorded in the m/z range from 1400 to 1800 with an average of 150 scans. Data
were collected and analyzed using the Xcalibur software.
4.2.6. TRAP assay. Cell lysates containing telomerase were extracted from
cultured HeLa cells. The cells from a 90% confluent 225 cm2 culture flask were washed
with cold phosphate-buffered saline(PBS) and scraped off from the culture flask in 1 ml
cold PBS. The cells were pelleted in 1.5 ml conical tubes by spinning for 5 min at
1000rpm and suspended in 1ml cold 1× CHAPS Lysis Buffer. The suspension was
incubated on ice for 30mins and centrifuged at 12,000g for 10 minutes at 4°C. The
supernatant was extracted and stored at -80°C.
A reaction mixture (50 μL) was prepared containing 5′-[32P]-labeled TS primer
(0.1 μg 5’-AATCCGTCGAGCAGAGTT-3’), RP (0.1 μg, 5’GCGCGGCTTACCCTTACCCTTACCCTAACC-3’), NT (0.1 μg, 5’ATCGCTTCTCGGCCTTTT-3’), TSNT (0.01 amol, 5’AATCCGTCGAGCAGAGTTAAAAGGCCGAGAAGCGAT-3’ ), buffer: [Tris-HCl (20
mM, pH 8.3), MgCl2 (1.5 mM), KCl (63 mM), 0.05% Tween 20, EGTA (1 mM)], cell
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lysate (1 μL), Taq polymerase (2 units), dNTP mix (50 μM), and TO derivatives (3.125100 μM). This solution was incubated at 30°C for 30 min, 94°C for 2 min followed by a
3-step PCR method (94 °C for 20 s, 59 °C for 30 s, and 72 °C for 30 s) with 25 cycles.
The reaction solution was mixed with 10 μL 10×loading dye and resolved with 10%
denaturing polyacrylamide gel [5% crosslink, 45% urea w/w].
4.2.7. MTT cell viability. MCF-7 cells (human breast adenocarcinoma cells) and
HeLa cells (cervical cancer cells) (a generous gift from Dr. William. K. Chan, UOP) were
maintained in advanced DMEM medium solutions supplemented with 5% fetal bovine
serum, L-glutamine and antimycotic at 37 °C in a humid atmosphere containing 5% CO2.
The TO derivatives were pre-dissolved in sterilized water. The cells were seeded in a 96well plate (3000 cells/well). After 24h incubation, the supernatant was removed followed
by adding 200 µl FBS free media containing TO derivatives. After 72h incubation, 20 µl
MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-di- phenyl tetrazolium bromide) (0.5 mg/ml) was
added for further 4h incubation. The supernatant was removed, and the formazan product
was dissolved in 150 µl of DMSO before measurement. The absorbance was measured at
590nm using a TriStar LB 941 Multimode Microplate Reader. Untreated cells and media
without cells were used as controls. To calculate the viability (%), the following equation
was used:
(𝐴𝑡𝑟𝑒𝑎𝑡𝑒𝑑 )−(𝐴𝑚𝑒𝑑𝑖𝑎 )
𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 )−(𝐴𝑚𝑒𝑑𝑖𝑎 )

Viability (%)=(𝐴

× 100%

Atreated: The absorbance of the solution containing treated cells
Amedia: The absorbance of the media
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Auntreated: The absorbance of the solution containing untreated cells
4.3 Results and Discussion
4.3.1. Thiazole orange derivatives stabilized human telomeric Gquadruplexes. In the previous studies of our group, all twelve derivatives were examined
by a thermal denaturation experiment monitored by fluorescence. CP6 containing a
polyamine side chain and CP9 containing a pyrrolidine side chain exhibited strong G4
stabilization effect. At the ratio of 10:1 (ligand:DNA), CP6 and CP9 elevated the melting
temperature (Tm) of the human telomeric G-quadruplex with 8.60 ˚C and 8.85 ˚C,
respectively. However, there were some concerns with this assay. A saturation of the Tm
increment induced by the compounds was never reached even in the presence of highly
concentrated compounds. As discussed in chapter 3, thermal denaturing monitored by
Fluorescence has certain drawbacks due to the interferences between the fluorescence
molecules and the tested compounds. Specifically, TO and TO derivatives have an
excitation/emission spectra at 501 nm/510 nm which is partially overlapping with the
spectra of the fluorophore probe in the thermal denaturation experiment (492 nm/517
nm). Thus, to obtain more reliable data, we conducted a thermal denaturation monitored
by Circular Dichroism (CD) in the present research.
Circular Dichroism (CD) spectrometry is a common technique to analyze DNA
G-quadruplex conformations. Different G-quadruplex structures can be distinguished
from the distinct features of their CD spectra.222 The conformation of the human
telomeric G-quadruplex DNA (G4, 5’-AGGGTTAGGGTTAGGGTTAGGGT-3’) is
cation dependent.58 It forms two distinguished conformations in the presence of Na+ and
K+ ions respectively (Figure 4-4). In the presence of K+ ions, a hybrid-type telomeric G-
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quadruplex is observed with a positive peak around 290 nm and a negative peak around
240 nm.58, 169 When Na+ ion is used, a positive peak around 290 nm and a negative peak
around 265 nm are observed indicating the presence of a basket-type G-quadruplex.58
Under both conditions, the positive peak at 290 nm represents the G-quadruplex
structures, and its intensity will decrease when a G-quadruplex dissociates into a random
coil (Figure 4-4). Thus, thermal denaturation of G-quadruplex DNA can be conducted by
monitoring the CD ellipticity at 290 nm. The melting temperature (Tm) is defined as the
temperature, at which 50% of the G-quadruplexes dissociate into random coils. It can be
extrapolated by the first derivatives from the plots of the molar CD ellipticity against the
temperatures.
CD thermal denaturation experiments in the presence of twelve derivatives were
conducted under two conditions: 100 mM K+ ions and 150 mM Na+ ions. These are the
most frequently used conditions in G-quadruplex related studies because they produce
reliable data. The physiological intracellular concentrations for these two ions in a normal
cell are approximately 14 mM for Na+ and 150 mM for K+.223 In cancer cells, a 30%
decrement of K+ ion concentration and a 30% elevation of Na+ ion concentrations
compared to those in normal cells are observed, which are closely related to
carcinogenesis and related signaling pathways.224 The concentration elevation of these
ions in cancer cells could directly regulate the G-quadruplex formation and are
considered as a sign of aggressive cancer cells.225-226 Thus, even not exactly same as the
intracellular concentrations in cancer cells, the conditions in our experiments are still
suitable for G4 ligands studies.
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Figure 4-4. CD spectra of G4 in the presence of 150 mM Na+, 100 mM K+, and in the
absence of cation.

Under the designated conditions, CD thermal denaturation experiments were
conducted in the presence of twelve derivatives, together with TO and TO acid in the
ratio of 1:4 (DNA:ligand). TO acid was tested here because it was the precursor used to
tether the side chains (Figure 4-1). The Tm values were extrapolated from the thermal
denaturing profiles (Figure A-10) and plotted in the bar graphs (Figure 4-5).
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Figure 4-5. G-quadruplex Tm values determined by the CD thermal denaturation
experiments in the presence of TO derivatives.

Table 4-1 . Tm values (˚C) of G4 in the presence of TO derevetives.
Blank CP1

CP2

CP3

CP4

CP5

CP6

CP7

100mM K+
150mM Na+

52.60
57.54

59.24
57.53

60.23
56.53

62.28
60.03

60.48
61.53

62.44
58.54

71.02
65.04

58.68
56.03

100mM K+
150mM Na+

CP8
59.41
57.03

CP9 CP10 CP11 CP12 TO
TO acid
69.44 64.03 59.67 64.88 63.99 NA
62.53 56.04 60.52 60.53 60.03 57.05

In the absence of any ligands (blank), the Tm value in 150 mM Na+ solution (57.54
˚C) was significantly higher than that in 100 mM K+ solution (52.60 ˚C). It is well-known

that Na+ and K+ ions have similar stabilization effects on G-quadruplexes and a higher
cation concentration can elevate the Tm of G-quadruplexes.227
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For the same ligand, the Tm increments in 100 mM K+ solution were always
greater than that in 150 mM Na+. All the compounds stabilized the G-quadruplexes
(produced a higher Tm than the blank) in 100 mM K+ and the highest Tm was acquired by
CP6 (71.02˚C). In 150 mM Na+, only seven compounds stabilized the G-quadruplexes
(CP3, CP4, CP5, CP6, CP9, CP11, CP12, and TO), and the highest Tm was 65.04 ˚C
produced by CP6. As discussed in previous chapters, cations sit between the G-quartets
and coordinate with the guanines. Meanwhile, cations also form a hydrated spine in the
DNA grooves. Thus, the highly concentrated salts in 150 mM Na+ solution will compete
with the ligand binding. This observation was consistent with many reports that highly
salted conditions significantly reduce the DNA-ligand binding.192
Regardless of the different extent of Tm values, two conditions produced similar
trends of G-quadruplex stabilization for the compounds. Lower stabilization effects were
observed for aliphatic amine side chain containing derivatives CP1 (59.24 ˚C), CP2
(60.23 ˚C), and CP3 (62.28 ˚C) than TO (63.99 ˚C) in 100 mM K+ and nearly no
stabilization effect in 150 mM Na+. Aliphatic chains sometimes can provide hydrophobic
interactions with DNA in some reported ligands. However, in these TO derivatives, no
improvement was observed. This may occur due to the geometry of the side chains which
are not efficiently fitting with the G-quadruplex structure and consequently provides no
additional interactions. CP3, with the longest aliphatic chain, produced the highest Tm in
both conditions amongst the aliphatic amine derivatives, and suggested that the longer
side chain with higher flexibility may provide better interactions of the positive charge
with the grooves.
Amongst the compounds with polyamine side chains CP4 (60.48 ˚C /61.53 ˚C),
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CP5 (62.44 ˚C /58.54 ˚C) and CP6 (71.02 ˚C /65.04 ˚C), CP6, with the longest side
chain, had a much stronger stabilization effects than TO (63.99 ˚C /60.03 ˚C). Similarly,
a longer side chain is more favored for the G-quadruplex stabilization. CP6 was the
strongest ligand amongst all twelve ligands under both conditions and significantly
improved the binding affinity of TO. CP6 consists of three positively charged amine
groups on a long flexible side chain. Positively charged sites in CP6 interact with the
phosphate groups of the DNA backbones and enhanced the G-quadruplex binding. CP4
with one less positive charge exhibited a weaker stabilization effect than CP6.
Meanwhile, CP5 with similar two positive charges but a shorter chain length did not
exhibit the same stabilization effect as CP6, suggesting that a flexible long side chain is
indispensable for the binding of TO derivatives to G-quadruplexes. This was also
consistent with the stabilization behaviors of aliphatic amine derivatives CP1, CP2 and
CP3.
Polyethylene glycol side chains are more flexible than aliphatic side chains.
However, CP7 (58.68 ˚C/56.03 ˚C) and CP8 (59.41 ˚C/57.03 ˚C) gave the worst
stabilization effects under both conditions. The electronegative oxygen atoms have
charge repulsion effects against the DNA phosphate backbone and consequently decrease
the stabilization effects. For the same reason, TO acid also exhibited poor stabilization
effect.
CP9, CP10, CP11, and CP12 contain piperidine or pyrrolidine side chains. Both
piperidine and pyrrolidine motifs can be protonated under physical conditions and form
positive charges. CP9 with a pyrrolidine ring at the end of the side chain was the second
strongest stabilizer amongst all twelve ligands. A pyrrolidine group in CP9 (69.44
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˚C/62.53 ˚C) gave better G-quadruplex stabilization than a piperidine group in CP10
(64.03 ˚C/56.04 ˚C). A similar observation was also reported by another research
group.228 Ligands with polyethylene glycol side chains, CP11 (59.67 ˚C /60.52 ˚C) and
CP12 (64.88 ˚C/60.53 ˚C), did not significantly enhance the G-quadruplex stabilization
effects of TO (63.99 ˚C/60.03 ˚C) because of the charge repulsion forces from the oxygen
atom(s), even coupled with a pyrrolidine or piperidine ring.
Overall, CP6 and CP9 exhibited the best stabilization among twelve compounds.
The pyrrolidine and polyamine side chain significantly improved the G-quadruplex
stabilization effect of TO. Meanwhile, a long flexible linear geometry side chain of the
ligands is essential for efficient interactions of the terminal amino groups with the Gquadruplexes.
4.3.2. Thiazole orange derivatives preserve G-quadruplex light-up probe
properties. DNA dyes such as TO has significant fluorescence enhancements upon
binding to DNA.229 TO-DNA complexes emit intensive fluorescence at around 530-540
nm with a significant quantum yield when excited at 500 nm. This light-up feature
enables TO and some of its derivatives to be used as probes for both duplex and Gquadruplex DNA in living cells and electrophoresis gels. Meanwhile, TO is frequently
used in a Fluorescence Intercalation Displacement (FID) assay to study other DNA
ligands, in which a pre-bond TO molecule can be displaced off from the DNA by a strong
ligand. In order to study the side chain effects on the fluorescence signal of TO-DNA
complexes, we incubated all the derivatives with a human telomeric G-quadruplex (G4,
5’-AGGGTTAGGGTTAGGGTTAGGGT-3’) and recorded the yielded fluoresce (Figure
4-6).
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Figure 4-6. Fluorescence scan of TO derivatives in the presence of human telomeric Gquadruplex. CG-quadruplex=0.25 µM; CTO=0.5 µM.

The background signals of the derivatives in the absence of DNA are nearly zero
in solution. The maximum fluorescence intensities of the compounds were all present at
around 535 nm. No significant shift of the maximum fluorescence emission was observed
for any of the derivatives because the conjugated chromophore structures of the
derivatives were not greatly affected by the side chains.
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Figure 4-7. Maximum fluorescence intensities of twelve TO derivatives in the presence
of G-quadruplexes.

The maximum fluorescence intensities of the ligand-DNA complexes were plotted
in a bar graph and compared with TO (Figure 4-7). Firstly, the overall quantum yield of
twelve derivatives and TO acid in the presence of G-quadruplexes were notably lower
than TO (342.7 au). Most of the side chains have more than one positive charges and
may decrease the hydrophobicity of the local environment which can partially quench the
fluorescence signal. Another previous reported TO conjugate with a positively charged
side chain at the same position was also found diminishing the fluoresce signal of TO.189
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Table 4-2. Fluorescence intensities (au) of TO derivative-G-quadruplex complexes.
Compound
Intensity (au)
Compound
Intensity (au)

CP1
98.4
CP8
96.7

CP2
88.8
CP9
288.7

CP3
181.8
CP10
288.7

CP4
265.9
CP11
224.7

CP5
126.3
CP12
262.8

CP6
250.9
TO
342.7

CP7
31.7
TO acid
76.9

Amongst all the derivatives, a general trend was observed: the derivatives that
exhibited good stabilization effects in the CD thermal denaturation experiments also
showed a relatively higher quantum yield including CP9 (288.7 au), CP4 (265.9 au),
CP10 (288.7 au), CP12 (262.8 au), CP6 (250.9 au), CP11 (224.7 au) and CP3 (181.8
au). Electronegative groups containing compounds CP7 (31.7 au), CP8 (96.7 au), and
TO acid (76.9 au) showed extremely low quantum yield. However, the rank order of Gquadruplex stabilization and fluorescence intensity are not exactly same. This
discrepancy may be partially explained by the different charge locations and charge
densities of the side chains. For instance, CP6 exhibited the best stabilization effect in
CD thermal denaturation experiment but was only at the fifth for the fluorescence
intensity measurements (250.9 au). CP6 has a side chain with three positive charges and
its fluorescence response can be significantly attenuated by the hydrophilicity of this side
chain.
Even with lower quantum yield compared to TO (342.7 au), the derivatives still
preserve the light-up probe properties, and several of them such as CP6 (250.9 au) and
CP9 (288.7 au) can be used to detect the presence of G-quadruplex with stronger binding
affinity than TO.
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4.3.3. Thiazole orange derivatives interact with human telomeric Gquadruplex with enhanced affinities. Because TO derivatives still preserve
fluorescence light-up properties, the binding constants of these compounds can be
conveniently extrapolated from the fluorescence titration curves. In a typical experiment,
a stock solution of human telomeric G-quadruplex (G4, 5’AGGGTTAGGGTTAGGGTTAGGGT-3’) was prepared and gradually titrated into a
solution containing the designated compound. The fluorescence spectra were recorded
after each addition and the maximum intensities were plotted against the concentrations
of the G-quadruplex in the mixture. The consequent curves were processed by leastsquared fitting and the equilibrium dissociation constant (Kd) values were calculated
accordingly. Monchaud and co-workers utilized this titration experiment to compare the
binding affinities of TO against G-quadruplexes with different conformations and a one
site binding mode was discovered for the TO-G-quadruplex complex.188 Similar to the
reported results, our titration indicated that TO binds to G-quadruplex with a one site
binding mode with the Kd value around 0.87 µM (Figure 4-8).
Six compounds (CP4, CP6, CP9, CP10, CP11, and CP12) were studied with this
titration method because they yielded relatively higher fluorescence intensities than the
others upon binding to DNA. CP4, CP9, CP10, CP11, and CP12 exhibited a similar one
site binding mode as TO. The Kd values of CP4 (0.32 ± 0.01 µM), CP6 (0.27 ± 0.02
µM), and CP9 (0.77 ± 0.01 µM) were lower than that of TO (0.87 ± 0.02 µM), while
CP10 (1.13 ± 0.04 µM), CP11 (1.65 ± 0.05 µM), and CP12 (2.18 ± 0.07 µM) produced
higher Kd values than TO (0.87 ± 0.02 µM) (Figure 4-8). This observation was highly
consistent with the results of CD thermal denaturation in the presence of Na+ ions, which
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was a similar condition used in this titration. In the CD thermal denaturing experiments,
CP10, CP11, and CP12 had similar or lower stabilization effects compared to TO, while
CP4, CP6 and CP9 had a higher stabilization effects than TO.
Interestingly, the binding mode evidenced by the least-square fitting of CP6 was
different from those of TO and other derivatives (Figure 4-8). By fitting with one binding
site mode, CP6 produced a Kd value of 0.27 µM which was the lowest amongst all the
derivatives (Figure 4-9). However, the chi-square value of the fitting was 0.97 which was
notably worse than those for other ligands (>0.99). Therefore, the same titration curve for
CP6 was fitted using the two binding sites mode and a chi-square value of 0.999 was
obtained. Two Kd values of CP6 obtained from this fitting mode were 0.07 ± 0.04 µM
and 1.73 ± 0.11 µM. The Kd value of the main binding of CP6 with the G-quadruplex
was remarkably lower than the value of TO (0.87 ± 0.02 µM), suggesting a very strong
binding. This result is consistent with the previous observation that CP6 stabilized the Gquadruplex most among all the TO derivatives. This fitting also suggested that there is a
second binding site in the G-quadruplex for CP6. Since CP6 is tethered with a side chain
containing three positive charges, groove binding could occur due to the charge
interactions between the ligand and the DNA backbones.
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Figure 4-8. Fluorometric titration curves of TO and TO derivatives against human
telomeric G-quadruplex. ----two binding site mode; —one binding site mode.

169

Figure 4-9. Kd values of TO and derivatives binding to G4 (solid) and ds17 (blank)
determined by the fluorometric titration experiments.

For the development of G4 ligands, selectivity against G-quadruplex over duplex
DNA is always a contradictory objective when improving the binding affinity. The most
efficient strategy to elevate the binding affinity of a ligand is to incorporate positively
charges that interact with DNA phosphate backbones. However, electrostatic interactions
do not usually provide sufficient selectivity for the ligands. In order to study the
selectivity of the twelve derivatives, the same titration experiments were conducted
against a 17 mer non-G-rich duplex DNA (ds17, 5’-GCCAGTTCGTAGTAACC-3’/3’GGTTACTACGAACTGGC-5’) (Figure 4-10). It was reported that TO has a similar
binding affinity against G-quadruplex and duplex DNA.188 In our experiments, the Kd
value of TO binding to ds17 was determined as 0.40 ± 0.00 µM which was within the
same range as that of G-quadruplex binding (0.87 ± 0.02 µM) under the same
experimental conditions. This Kd value is close to the reported values from other research
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groups.188

Figure 4-10. Fluorometric titration curves of TO and TO derivatives against ds17 ----two
binding site mode; —one binding site mode.
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The Kd values of CP4, CP6, CP9, CP10, CP11 and CP12 binding to ds17 were
also determined. Their selectivity for G-quadruplex over duplex DNA was compared with
the ratio of Kd-G4/Kd-ds17 (Table 4-3). The smaller the ratio is, the better the binding
selectivity is. As expected, the derivatives did not show a noteworthy improved
selectivity compared to TO because of the additional positively charged side chains. As
discussed in chapter 1, highly selective G4 ligands such as telomestatin usually contain
enlarged aromatic surfaces. The addition of multiple positively charged side chains
improves their binding affinity through the charge interactions with the DNA phosphate
backbones. This Coulombic attraction does not differentiate G-quadruplex from duplex
DNA. CP6 (Kd-G4/Kd-ds17=3.20) exhibited the worst selectivity amongst the
compounds because of the multiple charges in the side chain. CP9 (Kd-G4/Kdds17=2.04) was the only compound that produced a slightly better selectivity than TO
(Kd-G4/Kd-ds17=2.17). This was consistent with other researcher’s work that pyrrolidine
side chains can produce better selectivity than linear positively charged side chains in a
G4 ligand.230

Table 4-3. The ratio of Kd values between G-quadruplex and dsDNA.
Compound
TO CP6 CP4 CP9 CP10 CP11 CP12
Kd-G4/Kd-ds17 2.17 3.20 2.59 2.04 4.14 2.72 3.05

4.3.4. Thiazole orange derivatives associate with human telomeric Gquadruplexes with various ratios. Electrospray-ionization mass spectrometry is a
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highly sensitive analytical tool for biomolecules including oligonucleotides, peptides and
their non-covalent ligand complexes.231 Compared to other analytical technologies
including NMR and X-ray crystallography, ESI-MS has the advantages of easy sample
preparation and low sample consumption. Because of the known ion suppression effect
from non-volatile salts, ammonium acetate is one of the few salts that is compatible with
ESI-MS oligonucleotides analysis. Similar to K+ and Na+ ions, NH4+ ions can also
coordinate with guanines and stabilize G-quadruplexes. NH4+ ions locate themselves
between two adjacent G-quartets, and the observed number of the NH4+ ions (n) in the
MS spectra can be used to estimate the number of G-quartets layers (n+1).232 Thus, the
presence of NH4+ ions in the G-quadruplexes is very useful to report the formation of Gquadruplexes. Meanwhile, an intercalating G4 ligand may expel the bound HN4+ ions
from the G-quadruplexes which can be observed in the MS spectra. Therefore, ESI-MS is
capable to generate a plenty of information of the ligand-DNA association including the
binding affinity, stoichiometry and binding mode.233 In the present research, we examined
all the compounds mixed with the G-quadruplex (G4, 5’-AGGGTTAGGTTAGGGTTAG
GGT-3’) with negative-ion ESI-MS and Higher Energy Collisional Dissociation (HCD)
experiments. All the spectra are shown in relative abundances with the most abundant ion
in each spectrum corresponding to 100% ion intensity (base peak).
ESI-MS spectra obtained from a solution only contained G-quadruplex
(MW=7270.77) showed the most abundant ions at m/z 1459.85, corresponding to [G4+2
NH4+ -7H+]5- (calculated m/z 1459.95) (Figure 4-11, top graph). There were also two
smaller peaks representing [G4+1 NH4+ -6H+]5- at m/z 1456.46 and [G4+5H+]5- at m/z
1453.04. The latter peaks represent the unfolded, or half unfolded G-quadruplexes that
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were produced in the process of ionization. Then, the same G-quadruplex solution was
mixed with TO or a TO derivative in the ratio of 1-5 (DNA-ligand), and the
corresponding spectra were obtained under the same condition.

Figure 4-11. Negative ion ESI mass spectra of solutions containing CP1-3 and G4. *:
Free G4, α: 1-1 complexes, β: 1-2 complexes γ: 1-3 complexes.

In the spectra obtained from the solution of TO and the G-quadruplex, 1-1, 1-2
and 1-3 complexes were observed, and the 1-1 complex was the most abundant ion
(Figure 4-11-TO). This observation was consistent with previously reported studies that
TO forms complexes with a human telomeric G-quadruplex in the same three ratios.188
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Both CP1 and CP2 formed 1-1 and 1-2 complexes and the 1-3 complex was not
detected in the mass spectra. Similar to TO, CP3 formed three complexes with a ratio of
1-1, 1-2 and 1-3, respectively. The relative intensity of free G-quadruplex in the spectra
of CP3 was significantly lower than those in the spectra of TO, CP1, and CP2,
suggesting stronger binding of CP3 to the G-quadruplex. This observation is consistent
with the CD thermal denaturation results. CP3 showed better stabilization of the same Gquadruplex than TO, CP1, and CP2. It is plausible the longer side chain (six carbons) of
CP3 allows the terminal amino group to interact with the G-quadruplex groove and thus
stabilize the ligand-DNA complex. The side-chain length for CP1 and CP2 are two
carbons and four carbons respectively, which may not be long enough to optimize the
interaction between the amino group and G-quadruplex.
The binding of CP1, CP2, and CP3 to G-quadruplex could also result from the
hydrophobic interaction between aliphatic chains and G-quadruplex groove. However,
such interactions should be reduced or not exist without solvent in the gas phase
condition of ESI mass spectrometry.234 Therefore, the enhanced binding of CP3 came
from the electrostatic attraction between the terminal amino group and negatively charged
DNA backbones. In addition, the longer aliphatic chain of CP3 may allow it to have an
optimized fit to stack with the end G-quartet.
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Figure 4-12. Negative ion ESI mass spectra of solutions containing CP4-6 and G4. *:
Free G4, α: 1-1 complexes, β: 1-2 complexes γ: 1-3 complexes.

CP4, CP5, and CP6 all contain a side chain of polyamines. CP4 that contains a
short side chain with two amino groups formed three complexes with a ratio of 1-1, 1-2
and 1-3 (DNA-ligand), respectively (Figure 4-12). The mass spectrum of CP4 was
similar to that of CP3, with a decreased intensity of the peak representing free Gquadruplex. Surprisingly, CP5 and CP6 each containing three amino groups formed
much less abundant complexes. The intensities of 1-1, 1-2, and 1-3 complexes for these
two compounds were much less than those in the spectrum of CP4. The peaks
representing free G-quadruplex were dominant in the mass spectra of CP5 and CP6.
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These observations were not consistent with our previous studies that side chain with
multiple positive changes should enhance the binding of a ligand to DNA. This
discrepancy could be attributed to the following factors: 1) it was reported that for the
compounds with a polyamine side chains, when the charge number and charge distance
increase, their solubility will drop significantly.235-237 2) side chains of CP5 and CP6 are
similar to spermine which was known to cause DNA condensation at high
concentrations.238 Indeed, DNA condensation was observed when the concentration of
CP6 was over 80 µM in our experiments, which could reduce the detectable amount of
the complexes. 3) In the ESI mass spectrometric experiments, the interference between
the high concentration (150 mM) of NH4+ and CP5 or CP6 may exist. A recent study
suggested that ammonium ions competitively bind to DNA phosphate backbones and can
significantly decrease the binding of multiply charged compounds to the target DNA.239
In our case, the formation of low abundance of complexes between CP5 or CP6 with the
G-quadruplex in ESI mass spectra could result from the same reason.
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Figure 4-13. Negative ion ESI mass spectra of solutions containing CP7-8 or TO-acid and
G4. *: Free G4, α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes.

The formation of complexes between CP7 and the G-quadruplex was negligible
(Figure 4-13). Only a very small amount of 1-1 complex was observed (Figure 4-13).
CP8 formed good amounts of 1-1 and 1-2 complexes with the G-quadruplex. The short
ethylene glycol linker of CP7 significantly decreased the binding of CP7 to the Gquadruplex probably due to the repulsion between the electron-dense oxygen atom and
negatively charged DNA backbones. The longer ethylene glycol linker for CP8 enables
the interaction between the terminal amino group and DNA grooves; therefore, no
noticeable decrease of CP8 in the formation of the complexes was observed. TO acid
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formed less abundance of 1-1 and 1-2 complexes because of the repulsion between the
carboxylic acid group and the DNA backbones.

Figure 4-14. Negative ion ESI mass spectra of solutions containing CP9-12 and PCG1.
*: G-quadruplexes, α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes.

CP9 with a pyrrolidine side chain exhibited a much higher affinity than TO with
three complexes (1-1, 1-2, and 1-3) formed (Figure 4-14). The most abundant ions were
1-2 complexes and almost no free G-quadruplex was observed in the presence of CP9.
CP10, CP11 and CP12 also produced similar MS spectra comparable to CP9. The strong
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binding CP9 to the G-quadruplex determined by ESI mass spectrometry was consistent
with the results from CD thermal denaturation. The strong binding of these four
complexes with the G-quadruplex was probably due to the known binding effect of
pyrrolidine and piperidine to G-quadruplex DNA. In addition, the ESI-MS spectra
revealed that the most abundant complexes of these four ligands were with a ratio of 1-2
suggesting there are two main binding sites in G-quadruplex suitable for these four
ligands.
The relative binding affinity of ligands with DNA can be quantitatively
determined using the Intensity Ratio (IR), which is defined as an abundance ratio of all
the complex ions to the sum of all free G-quadruplexes and complex ions in an ESI-MS
spectrum (Equation 1).233
∑ 𝐼𝑟(𝐺+𝑛𝐿)

𝐼𝑅 = ∑ 𝐼𝑟(𝐺)+∑ 𝐼𝑟(𝐺+𝑛𝐿)

(1)

Here, ∑ 𝐼𝑟(𝐺 + 𝑛𝐿) is the total intensities of the complexes where n=1, 2 and 3;
∑ 𝐼𝑟(𝐺) is the intensity of free G-quadruplexes that was not associated with the
compounds. Therefore, the IR value reflect the binding affinity of the ligands to the Gquadruplex DNA (Figure 4-15).
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Figure 4-15. IR values for TO derivatives binding with G4.

Overall, all the derivatives except for CP7, produced abundant peaks in the ESIMS spectra representing the DNA-ligand complexes in the ratios of 1-1, 1-2, and 1-3. The
weak binding of CP7 to the G-quadruplex was also observed in the previous CD thermal
denaturation experiments. CP9, with a pyrrolidine side chain was proved to be a good G4
ligand binding to G-quadruplex with 1-1, 1-2 and 1-3 mode. The trend of the complex
formation by CP1, CP2, CP3, CP7, and CP 8 suggested that a long flexible side chain is
essential to enable the terminal positively charged group to interact with G-quadruplex
phosphate backbones.
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Table 4-4. IR values for TO derivatives binding with the G4 and the corresponding
complex compositions.
Compound

CP1

CP2

CP3

CP4

CP5

CP6

CP7

Free G4 (%)

100

100

37.17 68.39

100

100

100

1-1 (%)

97.81 77.43 96.79

1-2 (%)

36.74 24.60

1-3 (%)
IR (%)

0

0

100

100
61.20

42.66 46.61
5.69

5.96

22.39

57.36 50.50 85.50 70.21 32.59 34.46

Compound

CP8

CP9

CP10 CP11 CP12

Free G4

91.32

8.80

11.16 31.28 14.58 85.32

1-1 (%)

100

1-2 (%)

38.89

1-3 (%)
IR (%)

3.38

41.81 46.19 78.70 52.71

TO

3.27
TOacid
100

100

67.36

48.21

31.77

13.16

11.96

60.33 95.83 94.49 87.52 91.28 65.41

52.63

100

100

100

60.20 45.10 40.75

100

IR (%)= [1-1] + [1-2] + [1-3]/ G4 + [1-1] + [1-2] + [1-3]

Similar experiments were performed with CP3, CP6 and CP9 binding to a 17mer
duplex DNA (ds17, 5’-CCTCGGCCGGCCGACC-3’/3’GGAGCCGGCCGGCTGG-5’,
MW=10999.25) to study the binding selectivity. These three compounds were chosen
because they are the representative derivatives binding to the G-quadruplex efficiently in
each category.
The ESI-MS spectra showed that TO binds to ds17 with 1-1, 1-2 and 1-3 ratios
(Figure 4-16). CP3, and CP6 bind to ds17 with 1-1 and 1-2 ratios. In addition to these
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three ratios, CP9 binds to ds17 with a 1-4 binding ratio. In all the spectra, the peaks at
m/z 1833.00 representing intact ds17 [ds17-6H]6- were observed (calculated m/z
1832.21).

Figure 4-16. Negative ion ESI mass spectra of solutions containing ds17, CP3, CP6, and
CP9. *: ds 17, α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes, ρ: 1-4 complexes.

The IR values for duplex binding were calculated using the following equation
(equation 2).

𝐼𝑅𝑑𝑠 =

∑ 𝐼𝑟(𝑑𝑠 + 𝑛𝐿)
∑ 𝐼𝑟(𝑑𝑠) + ∑ 𝐼𝑟(𝑑𝑠 + 𝑛𝐿)

(2)

Here, ∑ 𝐼𝑟(𝑑𝑠 + 𝑛𝐿) is the total intensities of the complexes with ds17 where
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n=1, 2, 3, and 4; ∑ 𝐼𝑟(𝑑𝑠) is the intensity of free ds17 that was not associated with the
compounds. The IR value reflects the binding affinity of the ligands to ds17.
The obtained IRds values (Figure 4-17) were compared with their IRG4 values. TO
exhibited minimal selectivity as the IRds value is slightly higher the IRG4 value. CP9
showed a better selectivity for G4 over duplex DNA, indicated by its higher IRds than
IRG4. The selectivity of CP6 was worse than TO, suggested by the relatively higher
IRds/IRG4 ratio (Table 4-5). This observation is highly consistent with the results of
fluorometric titration, except for CP3 which was not studied by fluorometric titration due
to the low quantum yield. These data further confirmed that the pyrrolidine side chain of
CP9 enhances a moderate selectivity for G-quadruplex over duplex DNA. The overall
rank order for the strength of G4 binding is CP9 > CP3 > TO > CP6 and the rank order
for the strength of duplex DNA binding is CP9 > TO > CP3 > CP6. It is noteworthy that
the binding of CP6 could be underestimated because of its multiple positive charges as
stated in the previous sections.
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Figure 4-17. Comparison of IRG4 and IRds values of TO and derivatives.

Table 4-5. The ratio of IR values between CP9 binding G-quadruplex and dsDNA.
Compound
TO CP3 CP6 CP9
IR-ds/IR-G4 1.15 0.56 1.30 0.91

4.3.5. Thiazole orange derivatives form complexes with human telomeric Gquadruplexes with various binding modes. The binding modes of TO derivatives with
the G-quadruplex DNA were further investigated by studying the gas-phase dissociation
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behavior using the High Energy Collision Dissociation (HCD). Since CP9 gave the most
abundant complex ions in the ESI-MS spectra amongst all compounds, we chose CP9 as
a representative compound to demonstrate the binding modes. The study of the binding
mode of G4 ligands is based on previously reported collisional activated dissociation
(CAD) behaviors of the ligand-G-quadruplex complexes. The conclusions from this
report are as follows. A ligand with a low binding affinity can easily dissociate from the
G-quadruplexes at a relatively low collision energy and produces an intact G-quadruplex
(three G-quartets) with two NH4+ ions. In gas phase, G-quartets stacking ligands are often
observed for this dissociation behavior. By contrast, a strong ligand will be retained on
the G-quadruplex even when a high collision energy is applied. Usually, the loss of
guanine nucleobase(s) will happen before the strong ligand dissociates from the
oligonucleotide. If the ligand is a groove binder, the G-quadruplex complex can fully or
partially unfold into a complex structure with the groove binder attached, which can be
detected in the HCD. The distinct feature of the complex is that it has zero or one NH4+
ions, instead of two NH4+ ions as observed in the ligand-G-quadruplex complexes.240
Meanwhile, some ligands form dimers to bind with the G-quadruplexes which should be
taken into the considerations.241
In the HCD experiments, the energy-dependent product ion spectra for 1-1, 1-2
and 1-3 G4-ligand complexes were obtained at the collision energies of 5 and 10 arbitrary
units (au), respectively. For clarity, the rule of annotations below will be used for all the
spectra. The Greek letters α, β, and γ represent 1-1, 1-2 and 1-3 complexes, respectively;
The symbol nN denotes the number of NH4+ ions in the designated complexes. For
example, γ2N represents a 1-3 complex with two NH4+ ions. The symbols 0N and 1N
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represent zero or one NH4+ in the complexes. As indicated above, these two cases mostly
reflect a unfolded or partially unfolded complex structure (not an intact G-quadruplex
secondary structure). The possible fragment pathways of G4-CP9 complexes were
proposed based on the patterns we observed in MS/MS spectra, which will be explained
in detailed (Figure 4-18).

Figure 4-18. The proposed fragmentation pathway of G4-CP9 complexes in MS/MS.
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Figure 4-19. Energy dependent product ion spectra of G4-CP9 1-3 complexes (γ2N).
From top to bottom: a) ESI-MS spectrum of a solution containing CP9 and G4; MS/MS
product ion spectra of G4-CP9 [1-3] complexes at the collision energy of b) 5 au and c)
10 au. α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes; nN, n= the number NH4+
ions.

In this experiment, the 1-3 complexes γ2N [3CP9+G+2NH4+-7H]5- at m/z 1726.57
were isolated and collisionally activated at the energy of 5 au (Figure 4-19a). As
expected, the relative intensity of the precursor ion decreased to 24.13% compared with
the base peak (Figure 4-19b). The dissociation of the ligand yielded a 1-2 complex β2N
[2CP9+G+2NH4+ -7H]5- at m/z 1637.71 (Figure 4-19b). The presence of two NH4+ ions
suggested that this was a complex between two ligands and one intact G-quadruplex. In
addition, the binding of the lost ligand was relatively weak. The binding of the remaining
two ligands was stronger than the dissociated one; otherwise, we would observe a 1-1
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complex or fully dissociated complex. The binding mode of the dissociated ligand could
be end-stacking. It was reported that a G-quartets stacking ligand has relatively low
affinity in the gas phase and even the strongest stacking ligand can be easily removed
from the G-quadruplex at a low collision energy in MS/MS.240 Under the HCD condition
at the 5 au collision energy, β2N further dissociated into β1N [2CP9+G+NH4+-6H]5- at
m/z 1634.33 and β0N [2CP9+G-5H]5- at m/z 1630.94. The binding mode of the remaining
two ligands could be groove binding because β1N and β0N both contained unfolded or
partially folded G-quadruplexes. No observation of the 1-1 complex in the HCD
experiment also supported this conclusion (step c and d in Figure 4-18).
The binding mode of the third ligand could also be groove binding. There were
also 1-3 complexes γ1N [3CP9+G+NH4+-6H]5- at m/z 1723.15 and γ0N [3CP9+G-5H]5at m/z 1719.75 present in the product ions of 1-3 complexes at the 5 au energy level.
These product ions were produced by a precursor 1-3 complexes with three strong groove
binders (γ2N* in Figure 4-18). Three groove binders bind to the G-quadruplex with a
high affinity and they were all retained on the unfolded G-quadruplex (Step e and f in
Figure 4-18). The evidence for three groove binders also came from the HCD experiment
of γ2N [3CP9+G+2NH4+-7H]5- with the collision energy of 10 au (Figure 4-19c). Under
this condition, G-quadruplex fully dissociated, forming a complex ion γ0N [3CP9+G5H]5- at m/z 1719.75 with no NH4+ ions. The complex ion β0N [2CP9+G-5H]5- at m/z
1630.93 became the dominant peak amongst the complex ions containing two ligands and
DNA. Almost no 1-1 complex or free G-quadruplex was observed with the collision
energy of 10 au, further suggesting that two or three ligands of the 1-3 complexes had a
high binding affinity.
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Figure 4-20. Energy dependent product ion spectra of G4-CP9 1-2 complexes (β2N).
From top to bottom: a) ESI-MS spectrum of a solution containing CP9 and G4; MS/MS
product ion spectra of G4-CP9 [1-2] complexes at the collision energy of b) 5 au and c)
10 au. α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes; nN, n=the number NH4+
ions.

1-2 complexes with two NH4+ ions β2N [2CP9+G+2NH4+-7H]5- at m/z 1637.53
were also isolated and collisional activated at the energy of 5 au (Figure 4-20a). No
precursor ions were observed at the 5 au collision energy (Figure 4-20b). The dissociation
pattern was similar to that of 1-2 product complexes in the HCD experiments of 1-3
complexes. At both energy levels, peaks representing 1-1 complexes were observed with
very low abundance. With the collision energy of 10 au, only β0N [2CP9+G-5H]5- at m/z
1630.93 was observed as the dominant peak, suggesting two groove binders present in
the parent ion. The low abundance of α2N[CP9+G+2NH4+-7H]5- at m/z 1545.08
represented a complex formed between an intact G-quadruplex and one CP9 that strongly
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binds to G-quadruplex via groove binding (step d and k in Figure 4-18).
Interestingly, at the 10 au collision energy, a fragment ion at m/z 1600.89 was
observed, representing the loss of a guanine from the complex ion β0N [2CP9+G-5H]5at m/z 1630.90 (step o and k in Figure 4-18). The same guanine loss fragment pathway
was previously reported for several other strong G4 ligands especially those with
positively charged side chains.242 This observation indicated that the groove binding of
CP9 was remarkably strong and will be retained by the oligonucleotide even when the
fragmentation of DNA occurred.

Figure 4-21. Energy dependent product ion spectra of G4-CP9 1-1 complexes (α2N).
From top to bottom: a) ESI-MS spectrum of a solution containing CP9 and PCG1;
MS/MS product ion spectra of G4-CP9 [1-1] complexes at the collision energy of b) 5 au
and c) 10 au. α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes; nN, n=the number
NH4+ ions.
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The 1-1 complexes α2N [1CP9+G+2NH4+-7H]5- at m/z 1548.75 were isolated and
activated at the 5 au collision energy (Figure 4-21a). The single ligand CP9 remained
associated with the DNA, but all the secondary G-quadruplex structures were unfolded to
give α0N [1CP9+G-5H]5- at m/z 1541.89 (step m in Figure 4-18) (Figure 4-21b). At the
10 au collision energy, α0N still remained as the most abundant peak. There was still no
free G-quadruplex was produced but instead, many fragment ions were observed (Figure
4-21c). The major peak was a guanine loss fragment ion at m/z 1512 that was produced
from the ion α0N [1CP9+G-5H]5- m/z 1541.89 (step n in Figure 4-18).
Based on all the results from the HCD experiments of CP9, we can reasonably
conclude that three CP9 molecules could bind to the G-quadruplex. Two of them have
stronger binding affinities than the third one. The binding of the third CP9 to the Gquadruplex could be either end stacking or groove binding or both. Therefore, the
complexes formed by CP9 with different binding modes in the same solution may exist.
Such complexes cannot be differentiated via m/z values. Two CP9 molecules with
stronger binding affinities could also bind to the G-quadruplex via different modes. They
can bind to the G-quadruplex in two separate grooves with similar interactions. It is also
possible that they bind to the same groove of the G-quadruplex as a dimeric form. The
binding of DNA by cyanine dimers have been previously reported.243 Nevertheless, the
binding affinities of these two CP9 molecules should be similar because the dissociation
of one CP9 from the 1-2 complex was minimal in the HCD experiments.
There is a noteworthy discrepancy between ESI-MS and fluorometric titration
experiments (section 4.3.3). MS/MS suggested multiple binding sites for CP9, while only
1-1 binding mode was observed in the fluorometric titration experiments. In a
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fluorometric titration, the emission of the fluorescence majorly comes from the stacking
of the ligand to the G-quadruplexes. The groove binders does not provide as efficient
quantum yields as stacking ligands because the structure of bound groove binders is
relatively flexible.188 For most of the derivatives and TO, the quantum yields from the
groove binding were negligible. In addition, a perfect agreement between results from
fluorescence and ESI-MS should not be expected due to the differences in experimental
conditions.
We further studied CP9 with an intermolecular G-quadruplex [d(T2G5T)]4(G5) to
investigate the binding modes. Different from the human telomeric G-quadruplex PCG1
(G4), G5 was formed by four short G-rich sequences (S1, 5’-TTGGGGGT-3’,
MW=2496.70) containing five G-quartet layers. Therefore, four NH4 + ions were
incorporated in the structure. The use of the intermolecular G-quadruplex in a MS/MS
study allows us to determine the nature of the complex ions. For instance, if the ligand
non-selectively binds to DNA random coils, a complex ion (S1+ CP9) will be observed.
If the ligand can bind to the G-quadruplex, only the complex ion (G5 +CP9) can be
observed. Unlike the experiments using intramolecular G4, the m/z values of these two
complex ions are drastically different. In addition, if a ligand adopts the intercalation
mode, the ejection of NH4+ ions from the G5 should be expected.
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Figure 4-22. Energy dependent product ion spectra of G5-CP9 complexes. From top to
bottom: a) ESI-MS spectrum of a solution containing CP9 and G5; MS/MS product ion
spectra of G5-CP9 [1-3] complexes at the collision energy of b) 2 au and c) 6 au; d)
MS/MS product ion spectra of G5-CP9 [1-2] complexes at the collision energy of 10 au.
α: 1-1 complexes, β: 1-2 complexes, γ: 1-3 complexes;

The ESI-MS spectra revealed that CP9 predominantly binds to G5 with the ratio
of 1-2 β [2CP9+G5+4NH4+-10H]6- at m/z 1822.88 and 1-3 γ [3CP9+G5+4NH4+-10H]6- at
m/z 1896.91 (Figure 4-22 a). A small amount of 1-1 α [CP9+G5+4NH4+-10H]6- at m/z
1748.68 was also present. No free G5 was observed, suggesting the strong binding
affinity of CP9. Different from the binding of CP9 with G4, no ion peaks representing
partially folded or unfolded G-quadruplexes were present in the spectra. All the Gquadruplex exist as intact G-quadruplex with four NH4+ ions.
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The complex ion 1-3 γ [3CP9+G5+4NH4+-10H]6- at m/z 1896.91 was isolated and
subjected to the collision-activated dissociation at the energy of 2 au (Figure 4-22b).
Removal of one CP9 ligand from the λ ion yielded a 1-2 complex β [2CP9+G5+4NH4+10H]6-. The 1-1 complex, free G-quadruplex and S1 strand were not observed in the
product ions. A similar spectrum was obtained even when the collisional energy increased
to 6 au (Figure 4-22c). This observation suggested that, consistent with previous results
of CP9 binding with G4, one of the ligands in the 1-3 complex has a relatively low
binding affinity as compared to other two bound CP9.
The 1-2 complex β [2CP9+G5+4NH4+-10H]6- at m/z 1822.88 was also isolated
and subjected to the collision-activated dissociation at a relatively high energy (10 au)
(Figure 4-22d). No 1-1 complex or free G5 was observed, indicating a remarkably strong
binding of these two ligands. The base peak was at m/z 1722.03. Based on the charge
state and the m/z value, it represents the complex ion resulting from the loss of a
thymidine (nucleotide) from the  ion. The exact mechanism of the loss of thymine
remains unclear to us at this point. Interestingly, reanalyzing the ESI-MS spectra obtained
from the HCD experiment of the CP9-G4 mixture showed a similar ion with a very low
intensity. Apparently, the loss of thymidine from G5 is much easier than that from G4
probably because the thymidines in G5 are more accessible (located at the both ends of
the sequence). The intramolecular G4 only has one thymine at the end, and its
accessibility is restricted by the loops on top of the G-quartets.
Among the product ions of 1-2 complexes, the ions representing S1 single strand
[S1-3H]3- at m/z 830.81 and [S1-2H]2- at m/z 1247.22 were observed. Interestingly, these
two strands were found as free oligonucleotides without the association of any ligands.
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The sequence of S1 is too short to form certain secondary structures for the binding of
CP9.
All the CP9 containing ions in the spectra have all four NH4+ ions. It was reported
that only ligands intercalating to the G-quadruplex can expel NH4+ ions from the Gquadruplex.140, 244 The preserved NH4+ ions indicated that CP9 must adopt groove
binding and/or end stacking mode.
4.3.6. Thiazole orange derivatives inhibited the telomerase activity in vitro.
Since significant human telomeric G-quadruplex binding was discovered by different
biophysical methods for the TO derivatives, inhibition of telomerase-mediated telomere
extension was studied by a modified 32P-TRAP assay as illustrated in section 3.3.5.
Firstly, the concentration-dependent telomerase inhibition of TO was examined
(Figure 4-23) and inhibition of telomerase was observed when its concentration was
larger than 6.25 µM. To compare the telomerase inhibition of TO derivatives to TO, 6.25
µM was chosen as the concentration to be studied for all the derivatives (Figure 4-24).
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Figure 4-23. 32P-TRAP reactions in the presence of TO at concentrations of 50, 25, 12.5,
6.25, 3.125, 1.56, 0.78 and 0.39 µM (from left to right). Reactions in the presence BIBR
(50 μM) and TMPyP4 (50 μM) were carried out as controls. IS: Internal Standard (TSNT
as template).

For aliphatic amine side chain containing compounds CP1, CP2, and CP3,
telomerase inhibition effect increased with the increasing length of the aliphatic side
chains. CP3 exhibited a higher inhibition effect compared to TO at the same
concentration. This observation is in agreement with the results from our previous
biophysical studies. Hydrophobic side chains cannot provide sufficient interactions for
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the ligands binding. However, a better inhibition effect can be observed when the length
of the side chain is long enough to accommodate the terminal positive charge to the DNA
phosphate backbones.
Polyamine side chain containing compounds CP4, CP5 and CP6 exhibited the
best inhibition effects amongst all twelve derivatives. At 6.25 µM CP6 inhibited both
telomerase elongation and polymerase replication activity. Thus, a concentrationdependent study was necessary for CP6 for the reason explained in section 3.3.5.
Similar to our previous conclusions, CP7 and CP8 with polyethylene glycol
amine side chains and TO acid did not inhibit telomerase activity at 6.25 µM. The
electron-rich oxygen atoms in polyethylene glycol, and carboxylic acid group in TO acid
have the repulsive force with the DNA negatively charged backbones.
Piperidine/pyrrolidine side chains containing compounds CP9, CP10, CP11 and
CP12 inhibited telomerase activity at various levels. CP9, with a pyrrolidine side chain
was the best inhibitor amongst these four ligands which was consistent with the previous
results. Our observations suggested again that pyrrolidine rings had a better G-quadruplex
stabilization compared to piperidine rings.228 CP11 and CP12 showed less inhibition
effect than CP9 and CP10 due to their electronegative side chains.
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Figure 4-24. 32P TRAP reactions in the presence of TO derivatives at a concentration of
6.25 µM. Reactions in the presence BIBR (50 μM), TMPyP4 (50 μM) were carried out as
controls. IS: PCR product as internal standard (TSNT as template).

We conducted concentration studies for the effective compounds including CP4,
CP5, CP6, CP9, CP10, CP11 and CP12. The minimum inhibitory concentration for CP4
and CP5 were 0.63 µM and 1.25 µM respectively (Figure 4-25), which were significantly
lower than the minimum inhibitory concentration of TO (6.25 µM).
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Figure 4-25. 32P TRAP reactions in the presence of CP4 (left) and CP5 (right) at
concentrations of 10, 5, 2.5, 1.25, and 0.625 µM (from left to right). Reactions in the
presence BIBR (50 μM) and TMPyP4 (50 μM) were carried out as controls. IS: PCR
product as internal standard (TSNT as template).

CP6 showed the strongest inhibitory effect on telomerase activity. The minimum
inhibitory concentration was determined as 0.16 µM which was significantly lower than
TO. It is noteworthy that, CP6 adopted a similar structure of polyamine molecule
spermine. The minimum telomerase inhibitory concentration of spermine that determined
by the same assay was higher than 10 µM (Figure 4-26). Therefore, the significant Gquadruplex binding and telomerase inhibition effect of CP6 resulted from the synergistic
effect of the TO core structure and the polyamine side chain (Figure 4-26).
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Figure 4-26. 32P TRAP reactions in the presence of CP6 at concentrations of 10, 5, 2.5,
1.25, 0.625, 0.313, 0.156, and 0.078 µM (from left to right). Reactions in the presence
BIBR (50 μM), TMPyP4 (50 μM) and spermine (100 and 10 μM) were carried out as
controls. IS: PCR product as internal standard (TSNT as template).

Because of the observed remarkable telomerase inhibition effect of CP6, we
compared its activity with one of the best synthetic telomerase inhibitors BRACO-19155,
215, 245

under the same condition (Figure 4-27).
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Figure 4-27. 32P TRAP reactions in the presence of BRACO-19 (left) and CP6 (right) at
concentrations of 10, 2.5, 0.625, 0.156 and 0.039 µM (from left to right). Reactions in the
presence BIBR (50 μM) and TMPyP4 (50 μM) were carried out as controls. IS: PCR
product as internal standard (TSNT as template).

The results suggested that CP6 had a slightly better inhibition effect compared to
BRACO-19. At the minimum inhibitory concentration of 0.625 µM, the reaction in the
presence of CP6 produced less abundant telomerase elongated products than the reaction
in the presence of BRACO-19. However, CP6 had slightly worse selectivity compared to
BRACO-19. At the concentration of 10 µM, CP6 had a stronger inhibition effect for the
polymerase replication.
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Concentration-dependent studies were also performed for CP9, CP10, CP11 and
CP12 (Figure 4-28). CP9 (minimum inhibitory concentration 1.25 µM) exhibited the
strongest inhibition effect among these four ligands but not as good as CP6, and this
observation is highly consistent with the results of CD thermal denaturation and
fluorometric titration experiments. The minimum inhibitory concentrations were around 2.5 µM for CP10, CP11, and CP12. Since piperidine and pyrrolidine side chains were
incorporated into these compounds, PIPER, a known G4 ligand with a similar piperidine
side chain, was examined under the same conditions. At 10 µM, all four TO derivatives
exhibited much greater telomerase activity inhibition than PIPER.

Figure 4-28. 32P TRAP reactions in the presence of CP9, CP10, CP11 and CP12 (from left
to right) at concentrations of 10, 5, 2.5, 1.25, and 0.625 µM (from left to right). Reactions
in the presence PIPER (10 μM), BIBR (50 μM) and TMPyP4 (50 μM) were carried out as
controls. IS: PCR product as internal standard (TSNT as template).
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Overall, the TRAP assay clearly showed that the TO derivative CP6 containing a
polyamine side chain shows excellent inhibition of telomerase activity at a nanomolar
concentration which is comparable to the best developed synthetic telomerase inhibitor
BRACO-19. Conjugating with polyamine side chains at the nitrogen of the quinoline ring
remarkably improved the telomerase inhibition activity of TO and this activity is a
synergistic effect from the aromatic stacking of TO core structure and the electrostatic
interaction from the charged side chain. TO is a suitable scaffold for developing more
potent G4 ligands in the future.
4.3.7. Positively charged side chains decrease the cytotoxicity of thiazole
orange. TO was originally developed as a DNA dye for reticulocyte count in a flow
cytometry. One of the advantages of TO being a live-cell dye is its good cell membrane
diffusion ability, which is also one of the reasons that it was chosen as the core structure
in the present research. After discovering the remarkable telomerase inhibition effect of
CP6 by the TRAP assay, we investigated the cytotoxicity of twelve derivatives against
two telomerase-positive cancer cell lines: HeLa (cervical cancer) and MCF-7 (breast
cancer).
At the concentration of 100 µM, TO was found with cell viability of 20.22% for
HeLa and 40.09% for MCF-7. However, all our TO derivatives exhibited a lower
cytotoxicity value compared to TO (Figure 4-29).
This decreased cytotoxicity was closely related to the high polarity of the
molecules and the consequent low uptake efficiency. Although there are some native
endogenous polar molecules like polyamine present in living cells and can be transported
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into the cell nucleus, specific transport proteins have to be recruited by cells helping them
to pass through the cell membrane.246 The positively charged side chains increase the
polarity of the compounds and consequently decrease their cell membrane diffusion
efficiency.219 Thus, these TO derivatives cannot easily reach the cell nucleus where the
telomeres and telomerase are located. In order to develop these good TO based
telomerase inhibitors into anti-cancer drugs, we propose to explore the drug delivery
system to increase cellular uptake efficiency in collaboration with other groups in the
future.

Figure 4-29. Cell proliferation of two cancer cell lines treated by TO derivatives at 100
µM. The cell proliferation in the absence of a ligand was normalized to 100%.
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4.4. Conclusion
Twelve newly synthesized TO derivatives with positively charged side chains at
the nitrogen of quinoline ring were evaluated by various biophysical techniques for their
G-quadruplex DNA stabilization effects. Marked stabilization effects against human
telomeric G-quadruplexes were found for two of the derivatives with either a polyamine
side chain(CP6) or a pyrroline side chain(CP9). In contrast to TO, these TO derivatives
form 1-1, 1-2 and 1-3 complexes with a human telomeric G-quadruplex with both
stacking and groove binding modes. The binding affinity was significantly enhanced by
these positively charged side chains through electrostatic interactions with DNA
backbones.
In the TRAP assay, CP6 exhibited remarkable telomerase inhibition effect
comparable to BRACO-19, which is the most potent synthetic telomerase inhibitor.
Elongation of telomeric DNA by telomerase was significantly inhibited at nanomolar
concentrations by CP6.
Introducing positively charged side chains to TO decreased the cytotoxicity due
to the higher polarity of the molecules. To utilize CP6, as a strong G4 ligand and
telomerase inhibitor, we will explore suitable drug delivery systems. TO derivatives have
slightly lower quantum yields compared with TO when they bind to DNA. However, the
quantum yields of these compounds are still much higher than other fluorescent G4
ligands; therefore, it is still feasible to use these compounds as highly sensitive Gquadruplex probes with significantly stronger binding affinities than TO.
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A. APPENDIX
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Figure A-1. MS spectrum of Phen12-Ni_50% MeOH
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Figure A-2. MS spectrum of Phen15-Ni_50% MeOH

225

Figure A-3. MS spectrum of Phen18-Ni_50% MeOH

226

Figure A-4. MS spectrum of Phen20-Ni_50% MeOH.
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Figure A-5. MS spectrum of Phen21-Ni_50% MeOH
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Figure A-6. FID G4 titration course of 5-substituted Phen Ni(II) complexes.
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Figure A-9. Concentration study of effective 5-substituted Phen-Ni complexes on tumor
cells.
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Figure A-10. CD thermal denaturation smoothed profiles of TO derivatives.
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Figure A-11. Fluorometric titration of TO derivatives against a duplex 17mer.
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